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This section provides a medium through which
Canadian surgeons can declare themselves,
briefly and informally, on the day-to-day affairs of surgery.
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Breast Lumps — When Is a Cyst Not a
Cyst?
Charles J. Wright, MB, ChB, MSc, FRCSC, FRCS, FRCS(Edin)
Member, Editorial Board, Canadian Journal o f Surgery. Professor, Department o f Surgery,
University Hospital, University o f Saskatchewan, Saskatoon, Sask.

ne of the commonest problems
encountered in the general sur
geon’s office is that of breast cysts.
Fortunately, women with breast
cysts are no longer subjected to
open biopsy for diagnostic pur
poses. The diagnosis is made by
aspiration, and a typical thin,
yellow, brown, green or grey aspi
rate followed by disappearance of
the lump usually leads to a great
sense of relief that the patient’s
condition is benign. The ensuing
conversation with the patient may
go something like this:
“Mrs. Jones, I am pleased to see
that this breast lump is just a cyst.”

O
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1867 Alta Vista Dr.
Ottawa, Ont. K1G 3Y6

“What does this mean then, doc
tor?”
“It is simply a collection of fluid
which is a benign condition.”
“So, it’s not a cancer, doctor?”
“That’s right, but I would like to
re-examine you in a month or so to
make sure there’s no further prob
lem.”
How confident are we that aspira
tion represents appropriate manage
ment? It is a “risk management”
problem, since we know that breast
cysts are most unlikely to be malig
nant. The possibility of cancer can
not be excluded, however, and how
do we deal with the occasional
Tel.: (613) 731-9331

patient who pursues this conversa
tion much further, wishing to know
exactly what is the risk of a breast
cancer in association with the cyst?
We know that analysis and cytolog
ic examination of the cyst fluid
rarely give any useful information.
The article by Devitt in this issue
(pages 356 to 358) provides valu
able information to help answer
these questions. Dr. Devitt de
scribes his extensive experience
over the last 16 years, of 915
women with breast cancer and 812
with a breast cyst, to define the
relationship between the two condi
tions. The questions that his report
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helps to answer are those that often
concern surgeons and women with
breast problems alike. How often
does a cyst actually turn out to be
cancer? How often does a cancer
present with a significant cystic
component? How often does a can
cer coexist with a breast cyst on
presentation? Does cystic disease of
the breast predispose to subsequent
development of cancer?
In Devitt’s analysis four types of
association of breast cysts and can
cer were seen: cystic cancers, simul
taneous cancers and cysts, cysts
occurring after breast cancer and
cancers occurring after breast cysts.
Only 11 of the 915 patients with
breast cancer had fluid aspirated
from the lesion and it is noteworthy
that in most of these either blood
stained fluid was aspirated or there
was a residual mass after aspiration.
The data also demonstrate that this
association occurs almost exclusive
ly in older women. Concerning the
likelihood of breast cancer develop
ing after previous diagnosis of a
breast cyst, Devitt found that, over
16 years of follow-up of the 812
patients with breast cysts (more
than 5000 patient-years), a breast
cancer (11 ipsilateral, 8 contralater
al and 1 bilateral) subsequently de
veloped in 20. This incidence of
breast cancer falls within or close to
the range of the expected incidence
in the adult female population in

Canada. Analysis of these data in a
slightly different way reveals that
only 21 women out of 833 present
ing with cysts had breast cancer at
the time of presentation (11 had
cystic cancers and 10 had simulta
neous cysts and cancer). In other
words, the “pretest probability” of
having cancer in this population
was only 2.5%, even without any
diagnostic tests. After a thorough
clinical examination, aspiration,
fine-needle aspiration biopsy, mam
mography and ultrasonography it is
now unusual not to make a definite
diagnosis.
Devitt’s paper is an excellent ex
ample of how interesting and valu
able a retrospective study can be
when the number of patients is
large enough, when the questions
being asked are appropriate for the
type of study and when the conclu
sions reached are justified by the
data. This study helps us to set
aside the fear of occult cancer oc
curring in a breast cyst, because
this occurrence is extremely rare.
The occasional carcinoma with a
cystic component can be recognized
by the blood-stained nature of the
fluid in the cyst, by the persistence
of a mass after aspiration or by
rapid recurrence of the cyst. I agree
enthusiastically with Devitt’s rec
ommendations that all breast cysts
should be aspirated, but that a
localized mass still present after

aspiration should be excised. In
recent years, fine-needle aspiration
biopsy has enabled rapid and accu
rate diagnosis of breast lesions in
the office. Although not stated by
Dr. Devitt because of the historical
time period of his review, I would
make a further recommendation
that all breast lesions that do not
contain fluid on aspiration should
be subjected to fine-needle aspira
tion biopsy. As to the relation be
tween a breast cyst and the develop
ment of cancer later in life, the risk
is insignificant if it exists at all, and
it would certainly not justify any
special follow-up other than man
agement of lumps detected by the
patient herself. The hypothetical
conversation described in the first
paragraph is indeed appropriate,
and women and their doctors can
continue to feel the sense of relief
when a breast lump is aspirated to
reveal the typical fluid of a benign
breast cyst. The remote possibility
of cystic cancer or associated cyst
and cancer will be covered by the
repeat examination and subsequent
follow-up if indicated. It is never
possible to reassure a woman with
absolute certainty that she does not
have breast cancer, but this recom
mended protocol is a reasonable
compromise and represents appro
priate management of the breast
cancer risk in women with breast
cysts. ■
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T h e General Surgeon and Sepsis in the
Critical Care Unit
Roger G. Keith, MD, FRCSC
Member, Editorial Board, Canadian Journal o f Surgery. Associate Professor o f Surgery,
University o f Toronto, Division o f General Surgery, St. Michael’s Hospital, Toronto, Ont.
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critical care symposium
I nthattheappears
in this issue (pages
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319 to 336), Gregor and Prodger
(pages 331 and 332) acknowledge
that surgeons are becoming more
involved in the management of pa
tients in critical care units. More
importantly, these authors stress
the role of the general surgeon as a
consultant in the intensive care unit
to participate aggressively in the
diagnosis and treatment of septic
complications in critically ill pa
tients. The use of this integrated
approach through communication
with the supervising intensive care
physician is most valuable when
sepsis occurs as a complication of
abdominal surgery, abdominal trau
ma or abdominal disease, causing
an abrupt deviation from the antici
pated course. Knowledge of the
operative treatment, familiarity with
relevant abdominal disease and clin
ical acumen are assets for which the
intensive care physician has no lab
oratory substitute.
In another paper in this issue
(pages 327 to 330), Hamilton has
stressed the lethal consequences of
untreated intra-abdominal sepsis in
critically ill patients. The role of the
surgeon or radiologist as the defini
tive therapist for evacuating an ab
scess is appropriately dealt with in
the author’s description of the diffi
culties of diagnosis, localizing the
source of infection and the effects
of delay of definitive therapy.
Critically ill patients are often
VOL. 31, NO. 5 SEPTEMBER 1988/CJS

immunocompromised, so it is im
portant to differentiate between
generalized peritonitis and localized
abscess formation as the cause of
the sepsis. The course of patients
with generalized peritonitis will
progress from septic shock to mul
tiple organ failure and death more
rapidly than that of patients who
have a localized septic process in
the abdominal cavity. Escherichia
coli is frequently cultured from
blood, sputum, urine and secretions
of patients with sepsis. Growth of
this organism alone may indicate
translocation without a primary in
tra-abdominal focus; however, when
E. coli is one of a number of
organisms cultured, the source of
infection is most likely in the perito
neal cavity. Given that all radiologic
imaging techniques, including ra
dionuclide scanning, require either
a mass lesion or leukocyte aggrega
tion in order to produce positive
results from localization studies, at
tempts at localization will likely be
unsuccessful in patients with gener
alized peritonitis. Prompt surgical
intervention for peritonitis whose
cause has been determined by clini
cal features and results of cultures
will increase survival substantially if
treatment is initiated within 24
hours of diagnosis.1 However, as
Hamilton notes, when blind laparot
omy is carried out for sepsis of
indeterminate etiology and no intra
abdominal focus is identified, mor
bidity and mortality will be high.

The localization of intra-abdomi
nal septic foci will reduce the rate
of organ system failure. According
to the thesis of Fry,2 respiratory
failure occurred simultaneously
with the onset of sepsis in such
patients, but the subsequent devel
opment of organ system failure
ranged from 3 to 9 days. Thus,
accurate localization will allow pre
cise therapy to be instituted. Al
though documentation is not well
stratified, it seems that appropriate
treatment of localized intra-abdomi
nal sepsis can prevent further organ
failure if only one system is com
promised at the time of treatment.3
If intra-abdominal abscess is not
identified by stepwise use of ul
trasonography followed by comput
ed tomography, then radionuclide
scanning with indium-ill-labelled
leukocytes is indicated. This study
is technically complicated, expen
sive and requires 24 hours to com
plete. However, sonographic homo
geneity on ultrasonography and
equivalent tissue density on com
puted tomography may give false
negative results. When attention is
directed to the retroperitoneum by a
positive indium scan, dynamic com
puted tomography will differentiate
perfused from necrotic retroperito
neal tissue. In such cases, abdomi
nal surgery should include thor
ough exploration of the re
troperitoneum. If necrotic tissue is
found, debridement and drainage
are necessary, precluding the use of
301
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percutaneous catheter aspiration.
Several scoring systems have
been introduced to evaluate the
condition of these patients and indi
cate the likely prognosis. Although
each system has different defini
tions and deficiencies, all are based

on prospective studies of large
numbers of patients in multicentre
trials and thus are valid. The gener
al conclusion that in critically ill
patients with sepsis, multiple organ
failure and death will follow if no
treatment is instituted is a logical

»

one. However, acceptance of death
as predicted by the various scoring
systems should not be universally
accepted. Organ failure has been
reversed with eradication of the
initiating disease process. There
fore, continued aggressive therapy

A

1
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is indicated. Without surgical inter
vention, death is assured.
As advised by the authors con
tributing to the critical care sympo
sium in this issue, the continuing
education and training of general
surgeons as consultants in critical

care facilities is mandatory to en
sure appropriate and successful
therapy.
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Reliability of Treadmill
Exercise Test for Patients
With Claudication
To the editors: In their article “A
single treadmill exercise test does
not accurately quantitate claudica
tion” (Can J Surg 1987; 30: 446448), Harris and Meads make a
strong case for carrying out a series
of three treadmill exercise tests to
obtain an accurate assessment of
the walking distance of patients
with intermittent claudication due
to peripheral vascular disease. In a
recent study1 our group found the
reliability of walking endurance
high (r > 0.97, p < 0.0001) for
three tests. The differences between
our results and those of Harris and
Meads may have been due to meth
odology: our subjects were young
and healthy but theirs had peripher
al vascular disease; their treadmill
test consisted of a single speed and
grade (0.67 m /s, 12° incline), ours
was incremental (beginning at 0.25
m /s and 0% grade and increasing
every 90 seconds in either speed or
grade to a maximum of 2.75 m /s
and 20% grade); they conducted
five tests on the same day with
30-minute rests between tests
whereas the interval between tests
for our subjects was 1 week; and
they reported both the time to
claudication and the maximum time
walked (the former more variable
than the latter) whereas our sub
jects had no claudication and we
reported only the maximum time
walked. Although the average within-subject standard deviation in our
study was only 23 seconds, this
corresponds to a 95% confidence
interval of about 92 seconds, which
is of a magnitude similar to that
associated with many of the report
ed benefits of treatment on walking
distance. Therefore, despite the
slight differences in our methods
304

and findings, I agree with Harris
and Meads that the limits of reliabil
ity must be considered when con
clusions are drawn from treadmill
tests of walking distance.
R. Lee Kirby, MD, FRCPC
Department o f Medicine,
Dalhousie University,
Nova Scotia Rehabilitation Centre,
Halifax, NS
B3H4K3

Reference
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To the editors: We thank Dr. Kirby
for his interest in our paper.
We agree with his assessment
that the differences observed may
be largely related to methodology in
our studies. We were able to record
both the onset of muscle pain (in
termittent claudication) and final
muscle exhaustion related to re
duced blood supply to the lower
extremity. In all our patients we
noted a reduction in substrate and
oxygen delivery as measured by the
ankle-brachial pressure index. In
contrast, Dr. Kirby did not measure
ankle pressures. It has been docu
mented in the past, however, that
there is no fall in limb perfusion
with exercise in the normal sub
ject.1 We must therefore question
whether the end points measured
reflect the same pathophysiologic
mechanism.
Dr. Kirby’s patients walked for
considerably longer (mean ± SEM
991.4 ± 27.8 s) than our patients
(252.4 ± 29.4 s), which may serve
to minimize the variation seen in
the walking distance. In addition to
this, Dr. Kirby’s exercise test incor
porates its own training curve with
a slow, non-graded initial walk. Be

cause of the precarious blood sup
ply in our patients, there is limited
time for this within a single walk.
We agree with Dr. Kirby’s view
that the reliability of the treadmill
test must be assessed individually
for each laboratory. However, we
believe that we were assessing dif
ferent parameters in an entirely dif
ferent population and that extrapo
lation of one set of data from the
other may not be appropriate.

*

K.A. Harris, MD, FRCSC
G.E. Meads, MD, FRCSC
St. Joseph's Health Centre,
268 Grosvenor St.,
London, Ont.
N6A 4V2
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Fecal Diversion in Pelvic
Fractures
To the editors: In the March issue
(pages 90 to 92) Dr. N.V. Christou
discussed the use of fecal diversion
in pelvic fractures only in conjunc
tion with associated rectal injuries.
This is surprising. Trunkey1 stated
that fecal diversion is necessary in
all open pelvic fractures to prevent
perineal soiling and sepsis even if
the rectum is not injured. He re
ported that the routine use of fecal
diversion in patients with open pel
vic fractures lowered the death rate
from 50% to 25%.
Rothenberger and colleagues2
also reported a death rate of 50% in
open pelvic fractures not treated by
immediate total fecal diversion. In
their series of 22 patients with open
pelvic fractures, three of eight
deaths directly attributable to the
VOL. 31, NO. 5 SEPTEMBER 79SS/CJS
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pelvic fracture were due to sepsis.
In addition, 4 of the 11 survivors
had infectious complications.
Of the five patients who under
went colostomy immediately, three
survived; the two who died had no
evidence of pelvic infection.2 Simi
larly, Maull and colleagues3 recom
mended total diverting colostomy
with rectal irrigation for all deep
perineal lacerations associated with
pelvic fracture, regardless of wheth
er the rectum was intact, and de
scribed a rapid, simple method of
performing this procedure. Kusminsky and associates4 also recom
mended a diverting colostomy with
all open pelvic fractures.
The rationale for this more ag
gressive approach is to prevent peri
neal wound contamination from
feces and to avoid missing small
rectal injuries in the extensively
traumatized patient.
D. Ross, MD
Resident,
Department o f Surgery,
Dalhousie University,
Halifax, NS
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virtually the same as that used for
percutaneous nonendoscopic gas
trostomy.
Percutaneous gastrostomy, per
formed as an interventional radi
ologic technique, is a safe and rapid
method for gastric or jejunal feed
ing or obtaining decompression and
is associated with minimal morbidi
ty.1'2 This method of gastrostomy
has the advantages of requir
ing only one operator — the inter
ventional radiologist — and can
be performed in patients with highgrade esophageal obstruction, in
which case a fine angiographic
catheter can be maneuvered into
the stomach under fluoroscopic
control for air insufflation. A modi
fication of the standard method,
using balloon inflation of the stom
ach, has also been described for use
in patients with a partial gastrecto
my.3 Ascites is still a contraindica
tion.
For most purposes, the Gray-St.
Louis modification of the Wills—
Oglesby gastrostomy set (Cook,
Markham, Ont.), which is designed
for gastrojejunal feeding or decom
pression, is adequate and avoids the
problem of gastroesophageal reflux.
Wills and Oglesby4 have supplied an
excellent description of the tech
nique of percutaneous gastrostomy.
Richard N. Rankin, MB, ChB, DMRD,
FRCR,FRCPC
Associate Professor,
Department o f Diagnostic Radiology,
University Hospital,
University o f Western Ontario.
London, Ont.
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Percutaneous Gastrostomy
To the editors: The article by Deitel
and colleagues in the March issue
(pages 102 to 104) is interesting in
that the “introducer” technique is
VOL. 31, NO. 5 SEPTEMBER 1988/CiS

neous gastrostomy in a patient with par
tial gastrectomy. Radiology 1988; 167:
69-70
4. W ills JS, O glesby JT: Percutaneous gas
trostomy. Ibid: 41-43

To the editors: The radiologic per
cutaneous nonendoscopic gastros
tomy is a useful technique. Howev
er, the percutaneous endoscopic
gastrostomy has the advantage that
the light of the scope can be visual
ized, positioned precisely and pal
pated against the anterior abdomi
nal wall (further confirmed by visu
alizing endoscopically an indenta
tion made on anterior gastric wall
by the surgeon’s finger), ensuring
that the catheter is indeed inserted
into stomach. Furthermore, we
have sometimes noted on endosco
py that the balloon or mushroom
was not against the anterior gastric
wall when the abdominal surgeon
felt resistance and believed that
there was no further “ give” ; the
endoscopist then directed a further
pull, which apposed and sealed the
stomach against the anterior ab
dominal wall. The balloon or mush
room must be visualized against the
anterior gastric wall to prevent peri
tonitis and infusion of diet into the
peritoneal cavity. All techniques
have their complications, and we
are aware of nonendoscopic inser
tion into interposed small bowel and
also of gastric leak and peritonitis
by one of the radiologists in Dr.
Rankin’s references, subsequent to
his quoted paper.1
Mervyn Deitel, MD, FRCSC, FACS
Professor,
Department o f Surgery and Department
o f Nutritional Sciences,
University o f Toronto,
St. Joseph’s Health Centre,
Toronto, Ont.
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W ounds of the Abdomen.
Part 2: In Peace
A.C. Derby, MD, FRCSC
Until the mid 1960s in the United States, penetrating abominal wounds in civilians
were badly handled and often fatal. Little attention was paid to the methods used and
results reported by military surgeons in previous wars such as those in Korea and
Vietnam. In 1966 the National Academy of Sciences, National Research Council
Committee on Shock pointed out that there was an increasing incidence of severe
civilian injuries associated with unacceptably high morbidity and mortality and that
this was because of lack of organized civilian community care. As a result the
Trauma/Emergency Medical Service (T/EMS) was formed. The initiators based the
organization on the remarkable success of military concepts and techniques.
The improvement in the evacuation and treatment of penetrating abdominal
wounds in peace from the inception of the T/EMS to the present is described in this
paper. The methods used and results obtained through the T/EMS have made an
important contribution to both civilian and military surgery — a unique event in
peacetime.
Aux Etats-Unis, jusqu’au milieu des annees 1960, les plaies penetrantes abdominales subies en temps de paix etaient traitees de fa?on inadequate et elles etaient
souvent fatales. On pretait peu d’attention aux methodes et aux resultats signales
par les chirurgiens militaires au course des guerres precedentes. En 1966, les
Comites sur le choc de l’Academie nationale des sciences et du Conseil national de
recherche signalaient une augmentation de l’incidence des blessures graves chez les
civils, lesquelles etaient accompagnees d’une morbidity et d’une mortality inacceptablement elevees, a cause du manque de soins communautaires bien organises chez
les civils. En consequence, les services medicaux d’urgence pour traumatises furent
constitues. Les promoteurs etablirent les fondements de cet organisme sur le succes
des concepts et des techniques militaires.
On decrit l’amelioration des methodes d’evacuation et de traitement des blesses
souffrant de plaies penetrantes abdominales, depuis la mise sur pied des services
medicaux d’urgence pour traumatises a la fin des annees 1960, jusqu’a nos jours. II
est demontre que les methodes et les resultats des services medicaux d’urgence pour
traumatises ont contribue de fa?on importante a la chirurgie civile de meme que
militaire, ce qui constitue un evenement exceptionnel en temps de paix.
of well-trained person
B ecause
nel, adequate equipment and

supplies, adherence to sound princi
ples of military surgery and the
introduction of such innovative
measures as direct helicopter eva

cuation from battlefield to hospital,
97.5% of those wounded in the
Vietnam War survived. This was
not the case in the United States.
Van Wagoner1 examined the hospi
tal charts and autopsy reports of
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606 American soldiers who were
accidentally injured and died in hos
pital during the years 1957 to 1959
inclusive. The military kept good
records, but the same cannot be
said for the hospitals where they
died. Moreover, the management at
these hospitals was poor. One-sixth
would have survived with the most
basic prompt diagnosis and treat
ment, a further sixth received such
limited treatment that they too
would likely have recovered with
adequate care. Over one-half of the
remainder died of uncomplicated
head injuries.
Van Wagoner’s findings were
confirmed by a number of autopsy
studies related to fatal traffic ac
cidents.2-5 Even allowing for the
scanty records, Van Wagoner be
lieved that the loss of life among
healthy young men at that time was
appalling and that a serious prob
lem existed. The United States Na
tional Academy of Sciences agreed.
As a result, in the late 1960s, the
Trauma/Emergency Medical Ser
vice (T/EMS) was formed. This
organization was based primarily on
military experience. Since then the
treatment of injured civilians has
greatly improved.6-7 In this paper I
review the improved facilities and
treatment of wounds of the abdo
men in civilians.

Prehospital Treatment and
Patient Assessment
When helicopter service for the
evacuation of the seriously injured
was established, minimum stan307
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dards were set for personnel and
equipment for ground and air am
bulances. Paramedics were trained
and certified as emergency medical
technicians and had the ability to
perform advanced life-saving mea
sures under the direct supervision
of skilled medical personnel by twoway radio. Aprahamian and col
leagues8 and Jacobs and associates9
reported on the effect of paramedics
in reducing mortality in severe trau
ma.
Hospitals were graded according
to availability of equipment and
supplies and the presence of medi
cal and surgical specialists. To the
best equipped and staffed hospitals,
designated as trauma centres, the
most seriously injured were evacu
ated. Patients with minor problems
were sent to hospitals with lower
grading.
The pneumatic antishock gar
ment (PASG) was introduced in the
late 1960s, but its use is controver
sial.1011 Its ability to improve ve
nous return is in doubt and its use
is associated with such complica
tions as anterior compartment syn
drome, crush syndrome and in
creased intracranial pressure in
those with head injuries. It is most
beneficial in tamponading intra
abdominal or retroperitoneal he
morrhage and in splinting fractures.
Scales for measuring injury se
verity now exist. The most popular
is the injury severity score (ISS)
developed by Baker and associ
ates.12 Each injured area of the
body is assigned a score on a scale
of one (minor) to five (critical, sur
vival uncertain). The three highest
regional scores are then squared
and added together for a maximum
of 75 — the higher the total the
more severe the trauma.
Recently Sacco and colleagues13
have advocated a numerical trauma
score. It is a physiologic measure of
the severity of injury that incorpo
rates the Glasgow Coma Scale and
308

the cardiovascular and respiratory
systems. Standard numbers are as
signed on a sliding scale. When
combined with other information,
the trauma score provides an accu
rate indication of the patient’s sta
tus and assists in triage. Since there
is less room for variation of inter
pretation, this scale should be of
more value than earlier scoring sys
tems.

Initial Care in Trauma Centres
Rapid assessment of the patient
to ensure adequate airway, control
of external hemorrhage and replace
ment of blood volume loss is still
the keystone in the resuscitation of
the injured patient on arrival at the
trauma centre. Immediate rapid in
fusion of a balanced salt solution, if
necessary, should be carried out
through two to three ports until
blood is available to expand not
only plasma but also interstitial tis
sue.14 Monitoring of central venous
pressure, blood gas determinations,
insertion of an arterial line and
occasionally a Swan-Ganz catheter
and a volume respirator will be
indicated in the profoundly shocked
patient. Dopamine15 and dobutamine, which improve cardiac output
but do not increase peripheral vas
cular resistance, are most advanta
geous in low to medium doses.
The use of type 0 unmatched
whole blood and packed cells is
gaining popularity16 because both
are immediately available and no
recorded reaction or later develop
ment of blood group antibodies has
been noted; further, packed cells in
saline can be warmed as can the
blood.
Since the Vietnam War, when its
use was limited, autotransfusion
has continued to arouse inter
est.1718 Autotransfusion obviates
such problems as transmission of
disease and provides a ready source

of blood when a blood bank is not
available.

Surgical Management
Vascular Injuries

In previous wars, including Viet
nam, the cause of early death in
abdominal wounds was predomi
nantly hemorrhage. Patients with
abdominal wounds in profound
shock who reached the advanced
surgical centre alive frequently died
in the resuscitation ward or in the
operating room in spite of attempts
to re-establish blood volume and to
control bleeding. The most striking
advance in the treatment of abdomi
nal wounds by the T/EMS has been
the heroic attempts to control
major hemorrhage from the retroperitoneum and to treat associat
ed injuries to the duodenum, pan
creas, kidney and other retroperito
neal structures. The reported inci
dence of abdominal vascular inju
ries in civilians19 was much higher
than in the military20 because civil
ian handguns are less powerful than
artillery and rockets and, therefore,
more patients reached hospital
alive. Furthermore, it has been
proved that trained paramedics
using advanced life-support meth
ods have significantly increased the
number of exsanguinating patients
who reach hospital alive. If, in spite
of rapid resuscitation with two or
three units of Ringer’s lactate solu
tion followed by two or three units
of group 0 whole blood or packed
cells through two or three ports,
the patient’s condition remains un
stable with a blood pressure of less
than 80 mm Hg systolic, surgery is
indicated. One of two procedures
may be used — a left thoracoto
my2122 with proximal temporary
aortic occlusion followed by lapa
rotomy or laparotomy to gain proxi
mal control by a rapid generous left
VOL. 31, NO. 5 SEPTEMBER 1988/CSS
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retroperitoneal exposure in the case
of the aorta and its major branches,
and the use of an abdominal com
pressor.23-26 Occlusion clamps are
placed precisely immediately proxi
mal and distal to the injury. Repair
is carried out mostly by lateral
aortorrhaphy or patch grafting. Oc
casionally, resection and end-to-end
anastomosis or interposition graft
ing is necessary. Major aortic
branches, such as the superior mes
enteric, on occasion are transplant
ed further down the aorta.
Exposure of the vena cava or the
portal vein is best obtained by mobi
lizing the right colon, hepatic flex
ure, duodenum and pancreas, dis
placing them to the left.2728 In the
majority of cases, once the site of
bleeding is ascertained, the he
morrhage can be controlled by fin
ger pressure or a sponge stick
followed by application of vascular
clamps. Repair is possible in most
cases by lateral venorrhaphy. A pos
terior hole may be repaired through
an elongated anterior injury prior to
its repair. Suprarenal vena caval
injuries may require innovative
shunting techniques. Shunts may
be inserted through the right atrial
appendage or the infrarenal vena
cava.
The death rate from wounds of
the aorta has varied from 30% to
70%, depending on the site of the
wound and whether there were as
sociated gastrointestinal or major
vascular injuries.23-26 The death
rate from wounds of the suprarenal
aorta is high because of the vessel’s
inaccessibility. Mattox and col
leagues26 suggested that by mobiliz
ing the left colon, spleen, left kid
ney and tail of the pancreas upward
and to the right, better exposure
can be obtained. The line of Toldt is
initially divided by sharp dissection
followed by blunt dissection to ex
pose the aorta from the esophageal
hiatus to the iliac vessels.
In vena caval injuries, recovery
VOL. 31, NO. 5 SEPTEMBER 1988/CJS

depends on the location of the
injury. It varied from 70% in renal
and infrarenal injuries27 to 0% to
30% in suprarenal and intra- and
suprahepatic injuries.27 Trauma to
the portal vein system is associated
with a mortality of 39%.29 These
figures are remarkable considering
that Rich and associates20 reported
on 1000 major vascular repairs in
Vietnam, of which only 9 were in
cases of abdominal injury and all
were no higher than the common
iliac vessels. Hemorrhage is the
overwhelming cause of death in
major vascular injuries. Some inju
ries are so extensive that, despite all
efforts, exsanguination is inevitable.
Other patients die as a result of
slow oozing. Kashuk and col
leagues30 suggested that the coagu
lation defects were exaggerated by
hypothermia and acidosis, leading
to hemorrhage. They recommended
administration of fresh-frozen plas
ma with every 4 units of banked
blood and platelet concentrates with
the fifth unit and every subsequent
10 units. If bleeding continued,
fresh whole blood should be admin
istered. Acidosis should be combat
ted by restoring blood volume to
normal, if possible, and maintaining
pH at 7.2 with the use of sodium
bicarbonate. Hypothermia should be
controlled by preheating all intrave
nous fluids and always keeping the
patient warm. At operation, warmed
fluids should be used for intracavi
tary lavage (thoracic and abdomi
nal) and heated moisturized oxygen
administered with anesthesia.
Pancreatic, Renal and Hepatic
Injuries

Control of massive bleeding is the
top priority in pancreatic injury.3132
Once it is controlled, the entire
duodenum can be mobilized using a
Kocher maneuver. The condition of
the head and tail of the pancreas is
assessed by entering the lesser sac.

The questions to be answered are:
are the superior mesenteric artery,
vena cava, portal vein and pancreat
ic duct intact? Is the duodenum
viable and intact, and are the unci
nate process and the common duct
spared? Minor pancreatic injuries
such as contusions, capsular tears
or lacerations with no involvement
of the main duct system require
only hemostasis and drainage.
Major lacerations, extensive hema
tomas or main duct disruption in
the body or tail require distal pan
createctomy with closure or Rouxen-Y drainage into a jejunal loop.
Large hematomas, lacerations or
disruptions of the head of the pan
creas necessitate either pancreatoduodectomy or duodenal diverticulization. This procedure con
sists of vagotomy, hemigastrecto
my, tube duodenostomy and gas
trojejunostomy. The results of
major pancreatic, duodenal and
combined injuries using this tech
nique have reduced the death rates
in the past 10 years from as high as
33% to as low as 9%.3334
The approach to the retroperito
neal hematoma associated with kid
ney damage35 has been upgraded in
the past 15 years; 85% of cases can
now be treated conservatively.35 An
intravenous pyelogram or computed
tomogram demonstrating extravasa
tion of urine into Gerota’s fascia or
a nonfunctioning kidney or pedicle
injuries involving the renal vessels
are the indications for surgery. At
operation, it is imperative first to
control the renal vessels at the
pedicle with tapes before exploring
the kidney. In the majority of in
stances, repair or partial nephrecto
my is possible. In this way, total
nephrectomy seldom is indicated.
Published series36 on liver dam
age in civilians have usually reflect
ed a less severe injury than that
sustained in military conflict — the
death rate being between 12% and
20%. The management of liver inju309
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ries adopted in the Vietnam conflict
is still the accepted method of treat
ment.37
Postoperative Care
The majority of patients with
multiple trauma and high injury
severity scores (ISS), particularly
those with abdominal wounds and
sepsis, die postoperatively of multi
ple organ failure (MOF). It is postu
lated38 that because of persistent
hematomas, necrotic tissue, abscess
formation, peritonitis, free pancreat
ic enzymes and other prolonged
complement activation, polymor
phonuclear leukocytes are induced
to release prostaglandins and toxic
oxygen radicals. This leads to endo
thelial damage and permeability
edema that limit oxygen diffusion,
not only to the primary site but to
other vital organs, resulting in
anoxia and organ failure.
Prevention is the first step. Car
diovascular and renal failure can be
reduced by early aggressive resusci
tation to shorten the period of
hypotension. Immediate control of
hemorrhage when possible is essen
tial. At the time of surgery debride
ment must be adequate, hematomas
must be drained, blood clots re
moved from the abdominal cavity
and fractures splinted.
The management of established
MOF has two approaches: the un
derlying cause must be treated and
the failing organ must be support
ed. Because sepsis will be responsi
ble in 70% of cases39 therapy is
directed toward control of infection.
Antibiotics must be given before
and after operation. At laparotomy,
thorough examination of the abdo
men is carried out and sound surgi
cal principles are used to manage
abdominal wounds.
Driver and colleagues40 found
that in 70 of 782 patients with
abdominal wounds requiring reoper
ation, 45.5% had intra-abdominal
310

abscesses and 12.1% peritonitis.
Clinical signs of abscess after sur
gery for penetrating abdominal
wounds are often unimpressive;
awareness is usually the first step in
diagnosing an intra-abdominal ab
scess. Diagnosis is confirmed when
possible by roentgenography, ul
trasonography, sinography or com
puted tomography. However, celi
otomy may be indicated if tests are
negative but organ dysfunction and
the septic state continue.
Polk and Shields41 noted that
death rates with surgical drainage
of intra-abdominal abscesses post
operatively ranged from 21% to
50% in published reports. Even
these figures indicate a salvage rate
of 50% to 67% of patients who
otherwise face almost certain death.
If ventilation problems are antici
pated, controlled ventilation with a
volume respirator should be contin
ued postoperatively. Border42 dem
onstrated a marked reduction in the
death rate from adult respiratory
distress syndrome by the immediate
fixation of fractures, permitting
early ambulation. Oliguria, despite
adequate hydration, suggests posttraumatic renal insufficiency, which
can be managed by hemodialysis.
Adequate cardiac output should
be maintained, using inotropic
agents early, such as isoproterenol,
dopamine and epinephrine (a com
mon denominator in multiple sys
tem failure may well be a marginal
cardiac output with a reasonable
arterial pressure but inadequate
organ flow).
The frequency of stress ulcer
ation can be reduced by keeping the
stomach empty and administering
antacids through nasogastric tube
to maintain a gastric pH between 6
and 7.
Corrigan and associates43 have
shown that patients with septicemia
who are hypotensive have changes
in the coagulation system compati
ble with intravascular clotting. Hep

arin is given in such cases to pre
vent episodes of diffuse coagula
tion. The need for immediate nutri
tional support to prevent malnutri
tion (catabolism and anergy) has
been advocated.44-46

Comment
The overall mortality in penetrat
ing wounds of the abdomen, as
reported from trauma centres over
the past 15 years, varies between
7.4% and 12.7% (Moore EE: Per
sonal communication, 1986).47-49
These figures compare favourably
with the rates of from 2.4% to 10%
reported from the Vietnam War.37
With experience gained from the
T/EMS, advances in the treatment
of penetrating abdominal wounds
do not have to await the experi
ences gained through another war.
The Ben Staub Hospital in Hous
ton, Texas, reported receiving 1545
trauma patients in 1979,50 81% of
whom had penetrating wounds.
Sixty percent of the penetrating
wounds were caused by gunshots
and over 50% of these were abdomi
nal wounds that required laparoto
my for management.
The military surgeon must keep
abreast of peacetime advances in
the treatment of trauma and partic
ularly of gunshot wounds.
Freeark51 recently noted that ac
cident hospitals in the US will be
come semi-autonomous units treat
ing only trauma patients and simu
lating the “one hospital” concept
so successful in Vietnam. He also
suggested that the hospitals be
staffed by a new kind of health care
professional, a fulltime employee
who will choose to devote his or her
career to the care and rehabilitation
of the injured. To maintain the high
standard of military surgery in fu
ture wars it may be imperative that
our military surgeons be trained in
traumatology. It could also have
VOL. 31, NO. 5 SEPTEMBER 1988/CiS
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specific application to the surgeon
who elects to work in isolated or
small communities in Canada.
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Dalacin C Phosphate Sterile Solution
(clindamycin phosphate)

Antibiotic
Recommended Applications
Action: Clindamycin exerts its antibacterial effect by causing cessation of protein synthesis and also by
causing a reduction in the rate of synthesis of nucleic acids.
Indications: Dalacin C Phosphate (clindamycin phosphate) is indicated for the treatment of infections
where the oral route is not indicated or feasible.
Dalacin C Phosphate is indicated in the treatment of serious infections due to sensitive anaerobic
bacteria, such as Bacteroides species, peptostreptococcus, anaerobic streptococci, Clostridium
species and micro-aerophilic streptococci.
Dalacin C Phosphate is also indicated in serious infections due to sensitive Gram-positive organisms
(staphylococci, including penicillinase-producing staphylococci, streptococci and pneumococci)
when the patient is intolerant of, or the organism resistant to other appropriate antibiotics.
Contraindications: The use of Dalacin C Phosphate (clindamycin phosphate) is contraindicated in
patients previously found to be hypersensitive to this compound, the parent compound, clindamycin, or
clindamycin palmitate. Although cross-sensitization with Lincocin® (lincomycin hydrochloride) has not
been demonstrated, it is recommended that Dalacin C Phosphate not be used in patients who have
demonstrated lincomycin sensitivity.
Until further clinical experience is obtained, Dalacin C Phosphate is not indicated in the newborn (in
fants below 30 days of age), or in pregnant women.
Warnings: Some cases of severe and persistent diarrhea have been reported during or after therapy
with Dalacin C Phosphate (clindamycin phosphate). This diarrhea has been occasionally associated with
blood and mucus in the stools and has at times resulted in acute colitis. When endoscopy has been
performed, some of these cases have shown pseudomembrane formation.
If significant diarrhea occurs during therapy, this drug should be discontinued or, if necessary, con
tinued only with close observation. Significant diarrhea occuring up to several weeks post-therapy
should be managed as if antibiotic-associated.
If colitis is suspected, endoscopy is recommended. Mild cases showing minimal mucosal changes
may respondtosimpledrugdiscontinuance.Moderatetoseverecases.includingthoseshowingulceration or pseudomembrane formation, should be managed with fluid, electrolyte, and protein
supplementation as indicated. Corticoid retention enemas and systemic corticoids may be of help in
persistent cases. Anticholinergics and antiperistalticagents may worsen the condition. Other causes
of colitis should be considered.
Studies indicate a toxin(s) produced by Clostridia (especially Clostridium difficile) may be a principal
cause of clindamycin and other antibiotic-associated colitis. These studies also indicate that this
toxigenic Clostridium is usually sensitive in-vitro to vancomycin. When 125 mg to 500 mg of vanco
mycin were administered orally four times a day for 5 -1 0 or more days, there was a rapid ob
served disappearance of the toxin from faecal samples and a coincidental recovery from the diarrhea.
It should be noted that serious relapses have occurred up to one month after apparently successful
treatment. A relatively prolonged period of continuing observation is therefore recommended.
Precautions: Dalacin C Phosphate (clindamycin phosphate), like any drug, should be prescribed with
caution in atopic individuals. Dalacin C Phosphate must be diluted for intravenous administration.
(See Dosage and Administration)
The use of antibiotics occasionally results in overgrowth of nonsusceptible organisms - particularly
yeasts. Should superinfections occur, appropriate measures should be taken as dictated by the
clinical situation.
As with all antibiotics, perform culture and sensitivity studies in conjunction with drug therapy.
Since abnormalities of liver function tests have been noted occasionally in animals and man, periodic
liver function tests should be performed during prolonged therapy. Blood counts should also be
monitored,during extended therapy.
Dalacin C Phosphate may be used in anuretic patients. Since the serum half-life of clindamycin in
patients with impaired hepatic function is greater than that found in normal patients, the dose of
Dalacin C Phosphate should be appropriately decreased. Hemodialysisand peritoneal dialysis are not
effective means of removing the compound from the blood. Periodic serum levels should be deter
mined in patients with severe hepatic and renal insufficiency.
Adverse Reactions: Local
(a) Intramuscular Injections: Of 404 patients treated with Dalacin C Phosphate (clindamycin
phosphate) intramuscularly (with a solution containing 150 mg/ml), six (1.5%) demonstrated local
reactions as follows: Two complained of pain at the injection site, two demonstrated induration at
the injection site and two developed sterile absesses.
(b) Intravenous Infusions: Of 192 patients treated with Dalacin C Phosphate by intravenous infusion,
14 (7.3%) demonstrated local reactions. Eleven patients developed superficial thrombophlebitis and
one patient developed both superficial and deep thrombophlebitis. The majority of these cases
developed inconjuctionwiththeuseofindwellingI.V.cathetersanditisdifficulttoknowhowmuchthe
drug contributed to the irritation. Two patients developed localized erythema, swelling and pain at
the site of the infusion.
Systemic Side Effects: Twenty-eight patients of 596 treated with Dalacin C Phosphate (clindamycin
phosphate) by either the intramuscular or intravenous routes developed systemic side effects as follows:
Number o f Patients
Rash......................................................................................................................................................... 7
Urticaria................................................................................................................................................... 1
Pruritus..................................................................................................................................................... 1
Fever, Leucocytosis................................................................................................................................. 1
Nausea, with or without vomiting.......................................................................................................... 1
Diarrhea (See also under "Warnings')..................................................................................................... 4
Hypotension............................................................................................................................................. 1
Hypertension............................................................................................................................................ 1
Shortness of B'eath................................................................................................................................ 1
Superinfection'....................................................................................................................................... 4
Cardiac arrest* * ...................................................................................................................................... 1
Bad or bitter taste in mouth.................................................................................................................... 5

**

Superinfection is a complication of antibiotic therapy in general and is not necessarily a true side
effect of clindamycin phosphate.
Due to underlying myocarditis in this patient.

Clinical and Laboratory Findings: Patients treated during clinical trials of Dalacin C Phosphate
(clindamycin phosphate) were followed with clinical laboratory tests, including complete hematology,
urinalysis and liverand kidney function tests. Some of these tests were abnormal initially and returned
to normal during therapy with Dalacin C Phosphate, while others were normal initially and became
abnormal,during therapy. Overall evaluation of clinical laboratory values in these patients does not
indicate that Dalacin C Phosphate therapy has a toxic effect on the hematopoietic, hepatic or renal
systems. Transient elevations of serum transaminases have occured in some patients, but other liver
function tests (alkaline phosphatase, serum bilirubin) have not shown any tendency to increase and
there have not been clinical signs of drug-induced hepatic toxicity.
Symptoms and Treatment ot Overdosage: No cases of overdosage have been reported. No specific
antidote is known. Doses as high as 1200 mg every six hours (4800 mg/day) by infusion for five days
have been given without adverse effects.
DOSAGE AND ADMINISTRATION
Adults
Intramuscular Injection: 600 mg/day in 2 equal doses.
Moderately severe infections: 600 to 1200 mg/day in 2 or 3 equal doses.
Severe infections: 1200 to 2400 mg/day in 2,3 or 4 equal doses. Intramuscular injections of more than
600 mg into a single site are not recommended.
Intravenous Administration: Dalacin C Phosphate (clindamycin phosphate) must be diluted prior to
I V. administration to a dilution of 300 mg in 50 mL of diluent (6mg/mL) or more, and infused in not less
thanlOminutes. Administration of more than 1200mg inasingle 1 hourinfusionisnot recommended.
Dalacin C Phosphate should not be injected intravenously undiluted as a bolus.
Moderately severe infections: 900 to 1800 mg/day by continuous drip or in 2 or 3 equal doses, each
infused over 20 minutes or longer.
Severe Infections: 1800to 2700 mg/day by continuous drip or in 3 or 4 equal doses, each infused over
20 minutes or longer. In life-threatening infections, doses of 2700to 4800 mg/day by continuous drip or
in 3 or 4 equal doses each infused over 20 minutes or longer may be given.
Dilution and infusion rates:
Dose
Diluent
Time
300 mg
50 mL
10 min.
600 mg
100 mL
20 min.
900 mg
150 mL
30 min.
1200 mg
200 mL
45 min.
Alternatively, drug may be administered in the form of a single rapid infusion of the first dose followed
by continuous I.V. infusion as follows:
To maintain serum
Rapid
Maintenance
clindamycin levels
infusion rate
infusion rate
Above 4 mcg/mL
10mg/m in.for30min.
0.75 mg/min.
Above 5 mcg/mL
15mg/m in.for 30 min.
1.00 mg/min.
Above 6 mcg/mL
20 mg/min. for 30 min.
1.25 mg/min.
Children: (Over one month of age)
Intramuscular injection: 10 to 15 mg/kg/day in 2,3 or 4 equal doses.
Moderately severe infections: 15 to 20 mg/kg/day in 3 or 4 equal doses.
Severe infections: 20 to 30 mg/kg/day in 3 or 4 equal doses.
Intravenous Administration:
Moderately severe infections: 15 to 25 mg/kg/day by continuous drip or in 3 or 4 equal doses, each
infused over 20 minutes or longer.
Severe infections: It is recommended that children be given no less than 300 mg/day regardless of body
weight. (Dilute Dalacin C Phosphate Sterile Solution in the same manner as for adults.)
Dilution and Compatibility:
4 mL (600 mg) Dalacin C Phosphate when diluted with 1000 m t of the following commonly used in
fusion solutions was found to be physically compatible and demonstrated no significant change in pH
or antimicrobial potency over a period of 24 hours:
Sodium chloride injection
Dextrose 5% in water
Dextrose 5% in saline
Dextrose 5% in Ringer’s Solution
Dextrose 5% in half-strength saline plus 40 mEq potassium chloride
Dextrose 21/2% in Lactated Ringer's Solution (Hartmann s Solution)
Dalacin C Phosphate was not stable when added to Dextrose 5% in water plus vitamins. Therefore it is
not recommended that Dalacin C Phosphate be mixed with any infusion solution containing B vitamins.
Supplied:
Dalacin C Phosphate contains the following per mL of sterile solution:
Clindamycin phosphate equivalent to clindamycin base 150 mg
Benzyl alcohol 5 mg
Disodium edetate 0.5 mg
Water for injection q.s.
When necessary the pH is adjusted with sodium hydroxide and/or hydrochloric acid to maintain a pH
range of 5.5 to 7.0.
Dalacin C Phosphate is available in 2 mL and 4 mL ampoules.
NOTE: Do not store below 15°C.
Product Monograph available upon request.
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Intraoperative Doppler Flow Studies:
Emphasis on Colour Mapping
W.J. Duncan, MD, FRCPC;* M.J. Tyrrell, MB, BS, FACC, FRCPC;* B. Bharadwaj, MD, FRCSC;t
S.K.S. Iyengar, MB, BS, FRCSCt
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Colour Doppler flow imaging (CD) is a well-established method of assessing valvular
and congenital disease of the heart. The technique has proven useful
intraoperatively in patients undergoing valve repair or replacement or intracardiac
reconstruction.
In 21 patients with various cardiac anomalies, colour Doppler flow imaging was
used intraoperatively, before cardiac cannulation and again after cardiopulmonary
bypass. Previously undisclosed features were demonstrated preoperatively in two
patients and important residual defects after cardiopulmonary bypass in three
others. Adequacy of valve replacement was confirmed in four patients and small
leaks in ventricular septal defect patches were shown in another three. The
procedure facilitated repair of complex cardiac fistulas in two patients. There were
no apparent complications from CD.
As intracardiac repairs become more complex, the role of intraoperative CD will
expand.
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La visualisation couleur du debit sanguin par systeme Doppler est une methode
reconnue devaluation des maladies cardiaques valvulaires et congenitales. Cette
technique a demontre son utilite durant l’operation chez les patients qui subissent
une valvuloplastie, un remplacement valvulaire ou une reconstruction cardiaque.
Chez 21 patients souffrant de diverses anomalies cardiaques, la visualisation
couleur du debit sanguin par systeme Doppler a ete utilisee durant Tintervention,
avant le catheterisme cardiaque ainsi qu’apres la circulation extracorporeile. Des
caracteristiques prealablement inconnues ont ete demontrees preoperativement chez
deux patients et des effets residuels importants ont ete deceles chez trois autres,
apres circulation extracorporeile. La reussite du remplacement valvulaire fut
confirmee chez quatre patients, alors que de petites fuites a partir des plaques
refermant la paroi ventriculaire etaient revelees chez trois autres. Ce procede a
facility la reparation de fistules cardiaques complexes chez deux patients. On n’a
observe aucune complication apparente attribuable a la visualisation couleur du
debit par systeme Doppler.
Avec la complexity toujours plus grande des reparations cardiaques, le role de la
visualisation couleur par systeme Doppler est destine a s’etendre.
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ince the advent of open-heart
surgery, cardiac surgeons have
had to rely on postoperative studies
to assess the efficacy of their opera
tions. In the past, at the end of
cardiopulmonary bypass, subjective
observations on cardiac filling and
contractility would be made. A
search for thrills that could indicate
a persistent regurgitation and a
review of waveforms from indwell
ing lines or temporary needle mea
surements from various heart cham
bers would follow. The results of
such studies were vague and did
not answer the important question,

S

have we done the best operation
technically possible for our patient?

We review our experience with col
our Doppler flow imaging, a new
technique that can help to answer
this question.

History
Several reviews1"8 have demon
strated the applicability of intraop
erative ultrasonography.
The use of M-mode (single crys
tal) echocardiography in the operat
ing room was reported as early as
1972.1 With technical advances,
two-dimensional imaging systems
were introduced, providing useful
anatomical information after in
tracardiac repairs.2
The mating of Doppler flow infor
mation to two-dimensional echocar
diography supplemented intraopera
tive knowledge because two impor313
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tant parameters of cardiac flow,
velocity and output, could be deter
mined noninvasively.3
In 1984 sophisticated imaging
systems employing colour flow
mapping were introduced commer
cially; these gave cardiovascular
surgeons a powerful new tool for
intraoperative assessment of the
heart.4-8

The Device
Colour Doppler flow imaging
(CD) uses a computer-like device
called an autocorrelator to separate
and distinguish the minor ultra
sound frequency shifts (Doppler
shift) occurring over a defined area.
These variations are depicted as

colours relative to the transmitted
frequency. With the system used in
this article, blood flowing toward
the transducer is shown in red
(positive Doppler shift), the con
verse in blue. The colour flow infor
mation provides an overlay to the
cardiac walls and valves as depicted
by amplitude imaging ultrasound
signals (Fig. 1). The physics of this
system, as in all pulsed Doppler
systems, limits the measurable ve
locity for a given depth and fre
quency (Nyquist limit); hence, if the
blood is flowing faster than the
Doppler system can measure at a
given setting, the colour will
“alias” and the blood flow appear
to have reversed direction. Turbu
lent and very high velocity blood
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FIG. 1 — Schematic diagram of echocardiographic colour Doppler system.

Fig. 2a

flow will have a mosaic or confetti
like appearance because of the
swirling effect. A complete review
of the instrument is beyond the
scope of this article, but Omoto9
and Duncan10 have discussed the
technique in detail elsewhere.

Intraoperative Method and
Results
We adopted a cost-effective meth
od of intraoperative CD in 21 pa
tients with various cardiac anoma
lies. Instead of undertaking 24-hour
gas sterilization of the transducer,
which means buying two transdu
cers or using a transesophageal
transducer (costing approximately
$30 000), we place the instrument
inside a sterile bowel bag containing
a generous amount of airless gel.
The operator, scrubbed, gowned
and gloved, places the bag directly
on the epicardium to start the re
cording. We frequently perform pre
operative studies after cannulation
but before initiating cardiopulmo
nary bypass. A complete echocardiographic study is carried out using
the standard technique.4 Views are
obtained of all valves, septa, cham
bers and cannulation sites. Any dis-

Fig. 2b

FIG. 2 — Case 2. (a) “Four-chamber equivalent” view showing blue jet (arrowheads) of systolic periprosthetic regurgitation
passing from left ventricle (LV) to left atrium (LA), (b) After repair of third ventriculoatrial fistula, periprosthetic regurgitant jet
is no longer seen. RA = right atrium, RV = right ventricle, S = interventricular septum.
314
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eased areas are videotaped and pho
tographed for later comparison with
the postoperative appearances.
When the surgical procedure is
completed but before the cannulas
are removed, surgical sites are re
viewed by CD with respect to the
following:
• State of the surgical site (e.g.,
valve function, regurgitation, patch
integrity).
• Disease unrecognized preoperatively.
• Flow patterns and gradients.

Fig. 3a

• Cardiac output and regional
wall motion.
• Placement and position of in
dwelling catheters.
Only when the surgeon is satis
fied with the situation is the study
terminated and the operation com
pleted.
Preoperative use of CD on two
occasions yielded information that
had been missed preoperatively by
both invasive and noninvasive
studies. Intraoperative use prevent
ed possible reoperation in at least 4

of 21 patients and greatly facilitated
the surgery in 3 others with com
plex fistulas.
The following case reports are
examples of the type of information
CD studies can provide intraoperatively.

Case Reports
Case 1
A 12-year-old boy had evidence
of persistent mitral regurgitation 2

Fig. 3b

FIG. 3 — Case 2. (a) “Four-chamber equivalent” view shows broad band of systolic mitral regurgitant flow (open arrows) and
small amount of tricuspid regurgitation (small closed arrow). Asterisks represent plane of mitral valve leaflets, (b) After mitral
valve replacement, only small band of tricuspid regurgitation (arrow) was identified passing from right ventricle to right atrium.

Fig. 4a

Fig. 4b

FIG. 4 — Case 3. (a) “Four-chamber equivalent” view confirming left ventricular to right atrial jet (arrowheads), (b) As in (a)
with slight tilt to right and shift of colour flow cone to right. Jet passes to lateral wall of right atrium and interiorly toward
orifice of inferior vena cava (arrows).
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years after mitral valve replacement.
Preoperative CD and cardiac cathe
terization confirmed that there was
residual mitral regurgitation.
Intraoperative CD performed
after repair of two periprosthetic
fistulas showed (Fig. 2a) a persis
tent jet of blood passing from left
ventricle to left atrium, beside the
prosthesis.
The site was re-explored and a
third fistula, concealed under the
sewing ring, was discovered; this

was oversewn. Further CD con
firmed an intact repair (Fig. 2b).
Case 2
A 12-year-old girl, who showed
evidence of congestive heart failure,
was found to have severe mitral
regurgitation. A poor response to
medical therapy prompted an at
tempt at a mitral valve repair. In
traoperative CD (Fig. 3a) showed
severe systolic mitral regurgitation

passing across a broad front
through the closed mitral leaflets.
Attempted repair of the valve by
suturing a “cleft” and placing a
Carpentier ring in the annulus
proved ineffective on subsequent
CD, which demonstrated no sub
stantial improvement over the pre
operative recording. High left atrial
pressures confirmed persistent mi
tral regurgitation requiring mitral
valve replacement. After valve re
placement there was no mitral re
gurgitation (Fig. 3b), but mild tri
cuspid regurgitation persisted.
Case 3

FIG. 5 — Case 3. Continuous wave Doppler spectral display showing continuous
and systolic peaking high-velocity jet (3.6 m /s) of ventriculoatrial fistula.

Fig. 6a

A 53-year-old man who had un
dergone aortic valve replacement 4
years earlier, presented with fever,
malaise and a new loud pansystolic
murmur. Preoperative investiga
tions confirmed a fistulous tract
from the base of the aortic prosthe
sis to both right ventricle and right
atrium. After 4 weeks of antibiotic
therapy, surgical repair was at
tempted.
After cannulation but before in
tracardiac repair, CD confirmed a
high-velocity jet of blood flowing
from the left ventricle and the base
of the prosthesis to the right atrium

Fig. 6b

FIG. 6 — Case 6. (a) “Long-axis equivalent” view showing tumour mass (T) occupying mitral orifice in diastole. AO = aorta, (b)
“Short-axis equivalent” view showing similar features. Unobstructed portion of mitral valve orifice (MVO) is indicated by arrow.
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(Fig. 4a). Angulation of the trans
ducer confirmed that this jet was
directed at the right atrial wall and
deflected back toward the origin of
the inferior vena cava (Fig. 4b).
Continuous wave Doppler study
of the flow disturbance (Fig. 5)
confirmed the continuous and peak
ing patterns (3.6 m /s) of the ven
triculoatrial jet.
At surgery, Dacron patches and
pledgetted sutures were placed
around the area of tissue break
down. The septal leaflet of the
tricuspid valve was detached and
later resewn to the Dacron patch.
After bypass was discontinued,

CD confirmed an intact repair. The
patient made a successful recovery.

ma, was excised without difficulty
and complete resection confirmed
(Fig. 7) by CD.

Case 4
Case 5
A 33-year-old woman with mul
tisystem complaints and exertional
dyspnea was found, on echocardiog
raphy, to have a left atrial tumour.
Intraoperative echocardiography
was performed before and after tu
mour resection.
From long axis (Fig. 6a) and
short axis (Fig. 6b) views the tu
mour was seen to fill most of the
mitral valve orifice. The tumour,
histologically identified as a myxo

A 60-year-old woman with symp
tomatic isolated mitral stenosis un
derwent intraoperative Doppler as
sessment. The mitral pressure half
time, a measure of the degree of
mitral stenosis, is normally less
than 100 ms, range of severity from
115 to 400 ms (Fig. 8a), but in this
case it was greatly prolonged at
375 ms (Fig. 8b) as measured by
continuous wave Doppler recording
across the valve.
The valve was visualized and
photographed before (Fig. 9a) and
after (Fig. 9b) an open commis
surotomy performed using cardio
pulmonary bypass.
After commissurotomy the pres
sure half-time was reduced to 265
ms (Fig. 10). There was no serious
mitral regurgitation.
Follow-up echocardiographic
studies 1 month later demonstrated
a further improvement in mitral
pressure half-time (190 ms).

Discussion

FIG. 7 — Case 4. Post-resection long-axis view indicating complete removal of
tumour.

Intraoperative echocardiographicDoppler techniques have justifiably
earned a niche in the operating

Tj ” TQ - pressure 1/2 Ciae

Fig. 8a

Fig. 8b

FIG. 8 — Case 5. (a) Schematic method to calculate mitral pressure half-time, (b) Preoperative mitral valve pressure half-time.
Peak inflow velocity [x] at time T0 is divided by V 2 or 1.4 = y at time Tx — T0 = pressure half-time at 375 ms.
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has been reported.11’13 These proce
dures, however, require a specific
time commitment and a practical
knowledge of the instrument. The
surgeon must accept that an addi
tional 10 to 15 minutes will be
required for imaging, recording and
photography. A longer procedure
may slightly increase the risks of
operation and anesthesia, but these
risks are minimal and should be
offset by potential benefits to the
patient. We believe that this tech
nique has and will continue to re
duce the need for reoperation in
many patients, particularly patients
who undergo procedures other than
those for coronary artery disease.

5.

6.

7.

8.

9.
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Mead Johnson Critical Care Symposium
for the Practising Surgeon.
1. Transport of Critically 111 Adult Patients
M.J. Girotti, MD, FRCSC; G. Pagliarello, MD, FRCSC
Interhospital transportation of critically ill patients over long distances is common
in the tiered health care systems of North America. The authors describe their
1-year experience with a physician-assisted transport system, operating out of the
surgical intensive care unit at the Toronto General Hosptial. The application of a
well-known severity of illness measure (therapeutic intervention scoring system)
allowed them to correlate severity of illness, as assessed over the telephone before
patient transfer, with eventual outcome after admission to the surgical intensive care
unit. Their analysis of 107 critically ill patients transported by this system led them
to conclude that the system is reliable and is associated with acceptable morbidity
and mortality.

A cause de la structure etagee du systeme de soins de sante qui a cours en Amerique
du Nord, il est frequent de transporter sur de longues distances des patients
gravement malades qui doivent etre transferes d’un hopital a un autre. Les auteurs
decrivent l’usage pendant 1 an, d’un systeme de transport avec support d’un
medecin, fonctionnant a partir du service des soins intensifs du Toronto General
Hospital. L’emploi d’un systeme bien connu de cotation de la gravite de la maladie
(le systeme de cotation de Tintervention therapeutique) a permis d’etablir un rapport
entre la gravite de la maladie, telle qu’on avait pu l’etablir par telephone avant le
transfert du malade, et l’issue eventuelle apres son admission a l’unite de soins
chirurgicaux intensifs. L’analyse de 107 patients gravement malades qui ont
beneficie de ce systeme porte a conclure que le systeme est fiable et qu’il est lie a
une morbidity et une mortality acceptables.

ccess to medical and surgical
intensive care units is a pre
requisite in Canada’s tiered health
care system. Transportation is cur
rently designed to serve two pur
poses: to evacuate patients from the

A

scene of injury to a base hospital
and to transfer patients between
hospitals. The former is based on a
military model developed during the
Vietnam War.1 Civilian application
of such a system was pioneered by
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physicians and politicians in West
Germany who established and main
tained extensive aeromedical facili
ties for the resuscitation and trans
port of critically ill patients. Before
transport, patients should be stabi
lized because the journey to reach
the technology and personnel of
fered by advanced critical care units
may involve great distances. This
report focuses on the transfer of
critically ill patients between hospi
tals.
Transport over long distances
and for prolonged periods removes
patients from a stable environment
such as the emergency department
or the intensive care unit and ex
poses them to a less stable monitor
ing system. The sending and receiv
ing physicians must agree that the
benefits outweigh the risks of trans
port.
The components of an effective
transport system include the follow
ing:
• Coordination and dispatch
control
• The transport vehicle
• The driver or pilot
• Resuscitation personnel and
their equipment; this may include
physician, nurse, paramedic and
respiratory therapist.
T ransport system s include
ground ambulances staffed by basic
or advanced life-support ambulance
personnel, as available provincially.
Aircraft are staffed by specially
trained paramedics, nurses or physi
cians. The method of transport is
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influenced by severity of the pa
tient’s condition, vehicle availabili
ty, distance and weather conditions.
It is essential for institutions taking
part in a transport system to moni
tor their activities in an attempt to
develop epidemiologic tools for
more accurately estimating the
risks of transport. This will enable
them to match the patient’s needs
to the available resources.
We summarize our experience at
the surgical intensive care unit of
the Toronto General Hospital over 1
year (Feb. 1, 1986 to Jan. 31,
1987) with the transport of 107
patients by a physician-accompanied
transport system (PATS).

The Transport System
The PATS is based in the surgi
cal intensive care unit (SICU) at the
Toronto General Hospital and is
supervised by the staff members of
the unit (four surgeons, one anes
thetist). A physician wishing to ini
tiate transfer of a critically ill pa
tient contacts either the attending
SICU specialist directly or the re
ceiving surgical service which in
turn contacts the SICU physician.
Data on the patient’s condition are
obtained by telephone and an esti
mated severity of illness score,
based on the therapeutic interven
tion scoring system (TISS), for
transport is generated.2 This score
accurately reflects the number of
interventions required to stabilize a
given patient physiologically. Three
separate severity of illness scores
were generated: TISS-TEL, which is
the TISS assessed over the tele
phone before departure of the phy
sician-accompanied transportation
from the SICU; TISS-DEP, the
TISS assessed before the patient’s
departure from the referring institu
tion and TISS-1, the standard TISS
after 1 day of therapy at the Toron
to General Hospital. On the basis of
the distance, acceptable delay in
320

transfer and vehicle availability, the
receiving physician then arranges
for the appropriate vehicle —
ground ambulance, helicopter, tur
bo-propeller or jet aircraft — for
patient transport. The transport
team comprises a respiratory thera
pist and an SICU resident, usually
one with at least 2 years of post
graduate training, who is skilled in
all aspects of airway management
and resuscitation. The team carries
a resuscitation kit consisting of
intravenous solutions, standard car
diopulmonary drugs, and other
pharmacologic agents or special
equipment that may be necessary
for individual patient resuscitation
(e.g., a bronchoscope).
On arrival of the PATS team at
the referring institution, the patient
is assessed to determine suitability
for transport. Measures needed to
assure clinical stability are under
taken before departure: these in
clude intubation, insertion of chest
tubes, establishment of intravenous
routes for resuscitation or monitor
ing and administration of appropri
ate medications. Monitoring in tran
sit is within the limitations of the
transport medium. Physiologic
changes and any interventions un
dertaken are recorded on a specially
designed data sheet and re-recorded
on arrival at the Toronto General
Hospital. The data are stored in a
microcomputer database for future
analysis.
All data were recorded as the
mean ± the standard deviation.
Two sample comparisons were done
using an unpaired f-test.3 Group
T a b le

means were compared by the
Kruskal-Wallis modification of
ANOVA.4 The a error for statistical
significance was selected at 0.05.

Findings
The average age of the patients
was 52 years (range from 16 to 86
years). One hundred and seven pa
tients were transported using the
PATS; 21 because they were possi
ble major organ donors and 86 for
other reasons (Table I). The times
for the transport of patients to the
SICU are summarized in Table II.
“Start-up time’’ was the time from
initial phone call to departure of the
transport team from the Toronto
General Hospital. “Time to” was
the time taken by the team to reach
the referring hospital and the
“pack-up” time was the time re
quired for patient stabilization. The
“time in” was the time needed to
return to the hospital. The dis
tances transported ranged from 1 to
8000 km. A time to distance ratio is
related to the final outcome (Table
II). Of the 107 patients, 56% were
transferred by land ambulance, 22%
by helicopter, 15% by fixed wing
aircraft and 7% by jet.
The majority of patients were
intubated (82%) and required assis
ted mechanical ventilation (71%).
Vasopressor agents were used in
27% of patients, and 24% needed
both mechanical ventilation and
vasopressors to maintain cardiopul
monary stability.
Problems of a technical or logisti
cal nature were encountered in the

1-Transfer Diagnosis and Outcome from SICU Admission

D iag n o sis

Sepsis
Respiratory failure
Trauma
Gastrointestinal hemorrhage
Postaneurysmectomy (emergency)
Miscellaneous
Organ donor*

O v e ra ll

S urvivors

N onsurvivo rs

24
17
6
19
9
11
21

14
12
6
12
4
7
0

10
5
0
7
5
4
21

'Determined before transfer.
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transport of seven patients. These
included vehicular breakdown (1),
inappropriate vehicle (1) and avoid
able delay (1). Weather conditions
and patient condition necessitated a
change in vehicles in the remaining
four cases. At the referring institu
tions, major resuscitative efforts
were undertaken by the transport
team in 21% of patients. This was
reflected by an increase in TISSDEP compared with TISS-TEL, of
more than four points, which we
regarded as significant, based on
our experience with TISS in over
1500 patients managed in an inten
sive care unit.5 There was one
death; this was in an elderly man
with a rapidly expanding abdominal
aortic aneurysm. Emergency resec
tion could not be completed at the
referring hospital for technical rea
sons and a transport team was
dispatched to retrieve the patient
from the referring hospital 100 km
away. Approximately 5 km from
Toronto General Hospital the aneu
rysm ruptured. During reoperation
he unfortunately suffered myocardi

al infarction with subsequent pro
found myocardial failure from
which he could not be resuscitated.
In our analysis of TISS-TEL,
TISS-DEP and TISS-1 (Table III),
comparison of donors and nondo
nors revealed significant (p < 0.05)
increases in both TISS-TEL and
TISS-DEP in the donor population.
In the nondonor group, survivors
and nonsurvivors of SICU admis
sion were further analysed. The
nonsurvivors had higher TISS-TEL,
TISS-DEP and TISS-1 values than
survivors.
Comments
On the basis of our experience
we believe that the transport system
can handle critically ill patients for
prolonged periods without major
morbidity or mortality. The severity
of illness scoring system (TISS) was
a useful guide to the intensity and
sophistication of equipment and
personnel required for transport in
each case.
Our data cannot be compared

with those of other transport sys
tems with respect to the types of
patients transferred, the nature of
the transport team and the dis
tances involved. Physician-accom
panied transport systems have been
described,16' 8 but the majority in
volved the transport of neonatal or
trauma patients and few addressed
the transport of critically ill surgical
patients. A recent report from the
Stanford Medical Center reviewed
retrospectively 200 physicianaccompanied transfers over a 4-year
period6 —- the majority of patients
had cardiac-related diagnoses. Some
interesting comparisons can be
made between patients transported
by our PATS and those in the
Stanford group: only 36% of the
latter required ventilation, and
shock, necessitating vasopressors
during transport, was present in
only 14% of their patients, com
pared with 71% and 27% respective
ly in our series.
A number of questions arise from
this type of analysis. First, what is
the physician’s role in the transport

Table 11-Time and Distance Factors
Nondonors

Factor
Time, min
Start up
Time to
Pack-up
Time in
Distance, km
Time: distance, m in/km

Survivors
(n = 55)
377
144
97
70
85
45
1.1

±
±
±
±
±
±
±

240
195
102
45
64
836
1.3

Nonsurvivors
(n = 31)
288
114
49
71
52
141
2.4

±
±
±
±
±
±
±

172*
126
32*
47
35*
180*
3.7*

Overall
(n = 86)
345
133
79
70
73
342
1.6

±
±
±
±
±
±
±

221
174
87
45
58
692
2.5

uonors
overall
(n = 21)
286
126
55
45
55
519
1.6

±
±
±
±
±
±
±

356
231
107
20
99
1738
0.9

*p < 0.05 for survivors versus nonsurvivors.
Table Ill-Severity of Illness for Nondonors and Donors Analysed by Score Over Telephone Before Departure (TISS-TEL), Score Before Patient Departure
(TISS-DEP) and After 1 Day at Toronto General Hospital (TISS-1)
Nondonors
Scoring
Survivors
Nonsurvivors
Overall
type______________________________________________(n = 55)_________________ (n = 31)_________________ (n = 86)

Donors
overall
(n = 21)

TISS-TEL
15.4 ± 6 7
20.5 ± 6.8*
17.3 ± 7.1
22.2 ± 6 .5 t
TISS-DEP
15.8 ± 7.6
21.7 ± 7.1*
17.9 ± 7.4
22.7 ± 6 .0 t
TISS-1___________________________________________ 27.6 ± 10.5_____________ 40.3 ± 10.8*____________ 32.3 ± 12.2____________ - _________
*p < 0.05 for survivors versus nonsurvivors,
tp < 0.05 for donors versus nondonors.
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(Tjliefoxin
(sterile cefoxitin sodium, MSD Std.)

ANTIBIOTIC
ACTION

process? Many programs, notably
the West German system, rely heav
ily on physician participation in the
transport of severely ill patients.
Others, such as the privately oper
ated systems in the United States,
make extensive use of transport
nurses and paramedics to provide
for resuscitation and stabilization.
No formal comparisons have been
made between these and physicianassisted systems such as ours. Sec
ond, how does the transport system
ensure that patients are appropri
ately triaged and managed accord
ing to the severity of their illness
and factors such as weather and
distance of transport and can this
be accomplished by a variety of
scoring systems? The final question
is one of efficiency. Are different
systems required for different pa
tients and can cost savings be real
ized by eliminating the use of so
phisticated transport systems and
personnel except in appropriate
subgroups of patients?
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In vitro studies demonstrate that the bacteri
cidal action of cefoxitin, a cephamycin derived
fromcephamycin C, results from the inhibition
of bacterial cell wall synthesis. Evidence
suggests that the m ethoxy group in the
7a position is responsible for the resistance of
cefoxitin to degradation by bacterial betalactamases.

INDICATIONS AND CLINICAL USES
TREATMENT

The treatment of the following infections when
due to susceptible organisms:
1 - in tra -a b d o m in a l in fe c tio n s such as
peritonitis and intra-abdominal abscess
2 - G y n e c o lo g ic a l in fe c tio n s such as
endometritis and pelvic cellulitis
3 - Septicemia
4 - Urinary tract infections (including those
caused by Serratia m arcescens and
Serratia spp.)
5 - Lower respiratory tract infections
6 - Bone and jo in t infections caused by
Staphylococcus aureus
7 - Soft tissue infections such as cellulitis,
abscesses and wound infections
Appropriate culture and susceptibility studies
should be performed to determine the sus
ceptibility of the causative organism(s) to
MEFOXIN*. Therapy may be started while
awaiting the results of these tests, however,
modification of the treatment may be required
once these results become available.
O rganism s p a rtic u la rly a p p ro p ria te fo r
therapy with MEFOXIN* are:
Gram positive

Staphylococci, penicillinase producing and
non-producing
Streptococci excluding enterococci
Gram negative (beta-lactam ase producing
and non-producing strains)

E. coli
Klebsiella species (including K. pneumoniae)
Proteus, indole positive and negative
Haemophilus influenzae
Providencia species
Anaerobes

Bacteroides fragilis
MEFOXIN* may also be appropriate for the
treatment of infections involving susceptible
strains of both aerobic and anaerobic bacteria.
MEFOXIN* is not active against Pseudomonas,
most strains of enterococci, many strains of
Enterobacter cloacae,
and m ethicillinre s is ta n t s ta p h y lo c o c c i and L is te ria
monocytogenes.
Clinical experience has demonstrated that
MEFOXIN* can be administered to patients
w h o are a lso re c e iv in g c a rb e n ic illin ,
gentamicin, tobram ycin, or amikacin (see
PRECAUTIONS and ADMINISTRATION).
Intravenous Administration

The intravenous route is preferable for
patients with bacteremia, bacterial septicemia,
or other severe or life-threatening infections,
or for patients who may be poor risks because
of lowered resistance resulting from such
d e b ilita tin g c o n d itio n s as m a ln u tritio n ,
trauma, surgery, diabetes, heart failure, or
malignancy, particularly if shock is present or
impending.
PROPHYLACTIC USE

MEFOXIN* may be administered perioperatively (preoperatively, intraoperatively and
postoperatively) to patients undergoing
vaginal or abdominal hysterectomy and ab
dominal surgery when there is a significant
risk of postoperative infection or where the
occurrence of postoperative infection is
considered to be especially serious.
In patients undergoing cesarean section, intra
operative (after clamping the umbilical cord)

and postoperative use of MEFOXIN* may
reduce the incidence of surgery related post
operative infections.
Effective prophylactic use depends on the
time of administration. MEFOXIN* usually
should be given one-half to one hour before
the operation. Prophylactic administration
should usually be stopped within 12 hours. It
has been generally reported that continuing
adm in istra tio n of any a n tib io tic beyond
24 hours fo llo w in g surgery increases the
possibility of adverse reactions but, in the
majority of surgical procedures, does not
reduce the incidence of subsequent infection.
If signs of postsurgical infection should
appear, specimens fo r culture should be
obtained for identification of the causative
organism(s) so that appropriate therapy may
be instituted.

CONTRAINDICATIONS
MEFOXIN* is contraindicated in persons who
have shown hypersensitivity to cefoxitin or to
the cephalosporin group of antibiotics.

WARNINGS
Before therapy with MEFOXIN* is instituted,
careful inquiry should be made to determine
whether the patient has had previous hyper
sensitivity reactions to MEFOXIN*, cephalo
sporins, penicillins or other drugs. MEFOXIN*
should be given with caution to penicillinsensitive patients.
There is some clinical and laboratory evidence
o f p a rtia l c ro s s -a lle rg e n ic ity between
cephamycins and the other beta-lactam anti
b io tics, p e n ic illin s and cephalosporins.
Severe reactions (including anaphylaxis) have
been re p o rte d w ith m ost b e ta-la cta m
antibiotics.
Pseudomembranous colitis has been reported
with virtually all antibiotics. This colitis can
range from mild to life threatening in severity.
Antibiotics should therefore be prescribed
with caution in individuals with a history of
gastrointestinal disease, particularly colitis. It
is important to consider a diagnosis of pseudo
membranous colitis in patients who develop
diarrhea in association with antibiotic use.
While studies indicate that a toxin produced
by Clostridium difficile is one primary cause of
antibiotic-associated colitis, other causes
should also be considered.
Any patient who has demonstrated some form
of allergy, particularly to drugs, should receive
antibiotics including MEFOXIN* with caution.
If an allergic reaction to MEFOXIN* occurs,
administration of the drug should be discon
tinued. Serious hypersensitivity reactions may
require treatment with epinephrine and other
emergency measures.

PRECAUTIONS
The total daily dosage should be reduced
when MEFOXIN* is administered to patients
with transient or persistent reduction of
urinary output due to renal insufficiency (see
DOSAGE AND ADMINISTRATION) because
high and prolonged serum antibiotic con
centrations can occur from usual doses.
In patients treated with MEFOXIN* a false
positive reaction to glucose in the urine may
occur with Benedict’s or Fehling’s solutions
but not with the use of specific glucose
oxidase methods.
Using the Jaffe Method, falsely high creatinine
values in serum may occur if serum concentrationsof cefoxitin exceed 100/rg/mL. Serum
samples from patients treated with MEFOXIN*
should not be analyzed for creatinine if with
drawn within two hours of drug administration.
Increased nephrotoxicity has been reported
fo llo w in g co n co m ita n t adm inistration of
cephalosporins and aminoglycoside antibiotics.
The safety of MEFOXIN* in the treatment of
infections during pregnancy has not been
e s ta b lis h e d . If th e a d m in is tra tio n of

MEFOXIN* to pregnant patients is considered
necessary, its use requires that the anticipated
benefits be weighed against possible hazards
to the fetus. Reproductive and teratogenic
studies have been performed in mice and rats
and have revealed no evidence of impaired
fertility or harm to the fetus due to MEFOXIN*.
Cefoxitin has been observed in the milk of
nursing mothers receiving the drug.
Prolonged use of MEFOXIN* may result in the
overgrowth of non-susceptible organisms.
Repeated evaluation of the patient's condition
is essential and if superinfection occurs
during therapy, appropriate measures should
be taken. Should an organism become
resistant during antibiotic therapy, another
antibiotic should be substituted.
In children 3 months of age or older, higher
doses of MEFOXIN' (100m g/kg/day and
above) have been a sso cia te d w ith an
increased incidence of eosinophilia and
elevated SGOT

ADVERSE REACTIONS
MEFOXIN* is generally well tolerated. Adverse
re a c tio n s rare ly req u ire d cessation of
treatment and usually have been mild and
transient.
Local Reactions
Thrombophlebitis has occurred with intra
venous administration. Some degree of pain
and tenderness is usually experienced after
in tra m u s c u la r in je c tio n s u sin g w ater.
Induration has occasionally been reported.
Allergic
M aculopapular rash, u rtica ria , pruritus,
eosinophilia, fever and other allergic reactions
have been noted.
Gastrointestinal
Symptoms of pseudomembranous colitis can
appear during or after antibiotic treatment.
Nausea and vomiting have been reported
rarely.
Blood
Transient eosinophilia, leukopenia, neutropenia,
hem olytic anemia, and throm bocytopenia
have been reported. Some individuals, particu
la rly those with azotemia, may develop
positive direct Coombs tests during therapy
with MEFOXIN*.
Liver Function
Transient elevations in SGOT, SGPT, serum
LDH, and serum alkaline phosphatase have
been reported.
Kidney
Elevations in serum creatinine and/or blood
urea nitrogen levels have been observed. As
with the cephalosporins, acute renal failure
has been rep o rte d rarely. The role of
MEFOXIN* in changes in renal function tests
is d iffic u lt to assess, since factors pre
disposing to prerenal azotemia or to impaired
renal function have often been present.

TREATMENT OF OVERDOSE
Other than general supportive treatment, no
specific antidote is known. MEFOXIN* can be
eliminated by dialysis in patients with renal
insufficiency.

DOSAGE AND ADMINISTRATION
MEFOXIN* may be administered intravenously
or in tra m u scu la rly when required. (See
complete monograph on ADMINISTRATION
and RECONSTITUTION.)
TREATMENT DOSAGE
Adults
The usual adult dosage is 1 g or 2 g of
MEFOXIN* every 6 to 8hours. Dosage and
route of administration should be determined
by severity of infection, susceptibility of the
causative organisms, and condition of the
patient. The usual adult dosages are shown in
the Table below.

Usual Adult Dosage
Type of
infection

Daily
Dosage

Frequency
and Route

Uncom plicated
form s* o f in fections such as
pneumonia,
urinary tract
infection, soft
tissue infection

3-4 g

1 g every 6-8 h
I.V. o r I.M.

M oderately
severe o r severe
in fections

6-8 g

1 g every 4 h
or
2g every 6 -8 h I.V.

Infections
com m o nly
needing antibiotics in higher
dosage (e.g. gas
gangrene)

12 g

2 g every 4 h
or
3 g every 6 h I.V.

"Including patients in whom bacteremia is
absent or unlikely
Therapy may be started while awaiting the
results of susceptibility testing.
Antibiotic therapy for group A beta-hemolytic
streptococcal infections should be maintained
for at least 10 days to guard against the risk of
rheumatic fever or glom erulonephritis. In
staphylococcal and other infections involving
a collection of pus, surgical drainage should
be carried out where indicated.
Adults with Impaired Renal Function
MEFOXIN* may be used in patients with
reduced renal function but a reduced dosage
should be employed and it is advisable to
monitor serum levels in patients with severe
impairment.
In adults with renal insufficiency, an initial
loading dose of 1 g to 2 g should be given.
After a loading dose, the following recommen
dations for maintenance dosage may be used
as a guide:

pected, an appropriate antibiotic should be
used.
At p re se n t there is in s u ffic ie n t data to
recommend a specific dosage for children
with impaired renal function. However, if the
administration of MEFOXIN* is deemed to be
essential the dosage should be m odified
consistent with the recom m endations fo r
adults (see Table above).
PROPHYLACTIC USE
For prophylactic use, a three-dose regimen of
MEFOXIN* is recommended as follows.
Vaginal or abdominal hysterectomy and
abdominal surgery
2 g administered intram uscularly or in tra 
venously just prior to surgery (approximately
one-half to one hour before initial incision).
The second and third 2g[doses should be
administered at 2-6 hour intervals after the
initial dose.
Cesarean Section
The first dose of 2g should be administered
intravenously as soon as the umbilical cord
has been clamped. The second and third
2 g doses should be given intravenously or
intramuscularly four hours and eight hours
after the first dose.

AVAILABILITY
MEFOXIN* is supplied as sterile powder in
boxes of 10 vials:
3356 Ca - 1 g cefoxitin as sodium salt
3357 Ca - 2 g cefoxitin as sodium salt
Storage
MEFOXIN* in the dry state should be stored
below 30° C.

PRODUCT MONOGRAPH AVAILABLE
ON REQUEST

*®T rademark
RENAL
FUNCTION
Mild
im pairm ent
M oderate
im pairm ent
Severe
im pairm ent
Essentially
no function

CREATININE
CLEARANCE
mL/min

DOSE

FREQ UENCY

50-30

1-2 g

every 8-12 h

29-10

1-2 g

every 12-24 h

9-5

0.5-1 g

every 12-24 h

<5

0.5-1 g

every 24-48 h

(425-a,6,87x)

In the patient undergoing hemodialysis, the
loading dose of 1 - 2 g should be given after
each hemodialysis, and the maintenance dose
should be given as indicated in the Table
above.
Neonates (Including Premature Infants),
Infants and Children (See WARNINGS for
Neonates under ADMINISTRATION in the
complete monograph.)
Premature Infants
with Body Weights
Above 1500 g

MSP
MERCK
SHARft
DOHME
I paab I

I CM» e l

P.O. Box 1005, Pointe Claire
Dorval, Quebec H9R 4P8

20-40 m g/kg every 12 h I.V.

Neonates
01 week of age20-40 m g/kg every 12 h I.V.
1- 4 weeks of age
20-40 m g/kg every 8 h I.V.
Infants
1 m onth to 2 years
o f age
Children

20-40 m g/kg every 6 h or
every 8 h I.M. o r I.V.
20-40 m g/kg every 6 h or
every 8 h I.M. o r I.V.

In severe infections, the total daily dosage in
infants and children may be increased to
200 mg/kg, but not to exceed 12 g per day.
MEFOXIN* is not recom m ended fo r the
therapy of meningitis. If meningitis is sus
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2. Complications of Monitoring Systems
Thomas R. Todd, MD, FRCSC
Current invasive monitoring techniques, although valuable in the care of critically
ill patients, also have disadvantages. Complications of these techniques include
errors in interpretation of measurements and complications of venous access and
indwelling lines. To prevent these, the author recommends a standard routine for
inserting and changing catheters, regular calibration of transducers and insertion of
Swan-Ganz catheters with the balloon inflated with 1.0 to 1.5 ml of air.

Les techniques invasives de monitorage presentement utilisees peuvent etre utiles
chez les patients gravement malades, mais elles presentent aussi des inconvenients.
Parmi les complications de ces techniques, on compte les erreurs d’interpretation de
mesure et les complications des entrees veineuses et des catheters a demeure. Afin
de les eviter, l’auteur propose une procedure d’usage pour poser et changer les
catheters, la calibration reguliere des transducteurs et l’insertion de catheters de
Swan-Ganz dont le ballonnet est gonfle avec de 1.0 a 1.5 ml d’air.

T

he advent of elaborate, invasive
monitoring in intensive care
units allows us the luxury of a
physiology laboratory at the pa
tient’s bedside. There is no question
that these systems are beneficial in
the management of critically ill pa
tients. As with all interventions,
however, they also introduce their
own complications which are de
scribed in this paper. The principal
complications of invasive monitor
ing systems are: errors in interpre
tation, complications of venous ac
cess and complications of indwell
ing lines.

Errors in Interpretation
Errors of interpretation adversely
affect the outcome. The commonest
ones are associated with transducer
malalignment. This instrument
measures the hydrostatic pressure
at the tip of the attached catheter
and the height of the transducer
from the catheter tip. Thus, if it is
not referenced to the atmosphere or
is incorrectly positioned relative to
the left or right atrium, the mea
sured preload (central venous or
pulmonary wedge pressure) will be
inaccurate. Frequently the trans
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ducer falls off the bed or is posi
tioned on top of the patient, result
ing in wide fluctuations of mea
sured pressure. When recordings
are made from low-pressure sys
tems, the patient must be fully
supine and the transducer properly
aligned. It is not uncommon to see
a nurse record sequential pulmo
nary artery pressures from a moni
tor with the patient supine, in Fowl
er’s position or on either side and,
unfortunately, these pressures are
accepted by physicians. Arterial
pressure is less affected by trans
ducer malalignment. Malalignment
will, however, augment the upswing
of the arterial pressure tracing so
that recorded pressure will be erro
neously high. Nurses should rou
tinely check the monitor reading
against sphygmomanometer pres
sure assessment. A physician may
sometimes be alerted to artifactually
high arterial pressure tracings by
noticing that the upstroke of the
arterial pressure curve is abrupt and
that the peak is exceptionally nar
row.
Another error in interpretation is
a failure to monitor the pulmonary
artery wave form during measure
ment of wedge pressure. When a
balloon is inflated, the pulse pres
sure decreases and the mean pres
sure falls. However, if the balloon
should force the catheter tip against
the arterial wall, the mean pres
sure, although initially decreasing,
may then increase — so-called highpressure wedging which is often
higher than diastolic pressure. A
useful double check of the accuracy
of these measurements is to ensure
that recorded wedge pressure is
VOL. 31, NO. 5 SEPTEMBER 1988/CIS,
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always less than or equal to pulmo
nary diastolic pressure. A third
cause of artificially high wedge
pressure recordings is failure to
record pressure at end expiration.
In the patient with exaggerated
respiratory effort or in situations
where peak airway pressure is high,
respiratory artifacts can be substan
tial. Digital monitors display an
electrical mean across a sweep of
the screen; hence, a pronounced
increase in wedge pressure during
inspiration will artificially elevate
the mean pressure. This phenome
non can be overcome by recording
the pressure on the diastolic mode
to ensure that only the end-expira
tory pressure contributes to the
mean pressure recorded on the
monitor.
A fourth cause of erroneously
high recording of wedge pressure is
the development of a zone 2 phe
nomenon in the lung about the
catheter. Several years ago, West
and colleagues1 described three
zones in the lung, based on the
relationship between the pressures
in the pulmonary artery (PAP), left
atrium (PLA) and pulmonary alveo
lus (PALV). The first two are
low-pressure systems, subject thus
to changes along the hydrostatic
gradient created by gravity. The
gradient will alter the relationship
between the pressures, depending
on the distance above or below the
heart where the recordings are
made. In zone 2, PAP is greater
than either PLA or PALV, but
PALV is greater than PLA. When
the balloon of the Swan-Ganz cath
eter is inflated, flow stops and the
catheter tip cannot sense the pres
sure in the left atrium. Zone 2 thus
can be achieved by hypovolemia
with a low left atrial pressure or by
increased alveolar pressure. The
higher the tip of the catheter above
the left atrium, the more frequent is
the abnormal observation.2 Results
of experiments undertaken in venti
VOL. 31, NO. 5 SEPTEMBER 1988/CIS

lated patients in our intensive care
units have suggested that the phe
nomenon is unusual with a positive
end-expiratory pressure less than or
equal to 1.3 kPa.

Complications of Venous
Access
Complications of central venous
catheterization (Table I) are well
known to all intensive care physi
cians. The most common are he
morrhage and pneumothorax. The
former is fortunately uncommon in
the absence of coagulopathy, but
when coagulopathy is present,
venepuncture must be carried out
with particular care. Pneumothorax
can be prevented by ensuring the
patient is disconnected from posi
tive-pressure ventilation as the nee
dle is inserted under the clavicle or
into the internal jugular vein. Ar
rhythmias are frequent. Ventricular
tachycardia dictates immediate
withdrawal of the catheter. Ventric
ular premature beats are common
but fortunately disappear once the
pulmonary artery is entered. How
ever, the presence of a left bundle
branch block should preclude pul
monary artery catheterization with
out pacemaker standby.

Complications of Indwelling
Lines
Indwelling central venous lines
may cause several problems. Sub
clavian or vena caval thrombosis is
unusual and can be managed expe
ditiously with anticoagulation. Pen
etration of the vena cava occurs
during insertion. Penetration of the
atrium or ventricle, with cardiac
tamponade, can occur with time if
catheters are rigid or if they are not
correctly positioned in the vena
cava or pulmonary artery. Thus,
chest x-ray films should be carefully

checked for line position and rigid
introducers or firm catheters should
not be used. Infection is uncommon
within the first 72 hours after inser
tion. All central lines should be
changed every 72 to 120 hours,
depending on the clinical circum
stances. These lines can be changed
over guidewires if access sites are
not themselves superficially in
fected. Otherwise, completely new
sites should be found. A fever that
occurs on 2 successive days without
an obvious cause suggests that all
lines be removed. Knots in pulmo
nary artery catheters are rare. If the
catheter has been inserted through
the internal jugular vein, removal is
not difficult, because direct surgical
access is possible in the intensive
care unit. If the route is via the
subclavian vein, removal may be
facilitated by tightening the knot as
much as possible. This is not al
ways possible. In such cases, a
skilled angiographer can cut the
line and extract the catheter
through a separate peripheral ac
cess site.
Pulmonary artery disruption is
uncommon but when it occurs, usu
ally during line insertion, it can be
devastating. Patients likely to suffer
this complication are elderly and
may have pulmonary hypertension.
The commonest site is the right
middle lobe, and endobronchial he
morrhage is the presenting sign.
Although the hemorrhage may ap
pear profuse, these patients do not
die of blood loss unless there is
further bleeding into the pleural
space. They die of asphyxiation
Table I - Complications of Central Venous
Lines
Pneumothorax
Local hemorrhage
Knots
Venous thrombosis
Arrythmias
Pulmonary infarction
Pulmonary artery disruption
Sepsis
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from airway obstruction. In any
patient with significant airway he
morrhage, use of the rigid broncho
scope is essential because the air
way is rarely cleared effectively by
suctioning or fiberoptic bronchos
copy. Adequate ventilation could be
supplied by the Venturi effect or
high frequency ventilation. It is im
portant to remember that the sys
tem is a low pressure one, and thus
the initial hemorrhage is usually
temporary. Should the bleeding
continue however, the use of a rigid
bronchoscope also facilitates the in
sertion of a balloon catheter into
the damaged side. Double-lumen
tubes may be used at this point, but
never as the initial treatment, since
suctioning is difficult or impossible.
If rupture occurs during insertion,
Table II - Precautions Against Errors in
Interpretation
Check transducer alignment
Check catheter position radiologically
Remember that wedge pressure must be
< pulmonary artery diastolic pressure
Remember the effects of ventilation on
wedge pressure

Table III - Management of Indwelling Lines.
Precautions Against Complications of
Insertion
Sterile, careful insertion
Always insert Swan-Ganz catheter with
balloon inflated
Never use > 1.5 ml
of air in balloon
If < 1.0 ml of air is required,
readjust catheter
Watch position
on x-ray
Remove catheter if repeated
spontaneous wedging occurs
Change catheters every 72 to 120 h
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do not remove the catheter, as
radiologic verification of its position
may be the only indication as to
which side is affected. Hyperinfla
tion of the balloon to tamponade
the hole in the artery is to be
condemned because it may further
damage the thin-walled pulmonary
artery, and the bleeding almost al
ways stops spontaneously.
Unfortunately there are no satis
factory guidelines to determine
which patients should undergo tho
racotomy when pulmonary artery
disruption occurs. Frequently no
further sequelae develop and con
servative management is satisfac
tory. However, a second endobron
chial hemorrhage or perforation of
the pleural space may occur, which
in our experience is usually fatal.
The literature3’4 and our experience
suggest a thoracotomy should be
performed when there is continued
hemorrhage, an intrapulmonary he
matoma (as opposed to the alveolar
flooding of bronchial hemorrhage)
or a hemothorax.

Comment
Prevention of monitoring compli
cations is clearly the mainstay of
successful intensive care (Tables II
and III). It is suggested that a
routine be established for line inser
tion and changes (Seldinger tech
nique) and removal of central ve
nous apparatus, using sterile tech
nique. All transducers should be
calibrated by the nurse once per
shift and the blood pressure record

ings double-checked using a sphyg
momanometer. Swan-Ganz cathe
ters should be inserted with the
balloon inflated with 1.0 to 1.5 ml
of air, not just to achieve flotation
into the primary artery, but to en
sure that the catheter is passed into
the wedge position thus avoiding an
insertion so distal that perforation
of the artery may occur. These
catheters alter position so it is im
portant to ensure that each subse
quent measurement uses at least 1
ml of air for balloon inflation. Oth
erwise the catheter must be read
justed.
The monitoring of physiologic
variables has improved our inten
sive care management of critically
ill patients. All interventions, how
ever, carry their own set of compli
cations and errors. Their recogni
tion and the appropriate education
of intensive care unit staff will
prevent most of these problems.
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Action
In vitro studies indicate that the bacterial action ol CLAFORAN (cefotaxime sodium)
a semi synthetic cephalosporin antibiotic, results from inhibition of cell wall
synthesis.
Indications and Clinical Uses
Treatm ent: CLAFORAN (cefotaxime sodium) may be indicated for the treatment
of infections caused by susceptible strains of the designated micro organisms
in the diseases listed below.
Lower respiratory tract in fe c tio n s : pneumonia and lung abscess caused by
Streptococcus pneumoniae (formerly Diplococcus pneumoniae), other streptococci
(excluding enterocci, e.g. S. faecalis), Straphylococcus aureus (penicillinase and
non-penicillinase producing), Escherichia coli, Hemophilus influenzae, (including
ampicillin resistant strains) and unspecified Klebsiella species.
U rinary tra ct infections: caused by Escherichia coli, unspecified Klebsiella
species (including K. pneumoniae), Proteus mirabilis, indole positive Proteus, Ser
rate marcescens and Staphylococcus epidermidis. Also, uncomplicated gonor
rhea caused by N. gonorrhoeae including penicillin resistant strains.
B a cte re m ia /S e p tice m ia : caused by Escherichia coli, unspecified Klebsiella
strains and Ser/ate marcescens.
Skin in fe c tio n s : caused by Staphylococcus aureus (penicillinase and non
penicillinase producing, S. epidermidis, Group A streptococci, Escherichia coli,
Proteus mirabilis and indole positive Proteus.
Intra-abdom inal infections: caused by Escherichia coli, and unspecified Kleb
siella species.
Gynecological infections: including pelvic inflammatory disease, endometritis
and pelvic cellulitis caused by E. coli, Group A streptococci and Staphylococcus
epidermidis, anaerobic bacteria including unspecified Peptococcus and Peptostreptococcus strains and some strains of Bacteroides tragihs. In several cases, although
clinical cures were achieved, bacteriological follow up was not available.
Clinical experience with CLAFORAN in anaerobic infections is limited. CLAFORAN
has been used with some success in wound and intra-abdominal infections against
some strains of unidentified Bacteroides and anaerobic cocci.
CLAFORAN has been shown to be active against some strains of Pseudomonas.
In the treatment of infections encountered in immunosuppressed and granulo
cytopenic patients, results of therapy with CLAFORAN have not been impressive.
CLAFORAN should not be considered in the treatment of enterococcal infections,
i.e. Streptococcus faecalis.
Specimens for bacteriologic culture should be obtained prior to therapy in order
to isolate and identify the causative organisms and to determine their suscep
tibilities to CLAFORAN. Therapy may be instituted before results of susceptibility
studies are known; antibiotic treatment should be re-evaluated once these results
become available.
Prophylactic U s e : The administration of CLAFORAN perioperatively (preoperative
ly, intraoperatively and postoperatively) may reduce the incidence of certain infec
(ions in patients undergoing elective surgical procedures (e.g. abdominal or vaginal
hysterectomy, gastrointestinal and genitourinary tract surgery) that may be classified
as contaminated or potentially contaminated.
In patients undergoing caesarian section who are considered to be at increased
risk of infection, intraoperative (after clamping the umbilical cord) and postoperative
use of CLAFORAN may also reduce the incidence of certain postoperative infections
Effective use for elective surgery depends on the time of administration (see Dosage
and Administration).
For patients undergoing gastrointestinal surgery, preoperative bowel preparation
by mechanical cleansing as well as with a non absorbable antibiotic (e.g. neomycin)
is recommended.
If there are signs of infection, specimens for culture should be obtained for iden
tification of the causative organism so that appropriate therapy may be instituted.

infection occurs, therapy should be discontinued and appropriate measures taken.
Although CLAFORAN rarely produces alterations in kidney function, evaluation
of renal status is recommended, especially in severely ill patients receiving high
doses.
Patients with markedly impaired renal function should be placed on the special
dosage schedule recommended under Dosage and Administration, because nor
mal dosage in these individuals is likely to produce excessive and prolonged serum
antibiotic concentrations.
Positive direct Coomb's test is known to develop in individuals during treatment
with the cephalosporin group of antibiotics, including cefotaxime sodium.
In laboratory tests a false positive reaction to glucose may occur with reducing
substances but not with the use of specific glucose oxidase methods.
Adverse Reactions
The most frequent adverse reactions with their frequency of occurrence are:
Hypersensitivity (1.8%): Rash, pruritus, fever. Local (5%): Injection site inflam
mation with intravenous administration. Pain, induration and tenderness after in
tramuscular injection. Gastrointestinal (1.7%): Colitis, diarrhea, nausea and
vomiting. Symptoms of pseudomembranous colitis can appear during or after
CLAFORAN treatment. Hemic and Lymphatic System ( < 1%): Mild, reversi
ble leukopenia, granulocytopenia and thrombocytopenia have been reported. Some
patients developed positive direct Coomb's test during treatment with CLAFORAN.
Genitourinary System ( < 1%) . Moniliasis, vaginitis. Liver ( < 1%): Transient
elevations in SGOT, SGPT, serum LDH and serum alkaline phosphatase levels
have been reported. Kidney ( < 1%): Increased serum creatinine and BUN have
occasionally been observed. Central Nervous System (0.2%): Headache.
Symptoms and Treatment of Overdosage
Since no case of overdosage has been reported to date with CLAFORAN, no
specific information on symptoms or treatment is available. Treatment of over
dosage should be symptomatic.
Dosage and Administration
CLAFORAN (cefotaxime sodium) may be administered intramuscularly or in
travenously after reconstitution (see Table with recommended mode of reconstitution
according to route of administration).

large muscle such as the upper outer quadrant of the buttock (i.e. gluteus maximus); aspiration is necessary to avoid inadvertent injection into a blood vessel.
Intravenous: The intravenous route is preferable for patients with bacteremia,
bacterial septicemia, or other severe or life-threatening infections, or for patients
who may be poor risks because of lowered resistance resulting from such
debilitating conditions as malnutrition, trauma, surgery, diabetes, heart failure,
or malignancy, particularly if shock is present or impending.
For bolus administration a solution containing 1 or 2 g of CLAFORAN can be
injected over a period of 3 to 5 minutes. Using an infusion system, it may also
be given over a longer period of time through the tubing system by which the
patient may be receiving other intravenous solutions Butterfly* or scalp vein type
needles are preferred for this type of infusion. However, during infusion of the
solution containing CLAFORAN, it is advisable to discontinue temporarily the ad
ministration of other solutions at the same site.
Reg'd TM of Abbott Laboratories.
Reconstitution
For Intramuscular U s e : CLAFORAN should be reconstituted with Sterile Water
for Injection or Bacteriostatic Water for Injection in accordance with the volumes
recommended in the following table.
Reconstitution Table

Intramuscular

Guidelines for Dosage of CLAFORAN (cefotaxime sodium)

Approximate
Available
Vol. (mL)

Approx. Average
Concentration
(mg/mL)

2
3
5

2 .2
3.4
6.0

230
300
330

500 mg vial
1 g vial
2 g vial

‘ shake to dissolve.
For direct intravenous injection (bolus) a n d /o r continuous intravenous
in fu s io n : 500 mg, 1 and 2 g vials should be reconstituted with at least 10 mL
of Sterile Water for Injection. Reconstituted solution may be further diluted with
50 to 1000 mL of the fluids recommended for IV infusion.
Reconstitution Table

Dosage
Adults
The dosage of CLAFORAN should be determined by susceptibility of the causative
organisms, severity of the infection and condition of the patient.

Volume to be
Added to
Vial (mL)*

Intravenous

Volume to be
Added to
Vial (mL)*

Approximate
Available
Vol. (mL)

Approx. Average
Concentration
(mg/mL)

500 mg vial10
1 g vial
2 g vial

10.2
10
10

50
10.4
11.0

95
180

Daily Dose

*shake to dissolve.
Solutions for IV In fu s io n : CLAFORAN is compatible with the following infu
sion
fluids:
1
Uncomplicated
- Sterile Water for Injection
Gonorrhea
- 0.9% NaCI injection
1 g every 12 hours
2
Uncomplicated
- 5% dextrose injection
IM or IV
infections
- 0.9% NaCI and 5% dextrose injection
1-2 g every
Moderately
3-6
- 0.45% NaCI and 5% dextrose injection
8 hours IM or IV
severe to severe
- 0.2% NaCI and 5% dextrose injection
infections
- Sodium Lactate injection
2 g every
6-8
Very severe
- 5% dextrose and 0.15% KCI injection
6-8 hours IV
infections (e.g.
- Plasma-Lyte 56 Electrolyte Solution in 5% dextrose injection
septicemia)
- Ringer's injection
2 g every
Life-threatening
up to 12
- Lactated Ringer's solution
4 hours IV
infections
- Lactated Ringer’s with 5% dextrose injection
CLAFORAN is also compatible with lignocaine 1%.
To prevent postoperative infection in contaminated or potentially contaminated A solution of 1 g of CLAFORAN in 14 mL of Sterile Water for Injection is isotonic.
Stability of Solution
surgery, recommended doses are as follows.
(a) 1g IM or IV administered Vs to 1Vs hours prior to the initial surgical incision S torage; Solutions of CLAFORAN range from light yellow to amber, depending
to ensure that adequate antibiotic levels are present in the serum and tissues on concentration and the diluent used. The solutions tend to darken depending
on storage conditions and should be protected from elevated temperatures and
at the start of surgery
(b) 1 g IM or IV administered 1V2 to 2 hours following the first dose; for lengthy excessive light.
Contraindications
“ Reg'd TM of Baxter-Travenol Laboratories.
CLAFORAN is contraindicated in patients who have shown hypersensitivity to operative procedures, additional intraoperative doses may be administered, if
CLAFORAN reconstituted in the original vial as described under Reconstitution
necessary, at appropriate intervals (IV 2 to 2 hours) during surgery
cefotaxime sodium, the cephalosporin or the penicillin groups of antibiotics.
maintains satisfactory potency for 24 hours at room temperature (25°C) and for
(c) 1 g IM or IV administered within 2 hours following completion of surgery 48 hours under refrigeration (0-5°C). Only freshly prepared reconstituted solu
Warnings
Before therapy with CLAFORAN is instituted, it must be carefully determined whether The total cumulative prophylactic dose should not exceed 6 g in a 12 hour period. tions may be further diluted with 50 to 1000 mL of the recommended infusion
the patient has had previous hypersensitivity reactions to cefotaxime, Caesarian Section Patients
fluids in Viaflex** intravenous bags. Such solutions maintain satisfactory poten
cephalosporins, penicillins or other drugs CLAFORAN should be given with caution The first dose of 1g is administered IV as soon as the umbilical cord is clamped. cy for 24 hours at room temperature (25°C) and for 72 hours under refrigeration
to patients with Type 1 hypersensitivity reactions to penicillin. Antibiotics, including The second and third doses should be given as 1 g IM or IV at 6 and 12 hours (0-5°C). Any unused solutions should be discarded.
CLAFORAN should be administered with caution to any patient who has after the first dose.
CLAFORAN reconstituted with 1% lignocaine maintains satisfactory potency for
demonstrated some form of allergy, particularly to drugs. If an allergic reaction
up to 24 hours at room temperature and 48 hours under refrigeration (reference
Neonates, Infants, and Children
to CLAFORAN occurs, the drug should be discontinued and the patient treated
to lignocaine restrictions is advisable).
The following dosage schedule is recommended:
with the usual agents (eg. epinephrine, antihistamine, pressor-amines or
CLAFORAN solutions exhibit maximum stability in the pH 5-7 range.
Neonates:
0-1 week of age
50 m g/kg IV q 12 h
corticosteroids).
Special Instru ctions: Parenteral drug products should be inspected visually
1-4 weeks of age
50 m g/kg IV q 8 h
Pseudomembranous colitis has been reported with the use of cephalosporins
for particulate matter and discoloration prior to administration. Solutions of
Infants
and
children
(1
month
to
12
years).
For
body
weights
less
than
50
kg,
(and other broad spectrum antibiotics); therefore, it is important to consider its
CLAFORAN range from light yellow to amber, depending on concentration and
diagnosis in patients who develop diarrhea during the administration of CLAFORAN. the recommended daily dose is 50 to 100 mg / kg IM or IV of body weight divid diluent used. The dry powder as well as solutions tend to darken, depending
ed into 4 to 6 equal doses, or up to 180 m g/kg/day for severe infections.
This colitis can range from mild to life-threatening in severity.
on storage conditions.
Treatment with broad spectrum antibiotics, such as CLAFORAN, alters the nor For body weights 50 kg or more, the usual adult dosage should be used.
Incom patibilities: Solutions of CLAFORAN must not be admixed with
mal flora of the colon and may permit overgrowth of Clostridium difficile or other The maximum daily dosage should not exceed 12 grams.
aminoglycoside solutions. If CLAFORAN and aminoglycosides are to be ad
Clostridia. It has been established that a toxin produced by Clostridium difficile Administration of CLAFORAN should be continued for a minimum of 48 to 72 ministered to the same patient, they must be administered separately and not
is one primary cause of antibiotic-associated colitis.
hours after the patient defervesces or after evidence of bacterial eradication has as a mixed injection.
Mild cases of colitis may respond to discontinuation of CLAFORAN and replace been obtained; a minimum of 10 days of treatment is recommended for infec Solutions of CLAFORAN should not be prepared with diluents having a pH above
ment with a suitable specific antibiotic. Moderate to severe cases should be manag tions caused by Group A beta-hemolytic streptococci in order to guard against 7.5 such as Sodium Bicarbonate Injection.
ed with fluid, electrolyte and protein supplementation as indicated. When the colitis the risk of rheumatic fever or glomerulonephritis; frequent bacteriologic and clinical Availability
is not relieved by discontinuance of CLAFORAN administration or when it is severe, appraisal is necessary during therapy of chronic urinary tract infections and may Claforan (cefotaxime sodium) is supplied as a sterile, white to pale yellow powder,
an antibiotic specifically effective in antibiotic-associated pseudomembranous colitis be required for several months after therapy has been completed; persistent in
in vials containing 500 mg, 1.0 and 2.0 g of cefotaxime sodium (expressed as
(eg. vancomycin) or other suitable therapy may be indicated. Other possible causes fections may require prolonged treatment. Doses less than those recommended
acid on a dry basis).
of colitis should also be considered (see Averse Reactions).
should not be employed.
S to ra g e : CLAFORAN in the dry state should be stored at room temperature,
Precautions
Dosage for Patients with Impaired Renal Function
protected from light and heat.
CLAFORAN (cefotaxime sodium) should be prescribed with caution in individuals In patients with estimated creatinine clearance of less than 20 mL / min / 1.73m2
Product monograph available on request
with a history of lower gastrointestinal disease particularly colitis.
the dose of CLAFORAN should be halved (see Precautions).
The safety of CLAFORAN in pregnancy has not been established. Consequently, If serum creatinine values alone are available, the following formula (based on Reference
use of the drug in pregnant women requires that the likely benefit from the drug sex, weight, and age of the patient) may be used to convert these values into Jones R.N. et a l.: Antibiotic Prophylaxis of 1036 Patients Undergoing Elective
Surgical Procedures. The American Journal of Surgery, 1987; 153 : 341-346.
be weighed against the possible risk to the mother and fetus.
creatinine clearance.
Use of CLAFORAN in women of child-bearing potential requires that the anticipated
M ales: Weight (kg) x (140 - age) Females: 0.85 x above value
benefits be weighed against the possible risks.
72 x serum creatinine
Cefotaxime is excreted in human milk in low concentrations. Caution should be
exercised when the drug is administered to nursing mothers.
©Registered Trademark
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3. Monitoring and Investigation
of Intra-abdominal Sepsis
Stewart M. Hamilton, MD, FRCSC
Diagnosis and management of intra-abdominal sepsis continue to be major problems
in critically ill patients. Multiple system organ failure secondary to intra-abdominal
sepsis continues to cause serious morbidity and death. The first step in management
is to recognize the infection, while providing careful supportive therapy. A number
of radiologic investigations, including ultrasonography and computed tomography,
will help to diagnose a potential source of infection, which can be positively
identified by fine-needle aspiration and culture. The septic focus must be drained
either percutaneously or, if this fails, surgically. Use of specific antibiotics is
imperative. Delay in diagnosis and surgery increases the death rate, so all available
diagnostic modalities should be utilized, but these should not replace careful
ongoing clinical assessment.

Le diagnostic et le traitement des sepsies intra-abdominales represented toujours
des problemes majeurs chez les patients gravement malades. Les defaillances
plurisystemiques secondaires aux sepsies intra-abdominales sont encore la cause
d’une serieuse morbidity et de deces. Le premier pas de la marche a suivre consiste a
identifier l’infection pendant qu’on assure une therapie de soutien. Un certain
nombre d’examens radiologiques, dont l’echocardiographie et la tomodensitometrie,
aident au diagnostic des sources possibles d’infection; l’identification positive peut
etre faite par ponction-biopsie et mise en culture. Le foyer d’infection doit etre
draine, soit par voie percutanee ou, si cela s ’avere insuffisant, par voie chirurgicale.
L’utilisation d’antibiotiques specifiques s ’impose. Les delais de diagnostic ou les
retards a operer augmentent la mortalite. Tous les moyens diagnostics doivent done
etre mis en oeuvre, sans toutefois que ceux-ci remplacent une evaluation clinique
soigneuse.

n attempt to address all the
abnormal manifestations of ab
dominal sepsis is beyond the scope
of this paper. Prevention is the best
form of management, but when
intra-abdominal sepsis is suspected,
the first step is to establish its

A

presence. In this paper I shall focus
on clinical aspects and laboratory
values that are altered in sepsis and
on x-ray studies that may help to
localize the source. I shall attempt
to define the role of percutaneous
aspiration and drainage of septic
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foci in the abdomen and to address
the complex issue of the diagnostic
laparotomy in the critically ill pa
tient.
Infection within the abdomen
may range from a single unilocular
walled-off abscess, often the sequela
of appendicitis, to a systemic pro
cess resulting in multiple organ
system failure. The sequence of
events, which starts as a local in
flammatory reaction and may prog
ress to hemodynamic instability
with failure of the respiratory, he
patic, renal and coagulation sys
tems, is poorly understood and is
the subject of much research. The
ability of an infective process to
activate the immune response, caus
ing the release of vasoactive media
tors that affect distant organs, is a
concept that has been developed
over the past 10 to 15 years. Re
cent investigations to isolate a com
mon mediator have been directed
toward the white blood cell, specifi
cally tissue macrophages and their
ability to release tissue necrosis
factor (cachetin). This substance
has now been isolated and been
found, in animal studies, to produce
the septic shock syndrome.1
The cause of this syndrome is
multifactorial, and nosocomial in
fection is the most common factor.
In hospitalized patients the bacteri
al environment is altered by medical
practice, invasive monitoring de
vices and surgery, leading to coloni
zation by gram-negative bacteria.
The patients’ host defences may be
blunted by major trauma, anesthe
sia, neoplasia or underlying chronic
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medical disease. With the interplay
of these factors, sepsis can result
from minor infectious processes.
The development of septic shock
syndrome can be catastrophic, with
a death rate of more than 90% in
critically ill patients with intra
abdominal sepsis.2 The occurrence
of organ system failure (renal, he
patic and respiratory) as a function
of time and number of systems
involved, correlates directly with a
poor prognosis.3' 5
Other factors that can adversely
influence outcome in the septic pa
tient include antecedent use of anti
biotics, antimetabolites and cor
ticosteroids, the presence of con
gestive heart failure, azotemia or
diabetes mellitus. Hospital-acquired
infections are much more likely to
result in morbidity and mortality
than community-acquired infec
tions.3 Patients older than 60 years
are at increased risk.6
Local factors that increase mor
bidity and mortality include multiple
abscesses, lesser sac abscesses, pos
itive blood cultures and recurrent or
persistent abscesses.6 From a surgi
cal perspective the development of
peritonitis postoperatively is the
factor of most concern and out
weighs all others, including age.5
The diagnosis of sepsis postopera
tively is difficult and for this reason
reoperation is often delayed. More
over, many of the changes sought
in laboratory and x-ray studies that
are diagnostic of sepsis are altered
by the initial surgical procedure.

Clinical and Laboratory
Manifestations
The alert patient with an abdomi
nal infection usually complains of
abdominal pain associated with a
localized tenderness and guarding.
There is a rise in body temperature,
and a leukocytosis usually greater
than 12.0 X 109/L ; however, pro
found neutropenia with more than
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20% band forms also indicates an
overwhelming infectious process.
Blood cultures from such a patient
not previously on antibiotics will
frequently be positive within 24
hours. The clinical and laboratory
changes that accompany progres
sion of the localized process to the
septic shock syndrome are initially
subtle, but may be rapid.
Mental confusion, tachypnea and
intestinal ileus accompanied by a
coffee-ground aspirate from the na
sogastric tube are early signs of
sepsis. There is usually a bounding
pulse and a warm flushed skin with
sluggish capillary perfusion. The
blood pressure may drop precipi
tously, so that the patient requires
infusion of a large volume of fluid.
Rectal or core temperature is often
greater than 39°C. The platelet
count may be less than 100 X
109/L . Arterial blood gases drawn
during this phase will show hypo
capnia as a compensatory mecha
nism for the metabolic acidosis of
septic shock. Initially hyperventila
tion maintains adequate oxygena
tion, but the situation can deterio
rate rapidly in unchecked sepsis
associated with aggressive fluid re
suscitation.
Invasive hemodynamic monitor
ing is not always necessary for
assessing the progress of septic
shock. However, in patients who
are profoundly unstable after initial
fluid resuscitation or have a history
of respiratory insufficiency or cardi
ac disease, a flow-directed pulmo
nary artery catheter will help in the
administration of fluids. Should
such a catheter be in place, findings
usually indicate a hyperdynamic
cardiovascular system with an ele
vated cardiac output and low sys
temic vascular resistance. Measure
ment of mixed venous oxygen ten
sion reveals peripheral shunting and
poor peripheral oxygen extraction.
The initial hyperdynamic cardiac re
sponse may deteriorate to low cardi

ac output, high peripheral resist
ance and hypoperfusion of the pe
riphery as manifested by poor uri
nary output and a worsening meta
bolic acidosis.23
Although they do not indicate
the source of sepsis, abnormal liver
function measurements occur in a
patient with overwhelming infec
tion. The serum albumin and cho
lesterol levels fall; the serum alka
line phosphatase and serum aspar
tate aminotransferase levels may be
elevated.7 Blood cultures that reveal
a polymicrobial bacteremia in the
absence of a burn wound, an ampu
tation or pulmonary aspiration, al
most certainly indicate an intra
abdominal septic process. The pre
dominant organisms cultured in
clude Enterococcus, Escherichia
coii, Bacteroides fragiiis, Klebsiella
sp, and Pseudomonas sp.8
The best prognostic indicator of
sepsis is the presence of shock
itself. Additional measurements that
help in assessing prognosis include:
arterial lactate levels, which are
higher in septic patients (the over
lap with normals is too great to
allow adequate sensitivity9); metabo
lites of the cyclo-oxygenase system,
which are abnormally high (this test
is not readily available3) and fibronectin levels, which are often
depressed in septic patients (the
wide range of levels lacks sensitivi
ty3’10).

Radiologic Investigations
When clinical and laboratory
findings suggest a septic focus
somewhere in the body, the chal
lenge is to localize the site. Over
the past 10 to 15 years, improve
ments in diagnostic imaging tech
niques have made this task consid
erably easier. However, the abdomi
nal cavity remains a relatively diffi
cult area to evaluate radiologically,
and the decision to re-explore fre
quently must be based on a combiVOL. 31, NO. 5 SEPTEMBER 1988/CJS

INVESTIGATION OF INTRA-ABDOMINAL SEPSIS

nation of suggestive physical and
laboratory findings and radiologic
evidence.
In the critically ill patient when a
history cannot be obtained, the in
vestigation of intra-abdominal sep
sis must also rule out other sites of
infection. Culture material from the
sputum, urine and blood should be
examined routinely to determine if
colonization or active infection is
present. A recent infiltrate seen on
the chest x-ray film, associated with
a leukocytosis and fever, suggests
pneumonia.
If the physical findings suggest
an intra-abdominal infection, a thor
ough radiologic investigation of the
abdomen is warranted. Although
the findings are frequently nonspe
cific, abdominal films may reveal
gastric dilatation, a gas pattern sug
gestive of obstruction or an ady
namic ileus. Sometimes, extralumi
nal gas may be visualized in a
stippled pattern or as an air-fluid
level — both signs of an intra
abdominal abscess. Pneumoperito
neum can be detected on a left
lateral decubitus film. This may
represent perforation of a hollow
viscus, but in the mechanically ven
tilated patient with high airway
pressures, intraperitoneal gas can
occur secondarily to the ventilation.
Contrast x-ray studies of the
upper or lower gastrointestinal
tracts may show perforation or
signs of spasm and mucosal irregu
larity suggestive of an inflammatory
process. When intraperitoneal leak
age is suspected, a water-soluble
contrast agent should be used.
More sophisticated radiologic in
vestigations of intra-abdominal sep
sis include ultrasonography, com
puted tomography and radioisotope
scanning. Ultrasonography is gener
ally available and frequently is the
investigation used first to localize
fluid collections and to look for
visceral disease (e.g., cholelithiasis,
biliary obstruction, liver abscess,
VOL. 31. NO. 5 SEPTEMBER 1988/CiS

splenic abscess). False-positive diag
noses occur with sterile fluid collec
tions or fluid-filled bowel loops that
are thought to be a loculated collec
tion of fluid. False-negative exami
nations result from an inability to
demonstrate the lesion, more so in
the postoperative patient with a
large abdominal incision, multiple
drain sites, obesity and overlying
loops of bowel filled with gas. All of
these conditions compromise the
effectiveness of ultrasonography.11
Radioisotope scanning requires
special equipment and technical
staff. A HIDA scan of the biliary
tree is helpful in diagnosing acalculous cholecystitis. Scanning for a
focus of infection has recently be
come more sensitive and specific
with the advent of leukocyte scan
ning using the radioisotope indi
um-111. This test has supplanted
gallium scanning, particularly for
intra-abdominal sepsis, because
85% of the gallium is excreted in
the colon, making interpretation
difficult. Leukocyte scanning has
the major advantage of covering the
entire body. Preparation for the
scan takes approximately 2 hours
as the leukocytes must be with
drawn in a 30-ml blood sample,
labelled and then reinjected. False
positive results are obtained when
other inflammatory lesions, such as
inflammatory bowel disease or ar
thritis exist in conjunction with a
septic process. Accessory spleens
also will localize the isotope. False
negative results occur in abscesses
with no leukocytes (e.g., fungi, tu
berculosis), in chronic infections
when the polymorphonuclear leuko
cyte response has been blunted, in
patients who have been on long
term antibiotic therapy and in situa
tions in which leukocyte function
may be compromised, such as hype
ralimentation, hemodialysis and hy
perglycemia.11
Although availability may be a
problem, computed tomography of

the abdomen remains the most sen
sitive and specific diagnostic test for
intra-abdominal sepsis. In numerous
studies it has been associated with a
diagnostic accuracy of more than
90%, whether used in conjunction
with other modalities, or alone.211' 15
This degree of accuracy can also be
achieved in the post-laparotomy
state. False-positive diagnoses can
occur in patients with concomitant
necrotic tumours, thick-walled
cysts, seromas or hematomas and
where a bowel loop may simulate a
lesion, a situation usually rectified
by the use of contrast in the bowel
loops. A potential lesion simulating
a loop of bowel or fluid collections
that are identified and subsequently
turn out to be sterile may give rise
to false-negative diagnoses. A fur
ther advantage of computed tomog
raphy is that its accuracy and ana
tomical detail frequently permit per
cutaneous drainage or a localized
drainage procedure.1113

Percutaneous Aspiration and
Drainage
When a potential source of infec
tion is identified by computed to
mography the specific content can
be identified. In the absence of a
coagulopathy, aspiration can be
performed for Gram’s staining and
culture (aerobic and anaerobic).
Fine-needle aspiration poses rela
tively few risks except when the
location of the collection requires a
complicated approach. Transgress
ing the lumen of the colon or small
bowel may invalidate the culture
result or, more importantly, infect a
sterile fluid collection. In general,
however, fine-needle aspiration
poses minimal risk especially with
accurate mapping by computed to
mography.14' 16
The ability to aspirate a potential
source of infection also enables the
radiologist to place a catheter for
definitive drainage. If the abscess
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cavity is unilocular and not very
large, it should be possible to drain
it percutaneously. With experience,
increasingly larger catheters, in
cluding double-lumen tubes, have
been placed using the modified
Seldinger technique. Patients not
eligible for this mode of drainage
are those with extensive abscess
cavities that are anatomically inac
cessible, those with extremely viscid
material in the abscess and those
with a coagulopathy. When there is
no favourable response to percuta
neous drainage after 24 to 48
hours, open surgical drainage is
necessary.14-16
Laparotomy
In assessing the role of laparoto
my as a diagnostic and therapeutic
modality in intra-abdominal sepsis,
it is helpful to use the terms direct
ed and nondirected procedures. For
a time, the nondirected or “blind”
laparotomy was considered a diag
nostic test that could be used liber
ally with an acceptable morbidity
and mortality. This concept has
been refuted by a number of
studies25'1718 demonstrating high
death rates with this technique in
critically ill patients. However, in
the critically ill patient, manifesting
symptoms and signs of infection,
and with no source identified, a
nondirected laparotomy must be
considered. In a recently published
series of such cases2 the procedure
resulted in 58% positive findings
but when another focus of infection
was already identified, the rate fell
to zero. Delaying the procedure
until sepsis was present increased
diagnostic accuracy but decreased
the survival.2
The directed laparotomy is used
when clinical and x-ray evidence
points to an infective process within
the abdominal cavity. Its accuracy
improves as the evidence for an
intra-abdominal septic focus hard
330

ens. More than 90% of patients with
septic shock and a positive blood
culture who have a definitive lesion
on computed tomography were
found to have sepsis at laparoto
my.2 Unfortunately with this degree
of positive findings, the mortality
associated with the septic process
approaches 95%.2
Comments
Diagnosis and localization in the
critically ill patient with a possible
intra-abdominal focus of infection
remains a problem. The first step is
to recognize that infection is pres
ent, and while the source of infec
tion is being localized, careful sup
portive therapy must be provided.
Specific antibiotic therapy is imper
ative. A recent study19 concluded
that steroids have no role in such
patients. Fibronectin, on the other
hand, may have a beneficial ef
fect.10'20
Delay in diagnosis and surgical
intervention are associated with in
creased death rate. In the absence
of a highly sensitive diagnostic test,
an aggressive approach using all
available modalities must be under
taken. The availability of the newest
techniques should not replace care
ful ongoing clinical assessment by
experienced observers (at least one
study18 found physical examination
to be as reliable as the sophisticated
radiologic procedures).
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4. Abdominal Crisis in the Intensive Care
Unit
Paul Gregor, MD, FRCSC; J. Dwight Prodger, MD, FRCSC
Abdominal crises are common in critically ill patients who are admitted to the
intensive care unit for problems unrelated to the abdomen. General surgeons may be
asked to assess these patients for such reasons as pain, distension, possible sepsis,
radiologic or laboratory abnormalities. Since many of the diagnostic signs and
symptoms of acute abdomen are blunted or absent in critically ill patients who may
be comatose or have been given analgesics or steroids, frequent thorough physical
examination and close cooperation with the service admitting the patient are
necessary to ensure early diagnosis and aggressive treatment of the abdominal
crisis.

Les abdomens aigus sont frequents chez les patients gravement malades qui sont
re?us aux soins intensifs pour des raisons autres qu’abdominales. Le chirurgien
general peut etre appele a evaluer ces patients pour des raisons telles que douleurs,
distension, sepsie possible, anomalies radiologiques ou biologiques. Plusieurs des
signes et symptomes diagnostiques sont emousses ou absents chez ces patients
gravement malades qui peuvent etre comateux ou sous l'influence d’analgesiques ou
de steroi'des. II est done necessaire de pratiquer des examens physiques complets et
frequents et d’etablir une etroite collaboration avec le service responsable de
l’hospitalisation afin d’assurer un diagnostic precoce et un traitement vigoureux de
l’abdomen aigu.

ver the past 10 years, intensive
care medicine has grown faster
than the other medical subspecial
ties. Sophisticated methods of inva
sive and noninvasive monitoring
can provide crucial information to
identify numerous pathophysiologi
cal aspects of critical illnesses. The
influence of surgeons in the inten
sive care unit has now become so
important in the ongoing care of

O

severely ill patients that they are
sharing in the coordination of inten
sive care units. Thus, more patients
with advanced age and stage of
disease are being admitted to inten
sive care units and operated on. The
complication rate is correspondingly
higher, but so is the survival of
patients who would not previously
have been considered candidates for
surgery.
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In this paper I shall discuss how
abdominal crises present in the in
tensive care unit, but I shall not
consider specific surgical diagnoses
or postoperative care.
Surgeons are asked to participate
in the management of patients in
the intensive care unit for various
reasons, such as when the patient
has abdominal pain or distension,
sepsis, or when a radiologic or
laboratory abnormality is found that
raises the possibility of an abdomi
nal crisis. Modern pharmacologic
and physiologic manipulation, inter
action and complications of drug
therapy must be well understood by
the surgeon who sees patients with
abdominal crises in the intensive
care unit.

Diagnostic Signs
The surgeon must be aware that
pain in these patients may be mod
erated or even absent, despite the
abdominal crisis, because the pa
tient is obtunded or comatose or is
being treated with analgesics or
steroids. Thus, signs and symptoms
of acute abdomen are useful only if
they can be verified. Similarly, the
signs of peritonitis may be reduced
or absent.
Abdominal distension or an ileus
in a critically ill patient, although
nonspecific, may be the first indica
tor of an intra-abdominal crisis.
Difficult perioperative intubation or
reintubation after respiratory dis
tress may cause a large amount of
331

GREGOR & PRODGER

air to be introduced into the stom
ach, resulting in both gastric and
intestinal distension. However,
other causes are often responsible,
such as fluid and electrolyte imbal
ance, drug interaction or toxicity, a
worsening neurologic condition,
perforated viscus, the presence of
intra-abdominal sepsis or the devel
opment of pancreatitis. Poor cardiac
output with low flow not leading to
frank ischemia, but sufficient to
cause dysfunction in the gastroin
testinal tract, is a not uncommon
complication of ileus. The develop
ment of ileus may be so subtle as to
be suggested initially by the pa
tient’s intolerance to enteric feed
ing.
Jaundice, alone, is seldom a sign
of severe abdominal crisis, the
cause of which is usually multifac
torial. Measurement of the serum
bilirubin and liver enzyme levels
may clarify the situation; ul
trasonography and HIDA scanning
are occasionally required.
The diagnosis of hemorrhage is
usually obvious (Table I), but the
bleeding site may be obscured in
patients with a ruptured spleen,
torn liver or bleeding from intercos
tal vessels due to fractured ribs
associated with resuscitation after a
cardiac arrest. Rupture of an ab
dominal aortic aneurysm can occur
in the intensive care unit. The obvi
Table I - Diagnosis of Hemorrhage
Gastrointestinal tract
Upper
Lower
Cryptogenic origin
Anticoagulants
Postcardiac arrest
Ruptured spleen
Torn liver
Ruptured abdominal aneurysm
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ous upper and lower gastrointesti
nal hemorrhage, common in the
past, is now seen less frequently.
The introduction of H2 antagonists
and aggressive antacid therapy has
reduced the occurrence of stress
ulceration to low levels.
Frequently the general surgeon is
asked to see patients who have
sepsis of unknown origin, as evi
denced by unexplained spiking of
body temperature or, more unusual
ly, by positive blood culture, sug
gesting that the gastrointestinal
tract is the source. Causes would
include intra-abdominal abscesses,
cholangitis, acalculous cholecystitis
(predominantly in critically ill pa
tients), perforated viscus, ischemic
bowel or an infected aortic graft.
Uncontrolled sepsis will lead to mul
tiorgan failure, with subsequent
death of the patient if the cause is
not identified early and treated ag
gressively.
When radiologic investigations
yield unexpected results a surgical
consultation may be necessary.
X-ray films may reveal the presence
of free air on an upright view of the
chest, suggesting a perforated vis
cus, or air in the biliary tree may
suggest biliary tract sepsis. Com
puted tomography has become com
mon in the investigation of intra
abdominal disease. It may reveal
free fluid within the abdomen, pan
creatitis, ischemic bowel or unsus
pected intra-abdominal abscesses.
Computed tomography has low sen
sitivity in the diagnosis of acalcu
lous cholecystitis.
The presence of metabolic acido
sis may suggest a life-threatening
sepsis or ischemic bowel. Determi
nation of serum lactate and phos
phate levels may not be helpful

because of their low sensitivity and
specificity. Plain abdominal roent
genography, angiography and com
puted tomography have all been
used to help differentiate between
sepsis and ischemic bowel in a low
flow state due to poor cardiac out
put. Peritoneal lavage is useful in
diagnosing ischemic bowel disease.
To rule out other causes of meta
bolic acidosis, the anion gap is
determined; if the gap is increased,
the presence of drug-induced and
diabetic acidosis must be eliminat
ed.
Hyperamylasemia is being discov
ered more frequently in critically ill
patients and it is important to dif
ferentiate between the pancreatic
and nonpancreatic forms. Clinical
and radiologic examinations with
the addition of isoenzyme determi
nation can help in the differential
diagnosis.

Summary
It is important to realize that the
signs and symptoms of intra
abdominal catastrophes developing
in the intensive care unit are fre
quently blunted or even absent,
making diagnosis difficult. Frequent
and full physical examinations of
patients are mandatory to detect
early abdominal crises and to pre
vent further complications. Close
cooperation with staff members of
the service admitting the patient to
the intensive care unit will lead to
better understanding, quicker diag
nosis and earlier discharge. It is
important that the general surgeon
take an aggressive approach to
whatever diagnostic investigations
are required.*
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5. The Diagnosis and Management of
Common Soft-Tissue Infections
A.J. Davison, MD; O.D. Rotstein, MD, FRCSC
Soft-tissue bacterial infections range from the superficial, relatively benign form,
readily treated by oral administration of antibiotics, to the highly lethal variety
which requires extensive surgical debridement, administration of broad-spectrum
antibiotics and patient monitoring in the intensive care unit. The key to patient
survival in the latter group is early diagnosis and treatment. Those at risk of
serious infections include diabetic and cirrhotic patients and trauma victims who
have been treated either surgically or medically. In addition to awareness of the
possibility of serious infection, x-ray films of the soft tissue to show gas, aspiration
of fluid collections for Gram’s staining and local incision of the tissue to inspect
fascia and muscle are all useful aids in diagnosis. This review attempts to classify
soft-tissue infections and to recommend an approach to diagnosis and management.

Les infections bacteriennes des tissus mous peuvent prendre une forme superficielle
et relativement benigne qui se traite facilement par l’administration d’antibiotiques
oraux; elles peuvent toutefois etre d’une variete gravissime qui exige un debride
ment chirurgical large, l’administration d’antibiotiques a large spectre et la mise
sous surveillance du patient aux soins intensifs. Dans ce dernier cas la cle de la
survie reside dans un diagnostic et un traitement precoces. Les patients exposes a
des infections serieuses sont les diabetiques et les cirrhotiques, et les traumatises
qui ont re?u un traitement chirurgical ou medical. En plus d’etre aux aguets des
possibility d’infections serieuses, la recherche radiographique de gaz dans les
tissus mous, la ponction des epanchements liquidiens pour coloration Gram, et
l’incision locale des tissus pour examen des aponevroses et des muscles represented
des outils utiles au diagnostic. Cet article propose une classification des infections
des tissus mous et recommande une marche suivre pour leur diagnostic et leur
traitement.

ecause of the durability of its
keratinous layer, the skin is
generally resistant to infection. Dis
ruption of this layer or the presence

B

of a foreign body, such as suture
material or soil, renders the soft
tissues susceptible to infection by a
relatively small bacterial inoculum.
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Diabetes mellitus, vascular insuffi
ciency and venous stasis also en
hance susceptibility of soft tissues
to infection.

Classification
Soft-tissue infections can be clas
sified according to the anatomic
level affected: the skin and subcuta
neous tissues, the fascia and the
muscle layers. Because these layers
are in close apposition, infection in
one layer may initially appear to
involve another. For example, nec
rotizing fasciitis due to Streptococ
cus pyogenes may present with cu
taneous gangrenous changes due to
thrombosis of superficial vessels as
they traverse the infected fascial
layer. Generally, however, clinical
examination and a few basic tests
will lead to the correct diagnosis.
The purpose of this paper is to
review the clinical presentation, di
agnosis and management of com
mon bacterial soft-tissue infections.

Common Bacterial Infections of
the Skin and Subcutaneous
Tissue
Impetigo, erysipelas and folliculi
tis are the most common superficial
infections of the skin and subcuta
neous tissues. These infections gen
erally require no drainage or
debridement but occasionally may
resemble noninfectious lesions and
require biopsy for diagnosis.
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Impetigo, initially vesicular, pus
tulates and ruptures to form the
characteristic golden crusting.1 The
common epidemic variety appears in
infants and children during the
warm, humid months. Minor trau
ma or insect bites predispose to this
highly communicable infection. The
responsible agent initially is Group
A Streptococcus, but rapid superin
fection by Staphylococcus aureus
follows. Gram’s staining shows
gram-positive cocci, and culture of
vesicular fluid or exudate confirms
the diagnosis. Good hygiene and
topical use of antibiotics are help
ful, and penicillin may reduce the
incidence of glomerulonephritis as a
sequela. Erythromycin is an alterna
tive in mixed infections with penicil
linase-producing staphylococci.
Erysipelas is a distinctive superfi
cial cellulitis characterized by a
painful, red, indurated area sharply
demarcated by an advancing border.
High fever and leukocytosis are
common. Erysipelas often occurs in
the lymphedematous extremity fol
lowing radical mastectomy and
chest wall irradiation. Streptococ
cus pyogenes is the usual causative
agent, so penicillin is the drug of
choice. Three to 4 days of parenter
al antibiotic therapy are usually
necessary before the signs and
symptoms resolve.
Folliculitis is a pyoderma located
within hair follicles, usually caused
by S. aureus.2 Extension of this
infection into the subcutaneous tis
sues with involvement of several
hair follicles results in the develop
ment of a furuncle; further exten
sion produces a carbuncle which
causes subcutaneous abscesses with
multiple draining tracts along hair
follicles. This lesion usually occurs
at the back of the neck, on the back
or thighs, and systemic toxicity is
common. Carbuncles and furuncles
associated with cellulitis and fever
should be treated with an antistaphylococcal drug, since S. aureus is
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almost always the infecting organ
ism. Surgical drainage and under
mining through cruciate incisions
are necessary for large, fluctuant
furuncles and all carbuncles.
Cellulitis and subcutaneous ab
scesses are deeper extensions of the
superficial infections and involve si
milar pathogens. Classic cellulitis
due to S. pyogenes is painful and
appears most commonly on an ex
tremity as a poorly demarcated area
of erythema and edema and pain; it
is usually associated with fever,
chills and malaise.
Factors predisposing to cellulitis
are minor trauma or an underlying
skin lesion, although there may be
no apparent break in the skin.
Local skin necrosis and occasionally
abscess formation and gram-nega
tive superinfection may complicate
the condition. Lym phangitis,
lymphadenitis and bacteremia are
common. Cellulitis associated with
diabetic ulcers, decubitus ulcers or
chronic venous insufficiency is al
most always polymicrobial, contain
ing a mixture of gram-positive cocci
and both gram-negative aerobes and
anaerobes.
Standard management for celluli
tis is immobilization, elevation and
parenteral antibiotic therapy which
should include penicillin, usually in
combination with a penicillinaseresistant penicillin such as cloxacillin to cover S. aureus. Cellulitis
associated with diabetic or decubi
tus ulcers requires initial treatment
with broad-spectrum antibiotics
such as an aminoglycoside plus
clindamycin or an advanced-genera
tion cephalosporin. When underly
ing suppuration is signalled by fail
ure of the infection to respond to
antibiotic therapy, incision and
drainage should be carried out with
out delay.
Subcutaneous abscesses fre
quently complicate folliculitis, cellu
litis and trauma.3 Patients have pain
and swelling; systemic toxicity is

less prevalent than with cellulitis,
but lymphangitis and regional ade
nopathy may be present. While fluc
tuation is the sine qua non of
suppuration, it sometimes occurs
late, particularly with perineal and
breast infections. In these cases, the
indication for surgical drainage is
based on the presence of overlying
inflammatory change alone.
Under suitable anesthesia and
sterile conditions, the abscess is
drained and probed digitally. Thor
ough irrigation and loose gauze
packing of the abscess cavity are
important; packing is removed after
48 hours. Antibiotic use is contoversial but indicated in the follow
ing circumstances: in a clinically
septic patient with tachycardia and
fever, in facial or mastoid abscesses,
in systemic conditions such as rheu
matic heart disease and in immunosuppressed patients. Extremi
ty abscesses often result from S.
aureus infection alone, those of the
axilla and trunk frequently contain
a mixture of aerobes, and abscesses
below the umbilicus invariably yield
a mixture of aerobes and anaerobes.
Final culture results should dictate
the antibiotic therapy used.

Gangrenous Infections of
Subcutaneous Tissue and
Fascia
Gangrene of the skin with under
lying infection is a manifestation of
vascular thrombosis at the level of
the subcutaneous tissues, fascia or
muscle. Hence, the clinical finding
of gangrene is not diagnostic of
infection at any particular level, but
rather an indication for further in
vestigation. An x-ray film of the
soft tissues for the presence of gas
is mandatory. Air in the tissues
usually means the presence of gas
forming organisms such as Es
cherichia coli or anaerobic bacteria
and is an absolute indication for
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surgical intervention. Initially a
small incision should be made down
to the level of the fascia for direct
inspection. In necrotizing fasciitis,
the fascia appears grey and stringy
and an instrument can easily be
passed along the deep fascial plane.
Through the same incision, under
lying muscle can also be inspected.
Aspiration of fluid for Gram’s stain
ing and culture may help in the
choice of antimicrobial therapy.
Meleney’s synergistic gangrene is
an ulcerating necrotic lesion of the
skin and subcutaneous tissues
caused by the synergistic action of
microaerophilic streptococci and S.
aureus.4 It usually starts around a
foreign body such as a retention
suture and is characterized by an
ulcer surrounded by a ring of pur
plish-coloured skin, erythematous
at the periphery. Treatment in
cludes removing the foreign body,
excising the necrotic ulcerated tis
sue and providing appropriate anti
biotic therapy.
Clostridial anaerobic cellulitis, a
necrotizing subcutaneous infection,
does not involve deep fascia or
muscle. The associated extensive
crepitus and dark foul-smelling
drainage occur typically in traumat
ic wounds and areas contaminated
by fecal flora. Nonclostridial anaer
obic cellulitis is a similar infection
in which mixed anaerobic flora pre
dominate.
Necrotizing fasciitis is the gener
ic name for any infection causing
necrosis of the fascia. Systemic
manifestations vary, but usually the
patient is extremely toxic and has a
fever and hypotension. Pain may be
minimal because cutaneous sensa
tion is lost. Streptococcal gangrene
is a rare fulminant type of necrot
izing fasciitis caused by Group
A streptococci. Characteristically,
there is extensive skin necrosis re
sulting from thrombosis of the su
perficial vascular plexus. Dusky
patches and large bullae appear
VOL. 31, NO. 5 SEPTEMBER 1988/CIS

within 2 to 4 days, followed by
cutaneous gangrene and a burn-like
eschar. Subcutaneous gas is un
common. Gram-positive cocci are
found in the bullae. Bacteremia,
metastatic abscesses and death may
occur if prompt, radical, surgical
debridement is not carried out and
parenteral penicillin therapy is not
initiated.
The usual form of necrotizing
fasciitis is a synergistic bacterial
infection involving a combination of
aerobes and anaerobes, including
gram-positive cocci and gram-nega
tive bacilli.5 It is an uncommon type
of infection, generally introduced
through a break in the skin or
through the gastrointestinal tract.
Diabetes, cardiovascular disease and
renal disease predispose to the de
velopment of necrotizing fasciitis.
“Fournier’s gangrene”, a necrotiz
ing fasciitis of the scrotum, is char
acterized by extensive cutaneous
gangrene.6 It is frequently associat
ed with ischiorectal abscesses or
penetrating rectal cancers. The tes
ticles are usually spared. Cultures
usually grow facultative organisms
(E. coli, Klebsiella sp and enterococ
ci) and anaerobes (Bacteroides sp,
Fusobacterium sp, Clostridium sp,
anaerobic or microaerophilic strep
tococci).
Management of necrotizing fas
ciitis consists of surgical debride
ment of necrotic tissue, control of
the underlying disease and appro
priate antibiotic therapy. Incision of
the skin and subcutaneous tissue
should extend to healthy fascial
planes. Necrotic fascia should be
completely debrided and the wound
packed open to permit further exci
sion if necessary. For infections of
the perineum, buttock and thigh,
broad-spectrum antibiotic therapy,
effective against anaerobic and aer
obic bacteria, is required. A defunc
tioning colostomy is necessary
when the anorectal region is in
volved. The prognosis depends on

the age of the patient, site of the
infection and the presence of under
lying disease such as diabetes or
renal failure; for example, elderly
debilitated patients with perirectal
infections have a much greater
death rate than young drug addicts
with extremity infections.

Myonecrosis
In clostridial myonecrosis (gas
gangrene), a rapidly progressive
toxemic infection of muscle, Clos
tridium perfringens is the responsi
ble organism in about 90% of
cases.7 Important factors in the
pathogenesis of this infection are
clostridial contamination of devital
ized tissue from the gastrointestinal
tract or soil and the presence of
foreign material in the wound.
These may occur in both surgical
and nonsurgical trauma. Character
istically, severe pain, not in keeping
with the relatively benign appear
ance of the wound, is an early sign
of the disease. The patient rapidly
becomes sweaty and hypotensive
and experiences tachycardia; deliri
um, shock and renal failure follow.
Initially the wound is edematous
and tender and Gram’s staining of
the serosanguineous discharge
shows typical gram-positive bacilli
but few leukocytes. Tissue crepita
tion, blisters filled with dark fluid,
skin necrosis and x-ray films show
ing gas in the muscle are all late
signs.
To improve the poor prognosis
the condition must be diagnosed
early and necrotic muscle radically
debrided; a number of operations
are frequently necessary to accom
plish satisfactory debridement. Am
putation may be required and fasciotomies are occasionally necessary
to decompress and drain adjacent
muscle compartments. High intra
venous doses of penicillin are essen
tial and an aminoglycoside may be
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added for patients with traumatic
wounds. Hyperbaric oxygen therapy
is a useful adjuvant but is not a
substitute for surgical debridement
and antibiotic therapy.
Anaerobic streptococcal myone
crosis is a similar disease with a
longer incubation period and a less
fulminant course. Pain is less prom
inent and toxemia a later develop
ment. Synergistic nonclostridial an
aerobic myonecrosis is a necrotizing
fasciitis involving muscle. In mixed
infections B. fragilis is the key
pathogen; combinations of antibiot
ics and extensive debridement are
required.

Unusual Soft-Tissue Infections
Prophylaxis against infection is
the key to management of human
bite wounds. This is accomplished
by debridement of devitalized tissue
and foreign particles, and primary
repair of divided tendons, nerves
and blood vessels, in addition to
antibiotic and antitetanus therapy.
Superficial wounds are left open. In
bite wounds to the hand, it is
crucial to recognize any hidden in
jury to the extensor tendon and
metacarpophalangeal joint capsule;
oral bacteria thrive in the avascular
tendon tissues and may produce
mixed infections presenting as cel

lulitis, lymphangitis, necrotizing
fasciitis or osteomyelitis.8 Drainage,
debridement and parenteral penicil
lin are required for these estab
lished infections. Animal bites are
managed similarly. Pasteurella multocida inoculated by animal bites
can cause cellulitis, ulceration and
lymphadenopathy progressing to
necrosis and abscess formation.
These infections will respond to
pencillin.
The diabetic foot is subject to
soft-tissue infections due primarily
to peripheral neuropathy.9 Repeated
painless trauma to the pressure
points on the foot leads to ulcer
ation and secondary infection,
which typically is polymicrobial; an
average of five to six aerobic and
anaerobic species are usually cul
tured. Slow healing is aggravated
by peripheral vascular disease. Vari
ous diabetic skin lesions and fungal
infections may also predispose to
secondary bacterial invasion. Cellu
litis should be treated with broadspectrum antibiotics (cefoxitin or
gentamicin plus clindamycin). Con
trol of the diabetes, drainage of
abscesses and debridement of ne
crotic tissue may aid ulcer healing
and avoid amputation. X-ray films
of the soft tissues may indicate the
proximal spread of these undermin
ing infections along fascial planes.
As a preventive measure, podiatric

advice should be sought to recom
mend appropriate foot care and
shoes for diabetics.
We thank Miss Christina Wareham for
preparing the manuscript.
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SESAP V Question
136. Laboratory data supporting the diagnosis of systemic sepsis include all of the following EXCEPT
(A) hypoxemia with a normal chest roentgenogram
(B) platelet count 600,000/cu mm
(C) serum fibrin split products present in > 1:40 dilution
(D) blood glucose 480 m g/dl
(E) cardiac output 11.6 L/min
For the incomplete statement above select the one completion that is best of the five given.
For the critique of Item 136 see page 345.
(Reproduced by permission from SESAP V Syllabus; Surgical Education and Self-Assessment Program No. 5.
For enrolment in the Surgical Education and Self-Assessment Program No. 5, please apply to the American
College of Surgeons, 55 East Erie St., Chicago, IL 60611.)
_________
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Simple Method of Intraoperative Blood
Collection and Reinfusion During Aortic
Surgery
B. Laschuk, MD, FRCSC; K.A. Harris, MD, FRCSC; S.E. Carroll, MD, FRCSC;
G.E. Meads, MD, FRCSC; J.P. Sweeney, MD, FRCSC
The increasing fear of acquired immune deficiency syndrome and other
blood-transmissible diseases and increasing blood-bank shortages prompted a study
of the safety and feasibility of a commercially available hand-held unit for collecting
and reinfusing blood. The device was used on nine patients undergoing aortic
surgery and permitted a mean saving of 2.6 units of banked blood. The reinfusion of
collected blood did not result in any coagulation disturbances or changes in renal
function. The hemoglobin and platelet levels were comparable to those in a group of
patients receiving only banked blood. The unit does not require additional personnel
or technical training for its use. The authors conclude that this autotransfusion
device is a safe and feasible method of reducing the requirement for banked blood
during aortic surgery.
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La peur croissante d’attraper le syndrome d’immunodeficience acquise ou d’autres
maladies transmissibles par transfusion sanguine ainsi que les penuries de plus en
plus frequentes dans les banques de sang, sont a l’origine de cette etude portant sur
la securite et la possibility d’utiliser un appareil portatif, disponible dans le
commerce, pour prelever et retransfuser le sang. L’appareil a ete utilise chez neuf
patients soumis a une chirurgie aortique et il permit d’epargner, en moyenne, 2.6
unites de sang prises sur les banques de sang. La transfusion du sang preleve n’a
entralne aucune perturbation de la coagulation ou modification de la fonction renale.
L’hemoglobine et les plaquettes etaient comparables aux taux mesures chez un
groupe de patients qui rejurent seulement du sang provenant de la banque de sang.
L’appareil n’exige pas, pour son utilisation, de personnel additionnel ou d’une
formation technique speciale. Les auteurs concluent que cet appareil d’autotransfusion represente un moyen sur et applicable pour reduire les demandes a la banque
de sang durant les chirurgies aortiques.
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he increased public awareness
of acquired immune deficiency
syndrome (AIDS) and frequency of

T

blood-transmissible diseases have
sparked another surge of interest in
autologous blood collection and
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reinfusion. Autotransfusion was
first reported by Duncan in 18861
during an amputation of the lower
extremity for a crush injury. Lockwood2 first reported its use in North
America when he reinfused blood
collected during splenectomy for
Band’s syndrome. Since then, tech
niques have improved, and equip
ment has become more sophisticat
ed and costly.34 Cell collection and
washing with immediate reinfusion
is possible but requires special
equipment and trained personnel,
putting this technique out of the
reach of many institutions. A Euro
pean group5 recently reported their
experience with a simple self-con
tained unit not requiring personnel
trained in its use. Because of in
creasing public concern and fre
quent blood-bank shortages, we
used a similar commercially avail
able unit, the Solcotrans unit
(Solco Basle Inc., Boston, Mass.),
to assess the feasibility and
safety of autotransfusion by this
means.

Patients and Methods
Nine patients scheduled to under
go elective aortic reconstruction
were selected for the study. Eight
had abdominal aortic aneurysms
and one required an aortobifemoral
graft. The aorta was exposed
through a midline incision. After
the vessel was controlled proximally
and distally, the indicated graft re337
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placement was performed according
to the surgeon’s usual practice.
Five thousand units of heparin
were administered intravenously,
then the Solcotrans unit was con
nected to wall suction set at 80 mm
Hg and suspended vertically over
the operative field. A suction tip
was connected to the unit using 45
cm of large-bore polyvinyl chloride
tubing which permitted excellent
freedom of movement. Citrate phos
phate dextrose (40 ml) was aspir
ated into the unit, then pooled
blood was withdrawn from the oper
ative field until the heparin effect
was reversed. The unit was agitated
intermittently during the procedure
to encourage mixing of blood with
the anticoagulant. A 170 /rm in-line
filter was used between the suction
tip and the unit.
The unit (Fig. 1) comprises a
rigid plastic container with an inner
polyvinyl chloride lining bag into
which the blood is aspirated. When
the bag is full (500 ml) the tubing is
clamped and disconnected, and the
unit is passed to the anesthetist
(average time less than 1 minute);
another unit may then be set up if
needed. The anesthetist inverts the
unit, attaches a 40 mm filter and
reinfuses the blood through the exit
port. A separate valve between the
inner bag and rigid plastic box
permits safe reinfusion under pres
sure. The unit is not reusable.
The following blood analyses
were carried out before surgery, at
the end of infusion, 1 hour postoperatively and on postoperative day
1: hemoglobin level, platelet count,
prothrombin, activated partial
thromboplastin and thrombin clot
ting times, creatinine and urea ni
trogen levels and a qualitative anal
ysis of free plasma hemoglobin. For
comparison, 12 consecutive pa
tients who previously underwent
aortic aneurysm procedures and re
ceived only banked blood (control
group) were retrospectively re
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viewed. Results were compared
using the unpaired Student’s t-test.

Results
The nine patients received a
mean (± SD) of 2.4 ± 1 .3 units of
autotransfused blood and 1.0 ± 0.9
units of banked packed red cells
perioperatively. Over the same peri
od the control group received 3.6 ±
2.2 units of packed cells. The mean
hemoglobin level fell from 131 ±
16 g /L preoperatively to 116 ± 16
g /L on postoperative day 1, a dif
ference that was not significantly
different from that in the control
group (132 ± 19 g /L to 124 ± 18
g/L). Although there was a signifi
cant fall in the platelet count (243
± 39 X 109/ L to 184 ± 41 X
109/L), the levels remained within
the reference range for our labora
tory and did not differ from the fall
in the control group (304 ± 78 X

109/ L to 232 ± 61 X 109/L).
There was no significant change in
renal function although six of the
nine patients showed signs of a
short-lived rise in free plasma he
moglobin lasting less than 24
hours. Changes in coagulation sta
tus (Fig. 2, Table I) showed that the
preoperative and postoperative lev
els were within normal ranges.
Changes occurring intraoperatively
corresponded appropriately to the
administration of heparin. Fibrino
gen levels remained normal
throughout the study. No ill effects
could be directly or indirectly attri
buted to the auto transfusion. Three
patients received no banked blood
and three received only one unit.

Discussion
None of our findings suggested
that the Solcotrans unit for collect
ing and reinfusing autologous

FIG. 1 — (A) Unit is contained within sterile field suspended from anesthetic
screen, 80 mm Hg wall suction is applied and aspiration port is used to remove
pooled blood from operative field. (B) After unit is full, entire device is passed to
anesthetist who attaches blood filter and uses pressure infusion port to reinfuse
blood. Inner lining bag prevents air infusion.
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blood was unsafe, and the simplicity
of operation coupled with its low
cost makes it available to all hospi
tals. Units previously described
have involved collection, washing
and reinfusion of red cells.34 The
equipment required for this is avail
able in centres doing cardiopulmo
nary bypass but not in other hospi
tals. At least two units of blood
must be salvaged to make auto
transfusion with cell washing costeffective.4 The original unit cost,
the ongoing expense of personnel,
tubing and so on and the inability
to predict operative blood loss reli
ably all make this approach imprac

tical in many centres. The device
described in this study may be
stored on a shelf, is readily available
at any time and does not require
special personnel or training. Each
unit of blood has a self-contained
cost factor and therefore even the
salvage of 500 ml may be practical
if infusion of banked blood can be
avoided.
Although whole, unwashed blood
was infused, no disseminated in
travascular coagulation or major
clotting abnormalities were identi
fied. The 170 /urn aspiration filter
and the 40 /tm reinfusion filter
served to rid the blood of much

y
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FIG. 2 — Changes (± SD) in prothrombin time (hatched bars), activated partial
thromboplastin time (white bars) and thrombin clotting time (dotted bars) demon
strating preoperative and postoperative levels. They were within reference range
for laboratory. Rise in activated partial thromboplastin time and thrombin clotting
time is in keeping with intraoperative heparin dose.
T a b le 1 -

Changes in Results of Coagulation Studies

A

Preop
Study group
Control
Postop
Study group
Control
Postop day 1
Study group
Control

P ro th ro m b in
tim e , s
(8 .8 - 1 2 .4 s *)

A c tivated p a rtia l
th ro m b o p las tin
tim e , s
(2 4 - 4 2 s *)

10.8 ± 0 .2
11.1 ± 0 .5

31.4 ± 3.6
28.9 ± 1.2

9.1 ± 0.8
9.3 ± 0.8

11.7 ± 0 .5
11.9 ± 0 .6

33.9 ± 3.6
42.1 ± 23.8

9.7 ± 0.7
13.0 ± 7.7

11.6 ± 0 .6
12.0 ± 1.2

34.6 ± 1.5
33.3 ± 4.8

8.9 ± 0.8
9.6 ± 1.2

'Normal ranges for our laboratory.
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T h ro m b in
clotting
tim e , s
(6 .6 - 9 .9 s * )

debris. The use of low wall suction
and polyvinyl chloride tubing limit
ed damage to the red cells. If frag
mentation or collection of debris is
unavoidable then the blood may be
washed in the blood bank by stan
dard techniques. At present the au
totransfusion unit, like the more
expensive cell savers, cannot be
recommended for use in con
taminated fields or when malignan
cy is suspected.
There are several disadvantages
to the unit: the low pressure wall
suction may not remove blood from
the field as quickly as portable
suction; it is therefore suggested
that two intraoperative suction de
vices be available, one for blood
that is to be salvaged and one for
blood to be discarded. The Solcotrans unit works best at recovering
pools of blood rather than continu
ous small quantities since larger
volumes are drawn directly into the
chamber containing anticoagulant,
preventing coagulation within the
tubing. Because of the lower suc
tion used with these units to pre
vent red cell damage they may be
less useful in a situation of massive
hemorrhage than in one of predict
ed blood loss. Units can be changed
quickly, but necessitate a short (less
than 1 minute) break in the opera
tion which may occur at an inop
portune time. The maximum num
ber of units that may safely be
reinfused has not been studied.
With continued use one readily
adapts to these inconveniences.
We believe that the Solcotrans
unit is safe to use in aortic recon
struction where there is predictable
blood loss, and its self-contained
nature makes it applicable in hospi
tals where cardiopulmonary bypass
equipment and trained personnel
are not available.

Summary
The self-contained hand-held Sol339
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cotrans unit provides a safe and
feasible method of collecting and
immediately reinfusing autologous
blood during aortic surgery. Small
decreases in hemoglobin levels and
platelet counts were identified, but
they remained within the reference
range and did not differ significant
ly from the control group. Clotting
abnormalities were not identified.
Although free plasma hemoglobin

was evident for a short time in some
patients it had no adverse effects on
renal function. Further study may
result in the use of this unit during
many aortic reconstructions.
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BOOK REV IEW S

ACUTE PANCREATITIS. Research
and Clinical Management. Edited by
Hans G. Berger and Markus Buchler.
394 pp. Illust. Springer-Verlag, New
York, 1987. Price not stated. ISBN
0-387-17534-2.

This publication is the product of an
international congress held in Ulm, Ger
many in the spring of 1987. Contribu
tions from European and American in
vestigators are organized into sections.
Those dealing with morphology, epdemiology, pathophysiology, diagnosis
and prognosis describe laboratory ap
proaches to pancreatitis and attempt to
stratify disease severity. Few of the
methods present any new information;
the various contributors do not reach a
consensus, but rather maintain the es
tablished directions of their own cen
tres. The aim of investigators to find a
common acceptable standard that corre
lates with clinical disease prognosis is
not achieved through the tutorials pre
sented in this book.
The next sections deal with the clini
cal course of acute pancreatitis, biliary
pancreatitis and conservative treatment.
The last two suffer from repetition
through multiauthor descriptions of si
milar material. Nonsurgical therapies
presented include pharmaceutical and
endoscopic management, peritoneal la
vage and parenteral nutrition. The con340

elusions reached are not markedly dif
ferent from accepted outcomes for pan
creatitis reported by other authorities
and from previous publications of these
contributors.
The last three sections of the book
present the editors’ message — the
philosophy and science of surgery for
severe pancreatitis. An attempt to dis
tinguish between severe pancreatitis,
pancreatic necrosis and infected pancre
atic necrosis on the basis of imaging,
pancreatography and bacteriology is
not clarified. In order to select patients
for aggressive surgical treatment of
severe pancreatitis, this distinction is
necessary. Controversy regarding the
stratification is not settled, so that
subsequent sections describing conser
vative and aggressive surgical proce
dures relate methodology and outcome
to a potpourri of pathologic conditions,
and a comparison of results is not valid.
Unless a definition of severity of pan
creatitis is agreed to on a preoperative
basis and accepted internationally, the
application of surgical therapies will
continue to be controversial.
Frank sepsis following pancreatitis is
treated by operation in most centres.
Whether laboratory methods can pre
dict sepsis before it becomes clinically
evident is controversial. To consider
aggressive surgical treatment as an
early modality for preventing clinical

sepsis and reducing morbidity and mor
tality will arouse criticism from those of
conservative persuasion.
Overall, this textbook presents a sur
gical orientation to severe pancreatitis.
The issues presented are at the leading
edge of controversy in management.
The book does not allow conclusions to
be drawn from tutorials as presented in
this book by selected authorities in the
field of acute inflammatory disease of
the pancreas.
Roger G. Keith, MD, FRCSC, FRCS,
FACS
Chief,
Division o f General Surgery,
St. Michael’s Hospital,
Toronto, Ont.

ANAESTHETIC MANAGEMENT OF
CAROTID ENDARTERECTOMY.
Leonard C. Jenkins and David W.H.
Wong. 179 pp. Illust. Lloyd-Luke
(Medical Books) Ltd., London, 1987.
Price not stated. ISBN 0-85324-204-6.

Twenty years have passed since Jen
kins’ review “Anaesthetic consider
ations for carotid thrombo-endarterectomy” appeared in the Canadian Anaes
thetists Society Journal. This new book
continued on page 367
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Review of the Surgical Management of
Recurrent Hiatal Hernia: 5-Year Follow-up
Robert D. Henderson, MB, FRCSC;* Gary Marryatt, RNA; Robert F. Henderson
Symptoms in patients with hiatal hernia often respond to treatment consisting of
diet and medication. Operative procedures, designed to control gastroesophageal
reflux and avoid surgically induced problems, are reserved for those with intractable
symptoms. When these operative procedures fail, reoperation may be necessary. The
reoperative procedure is often technically complex because of esophageal and gastric
scar fixation. The authors reviewed the surgical management of recurrent hiatal
hernia in 168 patients followed up for 5 years or more; 43 of them had undergone
gastric surgery previously.
Radiologically, 97% of patients studied (142 of 146) had no evidence of anatomic
recurrence or reflux postoperatively. Manometric studies postoperatively in 114
patients showed that the mean tone of the high pressure zone was within the normal
range and lower esophageal disordered motor activity was decreased by 34.5% from
the preoperative level. Symptoms of recurrent hiatal hernia were abolished by
operation in 88% of the patients; only 4.8% had serious or recurrent symptoms.

Chez les patients souffrant de hernie hiatale, les symptomes repondent souvent a un
traitement reposant sur le regime alimentaire et la medication. Les interventions
chirurgicales destinees a empecher le reflux gastro-oesophagien et a eviter les
problemes provoques par la chirurgie, sont reservees aux personnes presentant de
symptomes irreductibles. Quand ces interventions echouent, il peut etre necessaire
de reoperer. Cette seconde operation est souvent techniquement complex a cause des
cicatrices gastriques et oesophagiennes. Les auteurs ont passe en revue le
traitement chirurgical de hernies hiatales recidivantes chez 168 patients qui ont ete
suivis pendant 5 ans ou plus; 43 d’entre-eux avaient subi des chirurgies gastriques
precedemment.
A la radiographie, 97% des patients etudies (142 sur 146) n’avaient aucun signe
postoperatoire de recidive ou de reflux. Chez 114 patients, des etudes manometriques postoperatoires ont montre que le tonus moyen de la zone de pression elevee
etait a l’interieur des limites normales et que l’activite motrice dereglee de
l’oesophage inferieur etait reduite de 34.5% par rapport au niveau preoperatoire.
Les symptomes de hernie hiatale recidivante ont ete elimines par l’operation dans
88% des cas; seulement 4.8% des patients ont presente des symptomes serieux ou
recurrents.

From the Department o f Surgery, Women’s College Hospital, Toronto, Ont.
Presented at the 7th annual meeting o f the Canadian Society o f Cardiovascular and Thoracic
Surgeons, held in conjunction with the 56 th annual meeting o f the Royal College o f Physicians
and Surgeons o f Canada, Winnipeg, Man., Sept. 13, 1987
*Deceased. Late Surgeon-in-Chief, Women's College Hospital
Accepted for publication Mar. 21, 1988
Reprint requests to: R.F. Henderson, c /o Department o f Surgery (Diane Coates), 6th Floor,
Women's College Hospital, 76 Grenville St., Toronto, Ont. M5S 1B2
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astroesophageal reflux, a com 
mon cause o f indigestion, o c
curs at all ages and with varying
degrees o f severity. Although reflux-induced symptoms in the ma
jority o f patients respond well to
minor dietary changes and medica
tion, some require H2 blockers. Sur
gery is reserved for those with
severe symptoms not responding to
appropriate medical management.
Operations are designed to control
reflux and avoid surgically induced
problems.
In this paper the term recurrent
hiatal hernia is used to describe
recurrence o f symptoms and major
reflux. Some patients with recur
rent hernia also suffer dysphagia
and overcompetence produced by
their initial operation.1
Surgical management o f a recur
rent hiatal hernia is technically
complex because o f esophageal and
gastric scar fixation. Detailed pre
operative investigation must evalu
ate the gastroduodenal disease and
problems created by the original
operation.
Reports o f the surgical manage
ment o f recurrent hernias are limi
ted2-4 and none have a follow-up o f
as long as 5 years. Most papers on
esophageal surgery do not refer to
the management o f previous associ
ated gastric surgery.5-8 W e there
fore reviewed the surgical manage
ment o f patients who had recurrent
hiatal hernia and were followed up
for 5 years, with reference also to
those who had undergone previous
gastric surgery.

G
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Patients and Preoperative
Studies
Our study was based on 168
consecutive patients (58 men, 110
women) with recurrent hiatal hernia
who were referred for surgery from
other centres and physicians. The
mean age of the patients was 47.2
years (range from 19 to 72 years)
and mean duration of symptoms
was 7.7 years. The patients were
investigated preoperatively by histo
ry (Table I) and radiologic, manometric, acid perfusion and common
cavity pH studies and by esophagogastroduodenoscopy.
Good quality radiologic studies
were available for review in 160
patients. An anatomic hiatal hernia
recurrence was demonstrated in 86
(53.7%) patients, reflux only in 32
(20%) and neither in 42 (26.3%).
Manometric studies were con
ducted in 166 patients, 1 could not
tolerate the procedure and a second
patient had a bleeding esophageal
polyp. The average tone of the high
pressure zone (HPZ) was 12.7 cm
H20 and disordered activity was
present in 45.8% of lower esopha
geal motor waves. Two patients had
clinical and manometric evidence of
scleroderma. Acid perfusion studies
performed on 148 patients were
positive in 131 (88.5%).
All patients underwent esophagogastroduodenoscopy and
were found to have disease in the
stomach as well as the esophagus.
Sixteen (9.5%) had esophageal stric
tures, 6 (3.6%) had severe and ex
tensive ulcerative esophagitis and
17 (10.1%) had moderate ulcerative
esophagitis. One patient (0.6%) had
a bleeding granulation tissue polyp.
Twenty patients (11.9%) had mild to
moderate gastritis, 2 had gastric
bezoars and 1 a bleeding gastritis.
One had a pyloric stenosis, one had
a pyloric ulcer and two had gastric
ulcers.
In addition to esophageal hernia
342

repair, 43 patients had undergone
gastric surgery: vagotomy and
drainage (20), Billroth I gastrec
tomy (5), Billroth II gastrectomy
(14), Billroth II gastrectomy with
Roux-en-Y anastomosis (3) and
esophagogastrostomy (1).

Operative Procedure
The operation in all cases was a
thoracoabdominal total fundoplication gastroplasty (TFG).910 In the
absence of previous gastric surgery,
a pyloromyotomy was added to im
prove gastric emptying.
The thoracoabdominal incision,
started immediately below the xyphoid, extends 10 to 15 cm into
the chest and 5 cm into the abdo
men. It may be further extended in
either direction to improve expo
sure in obese patients or those with
major scar problems. The costal
margin is divided, removing 1 cm of
cartilage directly beneath the xyphoid. The diaphragm is incised
circumferentially, preserving the
phrenic nerve and 1 cm of attach
ment to the chest wall. The esopha
gus is mobilized circumferentially
to the level of the inferior pulmo
nary vein and then along its pericar
dial and mediastinal pleural surfaces
to the inferior margin of the aortic
arch; lateral aortic attachments are
preserved to maintain blood supply
and reduce the risk of vagal nerve
injury. Scar tissue in the vicinity of
the hiatus is now divided.
The diaphragm is elevated and
sutured to the upper edge of the
incision, giving excellent exposure
for the subdiaphragmatic dissection
which is usually the longest part of
the operation because scar fixation
is often intense. Important aspects
of the operation include: entering
the lesser sac, exploring and pre
serving the crural surfaces, protect
ing both main vagi and the hepatic
branch of the vagus nerve, minimiz

ing injury to liver and spleen and
avoiding muscular injury or fenes
tration of the scarred esophagus
and stomach. It is essential to rec
ognize that previous sutures in the
esophagus or stomach may have
included mucosa and, when divided,
a small opening may result and
must be closed.
Mobilization is complete when
the distal esophagus is entirely free
and the proximal four or five short
gastric vessels have been divided. In
dissecting out the previous fundoplication the surgeon must ensure
that there is no damage to stomach
or vagi and the curve is intact with
peritoneal covering.
A first step in the revised repair is
careful placement of crural sutures
which should include the peritoneal
covering of the muscle. In our
experience crural breakdown is the
commonest cause of anatomic re
currence after gastroplasty.
The gastroplasty tube is fash
ioned in continuity from the lesser
curvature of the stomach over a no.
60 French Maloney bougie. It is
closed in two layers with a locking
Dexon and an invaginating 000 silk
suture. In most patients the tube is
5 cm long, but this length is in
creased when there is major eso
phageal shortening. Once the tube
has been created, posterior crural
sutures are tied and fundoplication
commences (Fig. 1). The newly cre
ated fundus of stomach is rotated
T a b le 1 - S y m p to m s in 168 P a tie n ts W ith
R e c u rre n t H iatal H ernia
S ym p to m
H e a rtb u rn
R e flu x
A s p ira tio n
E ru c ta tio n
H ic c o u g h s
W a te rb ra s h
N ausea
V o m itin g
T o ta l d y s p h a g ia
S tric tu re
C ric o p h a ry n g e a l
G a s tro e s o p h a g e a l

%
9 8 .8
7 9 .2
53
7 0 .8
28
25
7 6 .2
3 3 .9
8 7 .5
9 .5
4 1 .7
7 3 .2
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clockwise behind the esophagus
and gastroplasty; it is positioned so
that the tip is exposed in the lesser
sac opening above the hepatic
branch of the vagus. It is anchored
to the distal 1.5 cm of esophagus
and the gastroplasty tube with five
mattress sutures of 00 silk (Fig. 2).
The fundoplication is now comple
ted by approximating medial and
lateral aspects of fundus for 1 to
1.5 cm, using three mattress su
tures of 00 silk (Fig. 3), positioned
carefully to avoid excessive tight
ness of the fundoplication, as this

FIG. 1 — Esophagogastric junction is
exposed following thoracic and abdom
inal mobilization. Proximal short
gastric vessels are divided. Window is
created on medial side in lesser sac
above hepatic branch of vagus nerve,
exposing caudate lobe of liver and
right crus of diaphragm. Gastroplasty
tube 5 cm long is cut over bougie.

FIG. 2 — Fundus is rotated behind
gastroplasty tube and distal 1.5 cm of
esophagus. Medial tip of fundus is held
well posterior, and fundus is sutured
to distal 1.5 cm of esophagus and
through suture line of gastroplasty
tube.
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might produce symptomatic over
competence. Two final mattress su
tures of 00 silk are placed from
fundus to diaphragm.
When the pylorus is intact a
pyloromyotomy is added. In 11 of
the 43 patients with previous gas
tric surgery, the gastric procedure
was modified. In 4 of the 20 with
vagotomy and drainage the proce
dure was further modified in 2 by
conversion from a gastroenterosto
my to a vagotomy, in the third by
adding a gastroenterostomy and in
the fourth by adding an enteroenterostomy to a gastroenterostomy.
Six patients with a previous esophagogastrostomy had this conver
ted to a TFG. One other patient,
with a superior mesenteric artery
syndrome and obstruction to the
third part of duodenum, had a
duodenojejunostomy.
The thoracoabdominal incision is
closed using continuous interlock
ing Dexon suture invaginated with
000 silk. The abdomen is usually
not drained and a chest tube is
placed in the left thorax.

Postoperative Results
There was one postoperative
death (0.6%) from a mesenteric ar-

FIG. 3 — Lateral aspect of fundus is
lifted medially and sutured to medial
fundus with three sutures of 00 silk.
This fundoplication is very loose. Sin
gle suture is also placed to esophagus
medially and two are placed from fun
dus to diaphragm.

tery occlusion, unrelated to surgical
technique. Four patients (2.4%) had
wound infections. One had an em
pyema and one a subphrenic ab
scess, more than 30 days postoperatively; neither of these had evidence
of a fistula. Two patients required
splenectomy for surgical injury.
One patient had bowel obstruction
which resolved spontaneously. Two
patients had a fistula, one from
revision gastric surgery and one
from the TFG. Both fistulas were
drained and closed spontaneously
within 10 days.

Follow-up Evaluation
Follow-up, available for 5 or
more years after surgery, was by
radiologic studies in 146 (86.9%),
manometric studies in 114 (67.9%)
and by history in 163 (97%) pa
tients.
Most of the initial radiologic fol
low-up examinations were carried
out 3 or 5 months after surgery and
were repeated when indicated clini
cally. The water siphon test was
used routinely. Of the 146 patients,
142 showed no evidence of anatom
ic recurrence or reflux. One patient
had a diverticulum, one obstruction
and mucus retention and two pa
tients had anatomic recurrence.
In the 114 patients followed up
by manometric studies, the mean
postoperative HPZ tone was 16.9
cm H20 , an increase of 33.1% over
the mean preoperative HPZ tone
which was 12.7 cm H20. We stud
ied the effect of surgery on the
preoperative tone and found that in
those with a low tone the increase
was marked,11 whereas in those
with a normal or high preoperative
level, surgery did not affect or actu
ally reduced the HPZ tone (Fig. 4).
The average postoperative tone in
all groups was within the normal
range of 15 to 20 cm H20 . The
mean lower esophageal disordered
343
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motor activity postoperatively was
30% in these patients — a mean
decrease of 34.5% from the preop
erative rate of 45.8%.
Comfort and enjoyment of food
are clearly tied to indications for
surgery. A classification by symp
toms was used as follows: group A
— asymptomatic, no evidence of
recurrence or reflux; group B —
minor residual symptoms, no evi
dence of recurrence or reflux;
group C — persistence or recur
rence of symptoms with or without
anatomic recurrence or reflux;
group D — intraoperative or post
operative death. Using this classifi
cation in the 168 patients, we found
that 148 (88.1%) were asymptomat

ic (group A), 11 (6.5%) had minor
residual symptoms (group B), 8
(4.8%) had serious residual or re
current symptoms (group C) and 1
(0.6%) died in hospital (group D)
(Table II).
The major cause of operative
failure was analysed and compared
in those who previously underwent
esophageal surgery only and those
who had both esophageal and gas
tric surgery. Of 125 patients with
esophageal surgery, 6 were in
group B; 3 of them had scleroderma
with some residual dysphagia, 2
had recurrent gastritis and 1 a
diaphragmatic hernia. Two of the
six patients had some emotional
difficulties. There were six failures

FIG. 4 — Comparison of preoperative (dotted bars) and postoperative (hatched
bars) high pressure zone (HPZ) tones show return to normal range of 15 to 20 cm
H20 . Patients with low preoperative tone have major tone increase and those with
hypertonic HPZ preoperatively have tone decrease postoperatively.
T a b le II - R e su lts o f S u rg e ry f o r R e cu rre n ce

G ro u p

A ll p a t ie n ts ,
no. (% )

P r e v io u s e s o p h a g e a l
s u r g e r y o n ly ,
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P r e v io u s e s o p h a g e a l
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A
B
C
D

1 4 8 (8 8 .1 )
11 (6 .5 )
8 (4 .8 )
1 (0 .6 )

1 1 3 ( 9 0 .4 )
6 (4 .8 )
6 (4 .8 )
0 (0 )

3 5 (8 1 .4 )
5 ( 1 1 .6 )
2 ( 4 .7 )
1 (2 .3 )
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(group C); three had an anatomic
and symptomatic recurrence and
three had residual motor dysphagia.
Of the 43 patients who had had
previous gastric surgery, 5 were
classified as group B; 4 had gastri
tis and 1 had dumping. In addition
to gastritis one had psychiatric
problems. Two classified as group C
had esophageal diverticula pro
duced by intraoperative muscle in
jury. The one death in the study
was from a small-bowel vascular
occlusion.

Discussion
Reports on the surgical manage
ment of hiatal hernia recurrence are
sparse and none have documented a
follow-up of 5 years or more. In this
study we examined two aspects —
the effect of one technique of surgi
cal correction and the effect of
preoperative disease on the results
achieved. Some aspects of the preand postoperative findings merit
discussion. In the preoperative in
vestigation it is important to obtain
a thorough history, particularly of
the initial operation, as this helps to
recognize subsequent motor prob
lems and may indicate the effective
ness of reflux control.
Radiologic investigations were of
value in only 73.7% of our cases,
distortion from previous surgery
making interpretation difficult.
Preoperative manometric studies
are valuable in assessing the severi
ty of reflux and previous operative
trauma. Comparison between the
pre- and postoperative HPZ tone
shows that there is a greater aver
age increase in tone postoperatively
in patients with a low preoperative
tone (Fig. 4) and a tone decrease in
those with a hypertonic preopera
tive HPZ. The tone change is useful
in understanding the reflux control
mechanism present in a TFG. Since
tone returns to normal and postopVOL. 31, NO. 5 SEPTEMBER 1988/CIS
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eratively an increase or decrease
depends on preoperative tone, this
effect is best explained by transmis
sion of gastric tone through the
fundoplication. If the gastric wrap
were to cause the increase this
should be equal in each case, rather
than showing a strong relationship
to the preoperative tone.
In this study, all patients with an
intact pylorus had a pyloromyotomy.8 The theoretical rationale for
pyloromyotomy is that vagal func
tion is unlikely to be normal after
two mobilization procedures, even if
the nerves are intact. Poor gastric
emptying is a potential risk of hiatal
hernia surgery, and pyloromyotomy
is used to avoid this. There have
been no operative or postoperative
complications o f this procedure.
Our study has considered two
major factors — hernia recurrence
and previous gastric surgery. The
results achieved are not as good as
previously reported10 in an overall
review of TFG for primary and
secondary repair; 355 patients were
reported 5 years postoperatively. In
that study, group A results were
present in 93.1%, group B in 4.0%
and group C in 2.9%. The preopera
tive pathologic condition affects the

quality of the results and reopera
tive surgery gives poorer results
than primary surgery. Previous
gastric surgery exposes the esopha
gus to biliary and pancreatic secre
tions which can produce major re
flux injury.7’12
Despite these difficulties, the re
sults obtained in our group o f 168
patients have been good. Since this
is the first 5-year review, the results
obtained in comparable groups of
patients subjected to other surgical
techniques must be evaluated to
determine the optimal approach to
the management o f recurrent hiatal
hernia with or without previous
gastric surgery.

References
1. Henderson RD: Dysphagia complicating
hiatal hernia repair. J Thorac Cardiovasc
Surg 1984; 88: 92 2 -9 2 8
2. Herrington JL jr, Ibrahim A: Complica
tions of repeated operations to control
esophageal reflux (esophagogastrocutaneous and esophagogastropericardial
fistulas). Am Surg 1977; 43: 203-207
3. Hill LD, Ilves R, S tevenson JK, et al:
Reoperation for disruption and recur
rence after Nissen fundoplication. Arch
Surg 1979; 114: 542-548
4. Henderson RD: Surgical management o f

the failed gastroplasty. J Thorac Cardi
ovasc Surg 1986; 91: 4 6 -5 2
S, Den B esten L, Z ike
WL: Effect o f bile salts on the ionic
permeability o f the esophageal mucosa
and their role in the production of
esophagitis. Gastroenterology 1975; 68
(4 pt 1): 7 2 8 -7 3 3

5. S afaie-S hirazi

6. W asher GF, Gear MW, Dowling BL, et
al: Duodenal diversion with vagotomy
and antrectomy for severe or recurrent
reflux oesophagitis and stricture: an
alternative to operation at the hiatus.
Ann R Coll Surg E ngl 1986; 68: 2 2 2 226
7. Henderson RD, M ucashe F, Jeejeebhoy
KN, et al: The role o f bile and acid in
the production o f esophagitis and the
motor defect o f esophagitis. Ann Thorac
Surg 1972; 14: 46 5 -4 7 3
8. H enderson RD, M arryatt GV: Reflux

control following gastric surgery. Can J
Surg 1984; 27: 17-19
9. H enderson RD: Reflux control follow
ing gastroplasty. Ann Thorac Surg
1977; 24: 20 6 -2 1 4
10. H enderson RD, Marryatt GV: Total
fundoplication gastroplasty (Nissen gas
troplasty): five-year review. A nn Thorac
Surg 1985; 39: 7 4 -7 9
11. H enderson RD: Esophageal M anom etry
in Clinical Investigation, Praeger, New
York, 1983
12. W asher GF, G ear MW, Dowling BL, et
al: Randomized prospective trial of
Roux-en-Y duodenal diversion versus
fundoplication for severe reflux oeso
phagitis. B r J S urg 1984; 71: 1 8 1 -1 8 4

SESAP V Critique
ITEM 136
The systemic septic response involves abnormalities o f virtually every organ system, due to ill-understood cell
membrane abnormalities. Pulmonary dysfunction characterized by hypoxemia; disseminated intravascular
coagulation (DIC) causing an increase in serum fibrin split products; deranged glucose metabolism resulting in
hyperglycemia, and increased cardiac output due to decreased vascular resistance are all common during severe
sepsis. Thrombocytopenia resulting from DIC, rather than thrombocytosis, is a feature o f sepsis.
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Evaluation of Delivery Systems
Oxygenated Cardioplegia
Roderick W. Landymore, MD, FRCSC; Gerard Myers, RRT, CCP
The oxygen-carrying capacity of four delivery systems for blood and crystalloid
cardioplegia was evaluated: nonoxygenated crystalloid cardioplegia, crystalloid
cardioplegia oxygenated with a bubbler system and with a membrane system and,
finally, blood cardioplegia delivered by the Shiley-Buckberg system. The
nonoxygenated crystalloid cardioplegic solution delivered 0.56 ml of oxygen/dl of
solution, the bubbler oxygenating system delivered 3.2 m l/dl and the membrane
oxygenating system made available 3.7 ml/dl. Blood cardioplegia delivered 4.2
m l/dl when oxygen-carrying capacity was corrected for the shift in the
oxyhemoglobin dissociation curve that occurs with hypothermia. There appears to
be no advantage between blood and oxygenated crystalloid cardioplegia with respect
to the ability of these solutions to provide oxygen to the myocardium during
ischemic arrest. However, the bubbler oxygenating system is superior to the
membrane and blood delivery systems in that it could administer cold cardioplegia at
any time during the operation. In contrast, the membrane and blood cardioplegia
delivery systems both depend on integral heat exchangers which limit the delivery of
cold cardioplegia to the period of hypothermia.

On a evalue la capacite de transport d’oxygene de quatre systemes de cardioplegie
sanguine ou par cristalloide: la cardioplegie par cristalloide non oxygene, la
cardioplegie par cristalloide oxygene a l’aide d’un bulleur ou d’un systeme a
membrane, et, finalement, la cardioplegie sanguine produite a l’aide d’un systeme
Shiley-Buckberg. La solution cardioplegique de cristalloide non oxygene a trans
ports 0.56 ml d’oxygene/dl de solution, l’oxygenateur a bulk, 3.2 m l/dl et le
systeme d’oxygenation a membrane, 3.7 ml/dl. La cardioplegie sanguine a donne
une capacite de transport d’oxygene de 4.2 ml/dl, apres correction pour le decalage
de la courbe de dissociation de l’oxyhemoglobine qui survient avec l’hypothermie. II
ne semble pas y avoir d’avantage pour la cardioplegie sanguine par rapport a la
cardioplegie par cristalloide, en ce qui concerne leurs capacites respectives de
fournir de l’oxygene au myocarde durant un arret ischemique. Neanmoins,
l’oxygenateur a bulle est preferable aux systemes sanguin et a membrane, car il est
capable de fournir une cardioplegie froide en tout temps durant l’operation. Au
contraire, les systemes de cardioplegie sanguine ou par membrane dependent tous
deux d’un echangeur de chaleur qui limite la cardioplegie froide a la periode
d’hypothermie.
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linical investigations1-3 have
suggested that, during pro
longed ischemic arrest, blood cardi
oplegia may provide better myocar
dial preservation than asanguineous
solutions because the former can
oxygenate the ischemic myocardi
um. However, Digerness and col
leagues4 indicated that the affinity
of oxygen for hemoglobin increases
with hypothermia, and oxyhemoglo
bin dissociation does not readily
take place in cold sanguineous solu
tions. This concept has led to the
use of oxygenated crystalloid solu
tions as an alternative to blood
cardioplegia. In this study we evalu
ated a number of delivery systems
for oxygenated blood and asan
guineous cardioplegia, measured
the oxygen availability of these so
lutions and discussed the relative
merits of each delivery system.

V-

r

Patients and Methods
Oxygen-carrying capacity was de
termined for blood and crystalloid
cardioplegia in 32 patients, ranging
in age from 22 to 77 years (mean
60.5 years), who underwent cardiac
operations. The patients were divid
ed into four equal groups of eight
patients each. Group 1 patients re
ceived nonoxygenated crystalloid
cardioplegia and served as controls
(Table I). Group 2 received crystal
loid cardioplegia oxygenated with a
bubbler oxygenating system (Ameri
can Bentley Inc., Irvine, Calif.).
Group 3 received crystalloid cardio
plegia oxygenated with a membrane
oxygenating system (Terumo Corp.,
Piscataway, NJ) and group 4 reVOL. 31, NO. 5 SEPTEMBER 1988/CJS
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ceived blood cardioplegia infused
with a Shiley-Buckberg system
(Shiley Inc., Irvine, Calif.) which
delivered blood cardioplegia in a
ratio of 1 to 4.
Patients who received nonoxygenated crystalloid cardioplegia
(group 1) and crystalloid cardio
plegia oxygenated with a bubbler
system (group 2) were cooled by
means of a recirculation line that
was passed through an aluminum
coil immersed in a bucket of ice.
The cardioplegic solution was
cooled by an integral heat exchan
ger for the membrane crystalloid
oxygenating system in group 3 pa
tients and the Shiley-Buckberg sys
tem in group 4.
The crystalloid and blood cardio
plegic solutions were delivered into
the ascending thoracic aorta by a
roller pump, and cardioplegic tem
perature was monitored by a therm
istor positioned in line with the
delivery system. Samples for oxy
gen saturation were drawn directly
from the cardioplegia infusion cir
cuit during each administration and
every 20 to 30 minutes during
Table 1-

ischemic arrest. Hemoglobin con
centration was used to calculate
oxygen availability in patients re
ceiving blood cardioplegia. Mean
oxygen-carrying capacities for both
blood and crystalloid cardioplegia
were corrected for pH and tempera
ture as previously described by Kelman and Nunn.5

Surgical Technique
The ascending aorta was cannulated with a no. 24 Argyle cannu
la (Sherwood Medical, Saint Louis,
Mo.); in most cases venous return
was provided with a no. 51 twostage Sams cannula (Sarns Inc.,
Ann Arbor, Mich.). Bicaval cannulation was carried out only during
mitral valve replacement or for re
pair of congenital cardiac defects.
Core temperature was lowered to
between 25° and 30°C (mean
25.2°C). Initial cardiac arrest was
induced with an infusion of 10
m l/kg of either crystalloid or blood
cardioplegic solution, which was ad
ministered at 20- to 30-minute in
tervals or in the event of rewarming
or the presence of electromechani
cal activity. Myocardial protection
was augmented in each case with
topical iced saline, and myocardial
temperature was monitored contin
uously with a plunge electrode. Dis
tal and proximal anastomoses were
performed during a single aortic
cross-clamping in patients undergo
ing myocardial revascularization.

C o m p o s itio n o f th e E x tra c e llu la r
C ry s ta llo id C a rd io p le g ia

Component
R in g e r's s o lu tio n , m l
L o w -m o le c u la r-w e ig h t d e x tra n ,
ml
P o ta s s iu m c h lo rid e , m m o l/L
H e p arin , U /L
S o d iu m b ic a rb o n a te , m l
T o ro n to in s u lin , m l

Volume
800
180
25
2000
24
0 .0 4

Table II

Statistical Analysis
The results were reported as the
arithmetic mean ± the standard
error. Statistical comparisons were
made with the unpaired f-test.

Results
In group 1, nonoxygenated crys
talloid cardioplegia provided 0.56 ±
0.6 ml of oxygen/dl of solution
(Table II). In group 2, crystalloid
cardioplegia oxygenated with a bub
bler system increased dissolved oxy
gen to 3.2 ± 0.2 m l/dl and the
membrane system for oxygenating
crystalloid cardioplegia in group 3
made available 3.7 ± 0 . 1 m l/dl.
The membrane system provided sig
nificantly (p < 0.02) more dissolved
oxygen than the bubbler system.
The oxygen-carrying capacity for
blood cardioplegia administered to
group 4 patients measured 11.3 ±
0.5 m l/dl, but when corrected to
take into account the reduced oxy
hemoglobin dissociation that occurs
with hypothermia the actual oxygen
availability was 4.2 ± 0.2 m l/dl.
The blood cardioplegic solution was
significantly (p < 0.0001) more
acidic than the crystalloid solution,
probably reflecting the effects of
carbon dioxide pressure as blood
cardioplegic solution was drawn di
rectly from the oxygenator. The
delivery systems for oxygenated
crystalloid cardioplegia lowered the
temperature of the cardioplegic so-

- O x yg e n A v a ila b ility o f C a rd io p le g ic S o lu tio n s

Crystalloid cardioplegia

Measurement
pH
P 0 2 , m m Hg
P c o 2 , m m Hg
M y o c a rd ia l te m p e ra tu re , °C
C a rd io p le g ia te m p e ra tu re , °C
O x y g e n -c a rry in g c a p a c ity , m l 0 2 / d l

Unoxygenated
(group 1)
7 .9
9 0 .4
8 .9
9 .6
5.1
0 .5 6

± 0 .0 4
± 1.2
± 0 .8
± 1.4
± 0 .2
± 0.61

Bubbler
oxygenated
(group 2)

Membrane
oxygenated
(group 3)

Blood
cardioplegia
(group 4)

8 .3
577
4 .5
1 0 .5
7 .4
3 .2

8 .3 ± 0 .0 4
6 6 5 ± 15
3 .5 ± 0 .4
9 .6 ± 1 .3
7 .6 ± 0 .3
3 .7 ± 0 .0 8

7 .5
259
52
1 2 .5
1 2 .8
1 1 .3
4 .2

±
±
±
±

0 .0 6
27
0 .5
1.1
± 0 .6
± 0 .2

± 0 .0 1
± 25
=t 2 .6
± 0 .4
± 0 .8
± 0 .5
± 0 .2 *

* 0 x y g e n -c a rry in g c a p a c ity o f b lo o d c a rd io p le g ia w h e n c o rre c te d f o r th e s h ift in o x y h e m o g lo b in d is s o c ia tio n c u rv e th a t o c c u rs w ith h y p o th e rm ia .
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lution more effectively (p < 0.0001)
than the Shiley-Buckberg system
for blood cardioplegia. Myocardial
temperature also tended to be lower
after delivery of crystalloid cardio
plegia and was substantially lower
(p < 0.06) with the membrane
delivery system.

Discussion
Blood cardioplegia has been
shown1' 3 to provide better myocar
dial protection than crystalloid car
dioplegia during prolonged hypo
thermic arrest. Its superiority is
thought to be an ability to provide
sufficient oxygen for oxidative me
tabolism. Although this concept is
theoretically attractive, the capabili
ty of sanguineous solutions to deliv
er oxygen during hypothermic ar
rest is considerably reduced because
oxygen binding for the hemoglobin
molecule increases with hypo
thermia, thus preventing oxyhemo
globin dissociation.4 Furthermore,
the oxygen-carrying potential is di
rectly related to the hemoglobin
concentration, which may vary con
siderably with hemodilution. Bodenhamer and colleagues6 found that
blood cardioplegia was capable of
delivering 2.4 ± 0.15 ml of oxygen/dl of solution but asanguineous crystalloid solutions delivered
4.1 ± 0.1 ml/dl at 10°C. Coetzee
and associates7 reported similar
findings and indicated that oxygen
ated crystalloid solutions can deliv
er 4 m l/dl at 10°C. Digerness and
associates4 found that blood cardio
plegia released only 2.4 ml of oxy
gen at 10°C compared with 4 ml/dl
released by crystalloid cardioplegia.
Hypothermia reduces myocardial
oxygen demand. Hearse and col
leagues8 have indicated that at
15°C the oxygen demand is in the
range of 0.3 to 0.4 ml/min for
every 100 g of left ventricle. Similar
results have been reported by Guy
ton and colleagues9 who indicated
348

that the oxygen demand per 100 g
of left ventricle at 15°C was 0.27
ml/min. The nonhypertrophied
heart, therefore, requires approxi
mately 30 ml oxygen every 30
minutes. Our data indicate that oxy
genated crystalloid cardioplegia and
blood cardioplegia can provide oxy
gen between 3 and 4 ml/dl. Thus,
either solution could provide suffi
cient oxygen for oxidative metabo
lism, as long as the multidose cardioplegic technique was used dur
ing the period of hypothermic ar
rest.
Comparison of the delivery sys
tems for both solutions suggested
distinct advantages in using the
bubbler oxygenating system. The
cooling system for bubble oxygen
ated crystalloid cardioplegia con
sists of a recirculation line passed
through an aluminum coil and im
mersed in a bucket of ice. It could
provide cold oxygenated crystalloid
cardioplegia at any time during the
operation. In contrast, the Terumo
membrane system for oxygenated
crystalloid cardioplegia and ShileyBuckberg blood cardioplegia system
depended upon an integral heat
exchanger which required continu
ous cold water cooling. Cold cardio
plegia was, therefore, not available
once the rewarming phase had
started; this is a serious disadvan
tage if the heart has to be rearrest
ed in order to place additional su
tures in an arterial anastomosis.
The temperature of the cardioplegic solution and the final myocardi
al temperature after its delivery was
lower for oxygenated crystalloid
than for blood cardioplegia, because
the Shiley-Buckberg system for
blood cardioplegia employs a pediat
ric cooling system which is less
efficient than that used for oxygen
ated crystalloid cardioplegia. The
lower cardioplegia and myocardial
temperatures obtained with crystal
loid solutions offer a distinct advan
tage over the blood delivery system,

considering that optimal myocardial
temperatures are often more diffi
cult to maintain in patients with
critical coronary artery disease.
In summary, all the oxygenating
systems evaluated can provide suffi
cient oxygen as long as the mul
tidose cardioplegia technique is uti
lized during ischemic arrest. Re
sults indicate that the cardioplegia
temperature and final myocardial
temperature is lower with crystal
loid delivery systems, and that the
bubble oxygenating system is the
only one capable of providing cold
oxygenated crystalloid cardioplegia
at any time during the surgery.
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A n Unusual Facial Injury Highlighting
the Basics of Diagnosis in Maxillofacial
Trauma: a Case Report
Robert Cartotto, MD;* Ronald M. Zuker, MD, FRCSC, FACS
The authors present an unusual and bizarre missile type of maxillofacial injury in a
7-year-old girl, who was struck in the middle of her face by an iron hook. The area
between her forehead and upper lip was obliterated, making a clinical and radiologic
diagnosis impossible. The authors review the current diagnostic methods used in
maxillofacial trauma, including standard and computed tomography, to emphasize
the importance of a correct preoperative diagnosis in the management of
maxillofacial injuries.

Les auteurs decrivent un cas curieux et inhabituel de blessure maxillofaciale par
projectile, subie par une fillette de 7 ans qui fut frappee au milieu du visage par un
crochet de fer. L’espace compris entre le front et la levre superieure etait
litteralement oblitere, ce qui rendait impossible un diagnostic clinique et radiologique. Les auteurs passent en revue les methodes actuelles de diagnostic des
traumatismes maxillofaciaux, dont la tomographie conventionnelle ou assistee par
ordinateur, et ils soulignent l’importance d’un diagnostic preoperatoire adequat
dans le traitement des blessures maxillofaciales.

ccurate documentation of inju
ries sustained in maxillofacial
trauma is often difficult. Clinical
examination may be impaired by
swelling, bleeding, pain, fear and
the patient’s state of conscious
ness.1 Radiologic techniques, in
cluding standard and computed to
mography, may be required to dis
cover the nature and extent of
injury.
We present an unusual case of
facial trauma in which the clinical
and radiologic diagnosis was ob

A

scured. Although the outcome was
favourable, this case serves as a
reminder of the value of a correct
preoperative diagnosis in similar
cases.

Case Report

smashed through the windshield of
a car passing uphill at the same
speed and struck a 7-year-old girl,
riding in the back seat, in the
middle of her face. On arrival at a
nearby hospital the girl was found
to have the majority of the hook
embedded in her face, obliterating
the region between her forehead
and upper lip. Her airway was pa
tent, her vital signs were stable and
there was no external hemorrhage.
She was alert, not disoriented,
speaking clearly and moving all
four limbs. Her medical history in
cluded a tracheostomy for tra
cheomalacia, but was otherwise un
remarkable.
Although the large radiopaque
hook made interpretation of plain
x-ray films difficult, it did not ap
pear to penetrate the cranial cavity
(Fig. 1). However, there was de
struction of the nasoethmoid com
plex, displacement of the cribriform

A transport trailer travelling
downhill at 90 k m /h lost a frag
ment of an iron hook from its load.
The hook, weighing 400 g and
measuring 25 X 15 X 15 cm,
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FIG. 1 — Embedded hook with no
obvious intracranial extension.
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plate and disruption of the left
orbital roof. The cervical spine ap
peared normal.
The girl was given a general
anesthetic, intubated and ventilated;
she was paralysed with pancuroni
um bromide and an orogastric tube
inserted. Ringer’s lactate solution
was given intravenously and 4 mg
of morphine, 200 mg of phenytoin
and 500 mg of cefazolin were ad
ministered. She was then trans
ferred to Toronto by air ambulance.
Examination of the central ner
vous system on her arrival at the
Hospital for Sick Children (Fig. 2)
was impossible because of the ef
fects of the pancuronium bromide.
There was no otorrhea, hemotympanum or rhinorrhea. The chest,
cardiovascular system, abdomen
and extremities were normal. The
globe of the left eye was disrupted
superiorly and displaced temporally
out of the orbit. The right eye had
periorbital swelling, a chemotic con
junctiva and a pharmacologic mio
sis of the pupil. The cornea was
clear and there was a good red
reflex. Fundal examination revealed
retinal hemorrhages and edema of
the nasal retina and optic nerve
head. The fate of the optic nerve
was considered uncertain at this
point.
Fearing hemorrhagic shock on
removal of the hook, we started two
further intravenous infusions,
placed an arterial line, catheterized
the bladder and typed and crossmatched her blood. Since her im
munization status was unknown we
gave 5 ml of tetanus toxoid and
250 units of tetanus immune globu
lin. She also received 200 000 units
of aqueous penicillin G.
The hook created too much ar
tefact to interpret the computed
tomogram of the face. However,
axial scans of the brain showed no
intracranial injury.
In the operating room, we easily
rotated the hook out of its cavity in
350

a direction opposite to the one by
which it entered, suggesting that
the hook had been spinning on
impact (Fig. 3). The defect was
thoroughly irrigated, fortunately
without major hemorrhage.
The nasoethmoid complex, floor
of the nose, maxillary sinuses and
nasal septum were completely de
stroyed. The left frontal sinus had
been penetrated, the right zygoma
and maxilla were fractured outward
and there were bilateral comminut
ed fractures of the anteromedial
orbital walls.
The left eye was enucleated and a
plastic conformer placed in the con
junctival sac, which was then closed
with a running 6-0 catgut suture.
Indirect ophthalmoscopy of the
right eye revealed medial commotio
retinae, a few small retinal hemor
rhages and mild swelling of the
optic nerve head.
The right maxillary fracture,
which ran in the direction of a Le
Fort II, was approached from above
through the wound and from below
through a superior buccal sulcus
incision. The fracture was reduced
and fixed with intraosseous wire
loops. The fractures in the right

medial orbital wall were dealt with
in a similar fashion.
Numerous bony fragments in the
bottom of the cavity were retrieved
and wired together with no. 28 and
no. 30 wires to recreate a nasal
bone. This refashioned nasal bone
was then bridged with intraosseous
wires to the frontal bone using a
bone fragment that must have been
the frontal process of the maxilla
since it fitted perfectly. This scaf
fold was then built up on both sides
by wiring remaining bone fragments
into place (Fig. 4). The mucosal
remnants of the frontal and maxil
lary sinuses were then excised. Two
larger bone fragments, likely from
the bony nasal septum, were placed
as free bone grafts to cover defects
to the right of the nose and in the
right orbital floor.
Both medial canthal tendons
were avulsed from their bony ori
gins and reattached with wire su
tures to the reconstructed nasal
complex.
A viable skin flap based on the
middle segment of the nose was
positioned over the new bony skele
ton. The subcutaneous layers were
approximated with interrupted 4-0

FIG. 2 — Large iron hook embedded
in midface. N ote intact right eye and
displaced left eye.

FIG. 3 — Hook removed from midface.
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Dexon sutures and the skin was
closed with interrupted 6-0 Prolene
sutures.
The girl was transferred to the
intensive care unit and extubated
the following day. Dexamethasone
(25 m g/d) was given for 1 week to
reduce swelling of the optic nerve.
Cefoxitin (2 g/d) was given for 5
days intravenously followed by
cephalexin (1.5 g/d) orally for 2
weeks.
Postoperative computed tomo
grams showed Le Fort I and II

fractures, a displaced fracture of the
cribriform plate and total destruc
tion of the nasoethmoid complex
and maxillary sinuses (Fig. 5).
Over the next few days she
showed steady improvement with
no neurologic deficits except for
anosmia. Her midface was stable
but there was a mild degree of
malocclusion. There was also a
steady serosanguineous rhinorrhea

which was thought to contain cere
brospinal fluid. This drainage
ceased by day 14 and a radionucleo
tide scan at that time was negative.
The right eye gradually opened
as the swelling diminished. The
retina was intact and the edema of
the optic nerve head slowly re
solved. Her visual acuity was per
fect, colour discrimination was nor
mal and there were no visual field
defects or limitations of gaze (Fig.

6)
Plans for follow-up include fur
ther ophthalmologic examination,
placement of a left eye prosthesis,
orthodontic and dental work and
possible craniofacial surgery if the
midface fails to grow with the rest
of the face and head.

Discussion
The diagnosis of maxillofacial in
jury is clinical and radiologic. Al
though the clinical diagnosis is im
portant, its accuracy is reduced by
edema, pain, lacerations and altered
states of consciousness.1 Therefore,
radiologic investigations are crucial
in planning surgical reconstruction.
Standard and computed tomogra
phy may be required in addition to
plain films.

FIG. 4 — Bony architecture recon
structed.

Clinical Diagnosis

Fig. 6b
FIG. 5 — Postoperative direct coronal
computed tomogram. Note Le Fort I
and II fractures.
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FIG. 6 — Appearance 2 weeks postoperatively. (a) Frontal view, (b) lateral
view.

Injuries to the brain, cervical
spine, chest, cardiovascular system
and abdomen take precedence over
maxillofacial injuries.2 Injuries may
be classified as soft tissue (lacera
tions, abrasions, punctures, edema
and burns) or bony.3 Bony injuries
can be approached systematically by
routinely examining four regions:
eyes, nose, face and mouth.
The eyes are inspected for ocular
disparity, subconjunctival hemorrh
age, periorbital ecchymosis and
swelling. The orbital rims are then
palpated for step deformities. The
351

CARTOTTO & ZUKER

eyes are tested for limitation of
gaze and diplopia. Finally the in
fraorbital skin is tested for anesthe
sia. Any positive finding suggests
injury to the orbit or its rim.
The nose is then inspected for
deformity, epistaxis and septal he
matomas and palpated for defects
and tenderness.
The face is assessed for asymme
try and palpated for deformity and
tenderness. Midface stability is eval
uated by grasping the upper central
incisors and attempting to move the
middle third of the face.
Finally, the mouth is inspected
for ecchymosis, malocclusion and
loss of dentition. Sensation in the
mental nerve distribution is exam
ined, and the mandible should be
palpated both externally and intraorally. By following this protocol
important injuries will not be
missed.
Radiologic Diagnosis

Plain views of the face will pro
vide much information. 4 They in
clude the posteroanterior view
(Caldwell) to show the frontal sinus
es, the ethmoid air cells and orbital
margins; the oblique posteroanteri
or view (Waters) to demonstrate the
orbits, maxillary sinuses, zygomatic
and maxillary bones; the lateral
view to show the frontal sinuses,
the lateral orbital walls, maxillas
and mandible; and either the submentovertex or Towne’s view to
assess the zygomatic arches. The
panorex view of the mandible is
used to examine this structure .3
Simple isolated fractures are best
evaluated with plain films. Multiple
complex injuries may require fur
ther study with tomography.5
In linear and pluridirectional to
mography, the x-ray tube and film
move in opposite directions with
respect to a plane in the object,
leaving that plane in focus and all
others blurred. As a result, tomo
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grams give good spatial resolution
and show bony detail well. Howev
er, tomography does not show softtissue detail as well and this is
important when orbital injuries ex
ist. Also, in complex injuries the
blurred images of multiple fracture
fragments outside the plane of in
terest may accumulate and obscure
that plane.6-8 Although maxillary
fractures and orbital wall fractures
(including blowout fractures) are
easily seen on coronal tomograms,
fractures of the zygomatic arches
and anterior maxillary sinus walls
may not be identified. 16
Computed tomography is useful
in the diagnosis of traumatic facial
injuries.59 Direct axial or coronal
scanning may be performed or com
puter-reformatted coronal images
constructed using information from
direct axial scans. Only computed
tomography accurately demon
strates soft-tissue injuries, includ
ing those to the globe, optic nerve
and extraocular muscles. With little
extra delay, additional scans of the
brain can be made to rule out any
associated intracranial injury .5' 10-11
Computed tomography does have
some disadvantages. Fractures par
allel to the plane of scanning are
frequently not seen, therefore, scan
ning in two perpendicular planes is
usually necessary. In particular,
axial scans may miss orbital floor
and inferior orbital rim fractures. 12
Direct coronal scanning requires
that the patient hyperextend the
neck while lying prone or supine.
This is impractical in the intubated
or unconscious trauma patient with
a cervical spine injury. Direct coro
nal scanning may have to be done
later when the patient is stable.
Direct coronal scans may also be
obscured by artefact from dental
fillings. Although reformatted coro
nal scans avoid these problems,
their images lack sharp definition
and they can be difficult to inter
pret.

Computed tomography is most
helpful when direct axial and coro
nal scans are used in a complemen
tary fashion or when axial comput
ed tomograms are used in conjunc
tion with coronal tomograms if di
rect coronal tomography is not pos
sible. In this way most fractures will
be identified and injuries to the
orbit and its contents will be opti
mally shown. 12
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P en ile Corporeal Disproportion:
Long-Term Results of Surgical Treatment
Michael P. Leonard, MD; Alvaro Morales, MD, FRCSC
Penile corporeal disproportion (PCD) is frequently confused with the more prevalent
Peyronie’s disease, with which it shares the characteristic feature of penile
curvature on erection. The authors report on 13 patients with PCD, 9 of whom were
treated surgically, using Nesbit’s technique to correct the curvature. Results were
good to excellent in 89%, with a mean long-term follow-up of 6 years. The
diagnostic process is simple and accurate but requires participation by the patient.
Surgical treatment is indicated when the penile curvature is so severe that it
interferes with sexual intercourse.

La disproportion corporeale penienne (DCP) est frequemment confondue pour la
maladie de Peyronie, laquelle est plus frequente. Les deux partagent une caracteristique commune, soit une courbure prononcee du penis a l’erection. On decrit 13 cas
de DCP, dont 9 patients qui furent traites chirurgicalement a l’aide de la technique
de Nesbit pour corriger la courbure. Les resultats vont de bons a excellents dans
89% des cas apres une periode d’observation moyenne de 6 ans. La procedure
diagnostique est simple et precise, mais elle necessite la participation du patient. Le
traitement chirurgical devient indique quand la courbure du penis devient assez
prononcee pour nuire aux relations sexuelles.

enile corporeal disproportion
(PCD), a developmental defi
ciency involving either the corpora
cavernosa or the corpus spongosium, results in a deviation of the
erect penis toward the affected side
(laterally or downward). An abnor
mal erection is also characteristic of
Peyronie’s disease, but this condi
tion can be distinguished from PCD
by a fibrous plaque that develops in
the tunica albuginea producing a
painful erection in addition to the
penile curvature. Furthermore, pa
tients with PCD give a history of

P

curvature dating back to adoles
cence, but Peyronie’s disease ap
pears typically during middle age or
beyond.

Patients and Methods
From January 1979 to June 1986
we investigated 13 patients with
PCD. All were assessed by history,
physical examination, autophotog
raphy,1 cavernosography and the
induction of an artifical erection by
intracavernosal saline injection.
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Home autophotography, a tech
nique popularized by Kelami1 most
readily demonstrated the penile cur
vature. Three positions (superior,
lateral, anterior) were used (Fig. 1).
Cavernosography, dorsolateral
puncture of one of the corpora
cavernosa with a butterfly needle
and injection of 50 to 70 ml of
diluted contrast medium followed
by an x-ray film was used to show
the corporeal disproportion.
With the same butterfly needle,
an artificial erection was induced by
injecting normal saline with a pump
at a rising flow rate (60 to 150
ml/min). The dorsal, ventral or
lateral aspects were photographed.
With PCD the deviation is usually
lateral or ventral (Fig. 2).
Four patients did not require im
mediate surgical intervention two
because they were preadolescents
and two adults because they had
only moderate curvature, not seri
ously interfering with sexual perfor
mance. The abnormality was cor
rected surgically in nine patients
using the technique described by
Nesbit.2
Patients were followed up at reg
ular intervals ranging from 6
months to 8 years (mean 59
months) and autophotography was
done at least once postoperatively.

Surgical Technique
Nesbit’s procedure2 is as follows.
A circumcoronal incision is used.
Penile skin is retracted to its base
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and the penis insufflated with nor
mal saline to induce an artificial
erection. One or more ellipses are
then excised from the tunica al
buginea of the corpus on the con
vex portion of curvature (Fig. 3).
The resulting defects are then
closed with interrupted absorbable
sutures (Fig. 4). Depending on the
site of the excision, the dorsal neu
rovascular complex or the urethra
may need to be isolated and mobi
lized. A pressure dressing and a
urethral or suprapubic catheter are
left in place for 48 hours.

Results
The results (Table I) were classi-

fied as excellent if, on erection, the
penis was straight and the patient
able to have satisfactory inter
course, good if there was residual
penile curvature but intercourse
was satisfactory and poor if penile
curvature was the same or worse, if
there was penile sensory deficit or if
intercourse was not possible for
mechanical or psychologic reasons.
Six of the nine patients were
considered to have an excellent out
come and two were classified as
good. Of the latter group one had
an excellent initial result but several
months later scarring developed at
the operative site and the curvature
returned with features of Peyronie’s
disease. He is currently being followed-up at another institution and

is receiving treatment with vitamin
E; the second patient had an excel
lent result after his operation, but 6
years later presented with a slight
penile deviation on the opposite
side, characteristic of Peyronie’s
disease. The one patient with a poor
result had good straight erections
initially; however, 1 year later he
complained of short duration of
erections, decreased libido and in-

FIG. 2 — Lateral deviation in PCD
demonstrated by induction of artifical
erection.

Fig. la

Fig. lb

FIG. 1 — Penile corporeal disproportion (PCD) demonstrated by home autophotog
raphy using technique described by Kelami.1

FIG. 4 — Defect closed with interrupt
ed absorbable sutures.
Table 1-Outcome of Surgical
Treatment for Penile
Corporeal Disproportion*

Fig. 3a

Fig. 3b

FIG. 3 — Ellipse excised from tunica albuginea of corpus on convex side of
curvature.
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Result

No. (%)

Excellent
Good
Poor

6 (67)
2 (22)
1(11)

*Mean follow-up was 59 mo.
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ability to perform with a “mutilated
tool”. On further assessment psy
chologic problems were found to be
mainly responsible for his dysfunc
tion.

D iscussion

Congenital corporeal dispropor
tion is an uncommon cause of sexu
al dysfunction. However, it is im
portant that the physician be aware
of its occurrence since it is easily
confused with the more common
Peyronie’s disease. In the differen
tial diagnosis, a long history of
penile curvature on erection likely
indicates PCD, but a history of
acquired penile curvature with pain
on erection and no history of trau
ma or surgery is more in keeping
with Peyronie’s disease, particularly
beyond the fifth decade of life.
No physical defects are noted on
the flaccid penis in cases of PCD,
but in Peyronie’s disease or posttraumatic curvature, a plaque or
skin tethering are frequently pres
ent; the plaque can readily be dem
onstrated by ultrasonography. On
cavernosography a disparity in the
length of the corpora may be clearly

shown in patients with PCD, but in
those with Peyronie’s disease an
area of corporeal irregularity or a
filling defect may be detected. In
duction of an artificial erection
shows typically lateral or ventral
deviation of the penis and curvature
is most frequently in a dorsal direc
tion (Fig. 5).
Use of Nesbit’s technique usually
results in some loss of penile length
and often leaves a depression at the
site of excision (Fig. 6). To avoid
these residual defects Saalfeld and
colleagues3 used transverse ellipses
on the shorter corpus. The ellipses
are closed longitudinally in Heineke-Mikulicz fashion to obtain addi
tional length, compensating for the
shortening of the corpus. More re
cently Kelami4 has advocated the
use of continuous folding sutures
to prevent the appearance of a
depression where the segment of
tunica has been removed. We re
cently treated a patient in this fash
ion but follow-up has been too
short to assess the final result.
Utilizing the Nesbit2 procedure or
one of its variants, eight of nine
patients in our series obtained good
to excellent results. These compare
well with the results of one of the

most recent reports5 which indi
cates an 80% to 90% success rate in
the surgical correction of PCD.
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FIG. 5 — Dorsal deviation of penis
typical of Peyronie's disease.
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FIG. 6 — Depression of penis at site of
excision of ellipse of tunica albuginea.
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A ssociation of Breast Cysts and Breast
Cancer
J.E. Devitt, MD, FRCS(Edin), FRCSC
A review of 915 consecutive patients with breast cancer and 812 with breast cysts
showed that an association between the two is uncommon — 5% of breast cancers
were associated with cysts and 4% of cysts were associated with breast cancer. Four
types of association were identified: (a) cystic cancers — easily diagnosed because of
the characteristic features of the aspirate, failure of the mass to disappear and early
recurrence in a patient whose age and menstrual status were not usually associated
with cysts; (b) cancers occurring simultaneously with breast cysts — recognized
because they did not contain cyst fluid; (c) cysts occurring after breast cancer —
diagnosed by aspiration of the mass in premenopausal women; (d) cancers in
patients who have had breast cysts — usually occurring many years after the cyst
aspiration when menses had ceased. These associations were not sufficiently
frequent to justify specific follow-up, but all suspected cysts should be successfully
aspirated to confirm the clinical diagnosis.

L’etude de 915 patientes consecutives souffrant de cancer du sein et de 812
patientes ayant des kystes mammaires a revele qu’une association entre kystes et
cancer est peu frequente — 5% des cancers du sein ont ete associees a des kystes et
4% des kystes a un cancer du sein. Quatre types dissociations ont ete releves: a) les
cancers kystiques — facilement diagnostiques grace aux caracteristiques particulieres de la ponction-biopsie, a la persistance de la masse et a la recidive precoce
chez une personne dont l’age et l’etat menstruel ne sont pas generalement relies a
des kystes; b) les cancers qui surviennent concomitamment avec des kystes
mammaires et que l’on peut reconnaitre du fait que la ponction-biopsie ne ramene
pas de liquide kystique; c) les kystes qui surviennent apres un cancer du sein et qui
sont diagnostiques par ponction-biopsie de la masse chez des femmes qui ont un
cycle menstruel; d) les cancers vus chez des femmes qui ont deja eu des kystes
mammaires et qui surviennent habituellement plusieurs annees apres une biopsie du
kyste et apres l’arret des menstruations. Ces associations ne semblent pas etre assez
frequentes pour justifier une surveillance periodique specifique. Neanmoins, tout
kyste suspect doit faire l’objet d’une ponction-biopsie pour confirmer le diagnostic
clinique.

reast cysts are easily diagnosed
and treated in the office by
simple aspiration.1 Although breast
cysts and breast cancer each occur

B

in about 9% of Canadian women,
their association in the same patient
is uncommon, so lack of experience
may cause the surgeon either to
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delay diagnosis or to use excessive
intervention.
The purpose of this study was to
find out if there was an association
between breast cysts and breast
cancer. It was hoped that such a
review would not only reveal epide
miologic information of interest but
identify certain diagnostic features
o f breast cancer associated with
breast cysts that would lead to
confident, prompt and appropriate
management.

Patients and Method
The charts of all patients with
new breast cancers (915) and all
patients with a breast cyst (812)
seen for the first time in a consult
ing practice during the years 1971
to 1986 inclusive were reviewed.
The cancers were diagnosed histo
logically. Most cysts were diag
nosed by simple aspiration, the re
mainder at biopsy. Each new breast
cancer, whether ipsilateral or con
tralateral, was counted separately,
but, because of multiplicity and re
peated recurrence, breast cysts were
only counted once — at the time
the patient was first treated. Some
o f the breast cancer patients
claimed to have had previous breast
“ cysts” , but because the diagnosis
was usually not verifiable, this in
formation was not considered.

Follow-up
The 812 patients with cysts were
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BREAST CYSTS AND BREAST CANCER

followed up from 1 to 16 years,
451 for 5 or more years and 192
for 10 or more years. There were
over 5000 patient-years of follow
up.

-*

Observations
-

»

There were four ways in which
breast cysts and breast cancers were
associated.
Cystic Carcinomas

*

Of the 915 patients, 11 (1.2%)
had cystic neoplasms, that is, fluid
could be aspirated from the mass.
The patients ranged in age from 30
to 80 years but nine were aged 52
years or older. Only two patients,
aged 30 and 35 years were men
struating. The size of the lesion
varied from 0.5 to 15 cm; in all but
one patient the lesions were 4 cm or
smaller.
The aspirate was bloody in 8 of
the 11 patients; in 7 of them there
was a residual mass after aspiration
and in the other the cyst recurred
promptly. In the three patients
without a bloody aspirate, two had
a residual mass after aspiration, and
in the third the aspirate was unusu
ally thick and the mass recurred
quickly. Cytologic examination of
the aspirate in seven patients was
suggestive of or positive for malig
nancy in only three.
Nine of the patients had no can
cerous nodes, one had axillary
lymph-node metastases and one had
distant metastases.
Simultaneous Cysts and Cancer

There were 10 patients with si
multaneous cysts and cancers (1.2%
of those with cysts and 1.1% of
those with cancer). In 6 of the 10
patients the lesions were ipsilateral.
The patients ranged in age from 40
to 83 years and eight were 53 years
VOL. 31, NO. 5 SEPTEMBER 1988/CIS

or younger; six of the eight were
menstruating, one had had an
ovary-preserving hysterectomy and
the last patient was taking a hor
monal supplement.
Tumour size varied from 0.6 to
10 cm, but in nine instances it was
3 cm or smaller (one patient had
two simultaneous cancers).
In two of the patients there was a
mass clinically suggestive of cancer
(5 and 10 cm in diameter) and a
coincidental cyst was recognized,
which was aspirated and did not
recur. In the remainder, the mass
could not be aspirated, although in
one blood was obtained.
Cytologic examination of aspirate
gave negative results in three of the
six patients in whom it was per
formed. In six patients there were
no cancerous cells in the nodes,
in three patients there were axillary
lymph-node metastases and in one
other the tumour was locally ad
vanced.
Cysts Appearing A fte r a Breast
Cancer

In six patients a breast cyst devel
oped after diagnosis of breast can
cer. These patients ranged in age
from 44 to 52 years and all were
menstruating. The cysts were diag
nosed from 2 months to 20 years
after the diagnosis of breast cancer;
four were diagnosed by aspiration
and two by biopsy.
Breast Cancer Appearing A fte r a
Breast Cyst

In 20 of the patients with breast
cysts, 21 cancers subsequently de
veloped. Twelve cancers were ipsi
lateral and 9 contralateral (one pa
tient had bilateral breast cancers
and two patients had bilateral
cysts). The cancers were recognized
from 6 months to 13 years (median
78 months) after the first diagnosis
of a cyst.

Discussion
In spite of the uncommon associ
ation of breast cancers and breast
cysts, the observations reported
herein allow a confident clinical
diagnosis to be made in the office.
Most authorities2' 6 are prepared to
diagnose cysts by aspirating them,
without the unnecessary cost or
delay incurred by cytologic exami
nation or imaging procedures.
This study has confirmed an ear
lier report7 that cystic carcinomas
can be diagnosed with ease clinical
ly. They usually occur in women
past the age at which cysts are
expected, who are postmenopausal.
The aspirate is generally bloody or
differs from the usual thin, watery,
green, brown, yellow or grey cyst
fluid. Frequently, there is either a
residual mass after aspiration or
prompt recurrence. This combina
tion of clinical observations will
allow a confident diagnosis. Unfor
tunately, the results of cytologic
examination are often negative,7
presumably because cystic degener
ation results in an absence of recog
nizable cells in the fluid.
The rarity of simultaneous cysts
and breast cancer must be appreci
ated.8 Only 10 of the 812 patients
with cysts had such an association
even though in 75% of 812 patients
further cysts developed, in many
cases being multiple. Simultaneous
cysts and breast cancers were rec
ognized usually when another ap
parent cyst did not contain fluid on
attempted aspiration. Although cy
tologic examination of the aspirate
may be helpful, it will not always be
so. Thus, all suspected cysts should
be aspirated for diagnosis, and a
localized mass that cannot be made
to disappear by aspiration should be
formally biopsied.
Cysts after breast cancer are un
common2’8 but happy occurrences.
It is usually assumed that the pa
tient has a new breast cancer. If she
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is premenopausal, aspiration should
always be done because occasional
ly the lesion will be a cyst and not a
carcinoma; thus, anxiety and mor
bidity can be prevented.
There are reports3'58’9 claiming
that in patients with breast cysts,
breast cancer is two to four times
more likely to develop. The ultimate
incidence of cancers developing
after breast cysts is, of course, a
function of the length of follow-up
and is the major purpose of this
ongoing study. To date, the rela
tively small number of cancers
found (21) in the 812 patients with
breast cysts militates against any
special follow-up of patients in
whom breast cysts are diagnosed. It
may be that these patients will
eventually be found to be at higher
risk for breast cancer than others

but it appears now that the risk and
the yield are not sufficient to justify
a long follow-up. Fortunately, the
recognition of subsequent cancers
is facilitated because they occur
years after the cysts have stopped
forming when menstrual cycles
have ceased.5

Surgery, 4th ed, McGraw, New York,

1984: 536

5. H arrington E, L esnick G: The associa
tion between gross cysts of the breast and
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291-296
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(imipenem and cilastatin sodium for injection)
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the first carbapenem antibiotic

PRIMAXIN LV

(imipenem and cilastatin sodium for injection)
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A carbapenem, representing a totally new class of antibiotics

The broadest spectrum
single-agent antibiotic
possessing bactericidal activity against a great
m ajority of clinically significant pathogens

PRIMAXIN* offers the activity of
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the penicillins against gram-positive aerobes including coverage of Streptococcus faecalis

plus
the aminoglycosides and 3rd generation cephalosporins
against gram-negative aerobes including coverage of Pseudomonas aeruginosa
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plus
the antianaerobic agents including coverage of Bacteroidesfragilis

PRIMAXIN* is not active against Corynebacterium group JK, Fusobacterium varium, Mycobacterium spp.,
Chlamydia spp, Streptococcus faecium, Pseudomonas maltophilia, and some strains of: P. cepacia,
P. pseudomallei, methicillin-resistant staphylococci, and Plavobacterium spp.

Single-agent antibiotic for
documented and empiric
therapy in many importan
infections'

including
□ infections usually treated with combination
therapy
□ infections complicated by underlying
disease
□ nosocomial infections

Imipenem and cilastatin sodium are present in a 1:1 ratio in PRIMAX1N* I.V.
Imipenem is the sole antibacterial component. The role of cilastatin sodium is to
prevent the inactivation of imipenem in the kidney and obtain antibacterial
concentrations of imipenem in the urine.

+Caused by organisms susceptible to PRIMAXIN* I.V.
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Clinical efficacy in m any
im portant infections
EFFICACY IN INTRA-ABDOMINAL INFECTIONS

91% cure or
improvement
in 1 6 4 evaluable patients
1. Kager, L., Nord, C.E.: Imipenem/
cilastatin in the treatment of intra
abdominal infections: A review of
worldwide experience, Rev Infect Dis
7 (Suppl 3): S518-S521, July-August
1985.

EFFICACY IN LOW ER RESPIRATORY TRACT
INFECTIONS

2

85% cure or
improvement

v

in 2 0 4 evaluable
patients
2. Acar, J.F.: Therapy for lower
respiratory tract infections with
imipenem/cilastatin: A review of
worldwide experience, Rev Infect Dis
7 (Suppl 3): S513-S517, July-August
1985.

fCaused by organisms susceptible to PRIMAXIN* IV.
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EFFICACY IN BACTERIAL SEPTICEM IA

90% cure or
improvement
in 135 evaluable
patients
3. Eron, L.J.:
Imipenem/ cilastatin
therapy of bacteremia,
Am J Med 78 (Suppl 6A):
95-99, June 7, 1985.

EFFICACY IN GYNECOLOGICAL
INFECTIONS4

97% cure or
improvement
in 72 evaluable
patients
4. Sweet, R.L.: Imipenem/
cilastatin in the treatment
of obstetric and gynecologic
infections: A review of
worldwide experience,
Rev Infect Dis 7 (Suppl 3):
S522-S527, July-August 1985.
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PRIMAXIN* I.V offers management
advantages over combination ibeiapy
that includes an aminoglycoside
G enerally well tolerated safety profile
sim ilar to cefazolin 3
□ 1723 patients, including the severely ill, have received therapy in clinical trials.
The incidence of the most common adverse experience (nausea) was no greater
than 2%.
□ Avoids the potential nephrotoxicity or ototoxicity experienced with
aminoglycosides.
□ Avoids the potential hypoprothrombinemia and clinical bleeding experienced
with cephalosporins with M TT side chain.
□ Avoids the potential disulfiram-like effect experienced with metronidazole and
cephalosporins with MTT side chain.

Convenience of a single agent
The broadest spectrum single
agent antibiotic representing
a transformation of parenteral
antibiotic therapy
5. Calandra G.B., Ricci F.M., Wang C., Brown K.R.: Safety and
tolerance comparison of imipenem/cilastatin to cephalothin and
cefazolin, J Antimicrob Chemother 12 (suppl D): 125-131,1983.
+ Certain antibiotics which possess, as part of their molecular structure, the l-methyl-5-thiotetrazole (MTT)
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a disulfiram-like effect.
TEN-88-CDN-1049-JA

| P A A~B~|

MSP
MERCK
SHARfT
DOHME
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(imipenem and cilastatin sodium
for injection)
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Antibiotic
CNS adverse experiences such as myoclonic
activity, confusional states, or seizures have
been reported with PRIMAXIN* especially when
recommended dosages based on renai function
and body weight were exceeded. These exper
iences have occurred most commonly in patients
with CNS disorders (e.g., brain lesions or
history of seizures) and/or who have compro
mised renal function. However, there were rare
reports in which there was no recognized or
documented underlying CNS disorder. Close
adherence to recommended dosage schedules
is urged, especially in patients with known factors
that predispose to seizures.

Neisseria
Proteus (indole positive and indole negative
strains)
Providencia
Pseudomonas aeruginosa
Serratia marcescens

Gram-positive Anaerobes

•
•
•

Clostridium (excluding C. difficile)
Peptococcus
Peptostreptoccus

Gram-negative Anaerobes

•
•

Bacteroides fragilis
Bacteroides (non-fragilis)

CONTRAINDICATIONS
PRIMAXIN* (imipenem and cilastatin sodium for
injection) is contraindicated in patients who have
shown hypersensitivity to either component of this
product.

ACTION

WARNINGS

Imipenem exerts a bactericidal action by inhibiting
cell wall synthesis in aerobic and anaerobic gram
positive and gram-negative bacteria.

PRIMAXIN* (imipenem and cilastatin sodium for
in je c tio n ) SHOULD BE ADMINISTERED WITH
CAUTION TO ANY PATIENT WHO HAS DEMONS
TRATED SOME FORM OF ALLERGY, PARTICULARLY
TO STRUCTURALLY-RELATED DRUGS. IF AN
ALLERGIC REACTION TO PRIMAXIN* OCCURS,
DISCONTINUE THE DRUG. SERIOUS HYPER
S E N S IT IV IT Y R EACTIONS MAY REQUIRE
E P IN E P H R IN E AND OTHER EMERGENCY
MEASURES.

P R IM A X IN * con sists o f tw o co m p o n e n ts :
(1) im ipenem , a derivative of thie nam ycin , a
carbapenem antibiotic; and (2) cilastatin sodium, a
specific inhibitor of dehydropeptidase-l a renal
enzym e w hich m etabolizes and in a c tiv a te s
imipenem. Cilastatin blocks the metabolism of
im ipenem in the kidney, so that concom itant
administration of imipenem and cilastatin allows
antibacterial levels of imipenem to be attained in the
urine.
Inhibition of cell-wall synthesis is achieved in gram
negative bacteria by the binding of imipenem to
penicillin binding proteins (PBPs). In the case of
E s c h e r ic h ia c o li and s e le c te d s tra in s o f
Pseudomonas aeruginosa, imipenem has been
shown to have highest affinity for PBP-2, PBP-1a
and PBP-1 b, with lower activity against PBP-3. The
preferential binding of imipenem on PBP-2 and
PBP-1 b leads to direct conversion of the individual
cell to a spheroplast resulting in rapid lysis and cell
death without filament formation. When imipenem
is removed prior to complete killing of gram 
negative species, the remaining viable cells show a
measurable lag, termed a "post-antibiotic effect”
(PAE), prior to resumption of new growth.

INDICATIONS AND CLINICAL USE
PRIMAXIN* (imipenem and cilastatin sodium for
injection) may be indicated in the treatment of
serious infections when caused by sensitive strains
of bacteria. Where considered necessary, therapy
may be initiated on the basis of clinical judgment
before results of sensitivity testings are available.
Continuation of therapy should be reevaluated on
the basis of bacteriological findings and of the
patient’s clinical condition.
Imipenem is active in vitro against a wide range of
gram -positive and gram-negative aerobic and
anaerobic bacteria, including most strains which
are beta-lactam ase producing. Patients have
responded while under treatment with PRIMAXIN*
for single or mixed infections of the following body
systems, when they were associated with a number
of pathogenic species and strains of the genera
listed:
1.
2.
3.
4.
5.
6.
7.
8.

Lower Respiratory Tract Infections
Urinary Tract Infections
Intra-Abdominal Infections
Gynecological Infections
Septicemia
E ndocarditis caused by Staphylococcus
aureus
Bone and Joint Infections
Skin Structure Infections

Gram-positive Aerobes

•
•
•
•

Listeria monocytogenes
Nocardia asteroides
Staphylococcus (excluding many strains
which are methicillin resistant)
Streptococcus (excluding S. faecium)

Gram-negative Aerobes

•
•
•
•
•
•
•
•

Acinetobacter
Citrobacter
Enterobacter
Escherichia coli
Haemophilus influenzae
Haemophilus parainlluenzae
Klebsiella
Morganella morganii

Pseudomembranous colitis

Pseudomembranous colitis has been reported with
the use of PRIMAXIN*. Therefore it is important to
consider this diagnosis in patients who develop
diarrhea during or after therapy. This colitis may
range from mild to life threatening in severity.
Mild cases of pseudomembranous colitis may
respond to drug discontinuance alone. In more
s e v e re case s, m a n a g e m e n t m ay in c lu d e
s ig m o id o s c o p y , a p p ro p ria te b a c te rio lo g ic a l
studies, fluid, electrolyte and protein sup ple
mentation, and the use of a drug such as oral
vancomycin, as indicated. Other causes of colitis
should also be considered.

PRECAUTIONS
General

Prolonged use of PRIMAXIN* (imipenem and
cilastatin sodium for injectio n) may result in
overgrow th of resistant organism s. Repeated
evaluation of the patient's condition is essential. If
superinfection occurs during therapy, appropriate
measures should be taken.
CNS adverse experiences such as m yoclonic
activity, confusionaTstates, or seizures have been
reported with PRIMAXIN* especially when recom
mended dosages based on renal function and body
weight were exceeded. These experiences have
occurred most commonly in patients with CNS
disorders (e.g., brain lesions or history of seizures)
an d/or who have compromised renal function.
However, there were rare reports in which there was
no recognized or documented underlying CNS
disorder. Close adherence to recommended dosage
schedules is urged especially in patients w ith
known factors that predispose to seizures (see
D O S AG E AN D A D M IN IS T R A T IO N ). A n t i
convulsant therapy should be continued in patients
with a known seizure disorder. If focal tremors,
myoclonus, or seizures occur, patients should be
evaluated neurologically and placed on a n ti
convulsant therapy if not already instituted. If CNS
symptoms continue, the dosage of PRIMAXIN*
should be decreased or discontinued.

and death) at doses equivalent to the average
human dose in pregnant rabbits and cynomolgus
monkeys that is not seen in non-pregnant animals in
these or other species. In other studies, PRIMAXIN*
was well tolerated in equivalent or higher doses (up
to 11 times the average human dose) in pregnant
rats and mice (see REPRODUCTION STUDIES
under TOXICOLOGY in the complete monograph).
Nursing Mothers

It is not known whether PRIMAXIN* is excreted in
milk. If the use of PRIMAXIN* is deemed essential,
the patient should stop nursing.
Pediatric Use

Efficacy and tolerability in infants under the age of
3 months have not yet been established; therefore,
PRIMAXIN* is not recommended in the pediatric
age group below the age of 3 months.
Drug Interactions

C oncomitant administration of PRIMAXIN* and
probenecid results in only minimal increases in
plasma levels of imipenem and plasma half-life. It is
not recommended that probenecid be given with
PRIMAXIN*.
PRIMAXIN* should not be mixed with or physically
added to other antibiotics. PRIMAXIN* has been
administered concomitantly with some antibiotics,
such as aminoglycosides.
There is no evidence to suggest that association of
PRIMAXIN* with any other beta-lactam antibiotics
has any therapeutic advantage.

ADVERSE REACTIONS
PRIMAXIN* (imipenem and cilastatin sodium for
injection) is generally well tolerated. The following
adverse reactions were reported on 1,723 patients
treated in clinical trials. Many of these patients were
severely ill and had multiple background diseases
and physiological impairments, making it difficult to
determ ine causal re la tio n sh ip o f adverse ex
periences to therapy with PRIMAXIN*.
lo ca l Adverse Reactions

Adverse local clinical reactions that were reported
as possibly, probably or definitely related to therapy
with PRIMAXIN* were:
Incidence (%)

Phlebitis/thrombophlebitis
Infused vein pain
Vein induration
Infused vein infection

1.7
0.6
0.2
0.1

Systemic Adverse Reactions

Adverse clinical reactions that were reported as
p o s s ib ly , p ro b a b ly , o r d e fin ite ly re la te d to
PRIMAXIN* were:
Incidence (%)
Gastrointestinal

nausea
diarrhea
vomiting
tongue papillar hypertrophy
pseudomembranous colitis
(see WARNINGS)
hemorrhagic colitis
gastroenteritis
abdominal pain
glossitis
heartburn
pharyngeal pain
increased salivation

2.0
1.7
1.6
0.2
0.1
<0.1
<0.1
<0.1
<0.1
<0.1
<0.1
<0.1

Use in Patients with Impaired Renal Function

Dosage in patients with impaired renal function is
based on the severity of infection but the maximum
daily dose varies with the degree of renal functional
im p a irm e n t (see DOSAGE AN D A D M IN IS 
TR A TIO N - Dosage in P atien ts w ith Renal
Insufficiency).
Use in Pregnancy

CNS

fever
dizziness
seizures
(see PRECAUTIONS)
somnolence
confusion
myoclonus
vertigo
headache
encephalopathy
paresthesia

The use of PRIMAXIN’ in pregnant women has not
been studied, therefore, PRIMAXIN* should be used
during pregnancy only if clearly needed. Use of this
drug in women of childbearing potential requires
that the anticipated benefits be weighed against
possible hazards.

Special Senses

Reproduction studies with bolus I.V. doses suggest
an apparent intolerance to PRIMAXIN* (including
emesis, inappetence, body weight loss, diarrhea

transient hearing loss in
patients with impaired hearing
tinnitus

0.4
0.3
0.2
0.2
0.2
0.1
0.1
0.1
<0.1
<0.1

<0.1
<0.1

Respiratory
dyspnea
hyperventilation
thoracic spine pain
Cardiovascular
hypotension
palpitations
tachycardia

0.4
0.1
<0.1

<0.1
<0.1

rash
pruritus
urticaria
skin texture changes
candidiasis
erythema multiforme
facial edema
flushing
cyanosis
hyperhidrosis
pruritus vulvae

0.9
0.3
0.2
0.1
0.1
<0.1
<0.1
<0.1
<0.1
<0.1
<0.1

Body as a whole
polyarthralgia
asthenia/weakness

<0.1
<0.1

Adverse Laboratory Changes
Adverse laboratory changes, without regard to drug
relationship, that were reported during clinical trials
were:
Hepatic: Increased SGPT, SGOT, alkaline phospha
tase, bilirubin and LDH.
Hemic: Increased eosinophils, positive Coombs
test, decreased WBC and neutrophils, increased
WBC, increased platelets, decreased platelets,
decreased hemoglobin and hematocrit, increased
monocytes, abnormal prothrombin time, increased
lymphocytes, increased basophils.

I.V. A dm inistration
Severity
o f infection

Mild

Urinalysis: Presence of urine protein, urine red
blood cells, urine white blood cells, urine casts,
urine bilirubin, and urine urobilinogen.

TREATMENT OF OVERDOSAGE
There are no data available on overdosage.

The dosage recommendations for PRIMAXIN*
(imipenem and cilastatin sodium for injection)
represent the quantity of imipenem to be ad
ministered by I V. infusion only. An equivalent
amount of cilastatin is also present in the solution.
The dosage of PRIMAXIN* should be determined by
the severity of the infection, renal function, body
weight, the antibiotic susceptibility of the causative
organism(s) and the condition of the patient. Doses
cited are based on body weight of 70 kilos.
The median duration of treatment with PRIMAXIN*
in clinical trials for infections of the various body
system s ranged from 6 to 10 days except for
endocarditis and bone and joint infections for which
the median duration of treatment was 4 weeks.

D aily
D ose

6 h

1.0 g

250 mg

Moderate

500 mg

8 h

1.5 g

500 mg

6 h

2.0 g

CAUTION: CONTENTS OF VIALS NOT FOR
DIRECT INFUSION.

3.0 g
4.0 g

Each reconstituted 250 mg or 500 mg dose should
be given by intravenous infusion over twenty to
th irty minutes. Each 1000 mg dose should be
infused over 40 to 60 minutes. In patients who
develop nausea during the infusion, the rate of
infusion may be slowed.

Severe* infections
due to less
susceptible
organisms
or life threatening
conditions

1000 mg
1000 mg

Administration

* Primarily some strains of Ps. aeruginosa.

RECONSTITUTION

The maximum daily dose should not exceed 4 g or
50 mg/kg, which ever is less.

Contents of the 13 mL vials must be suspended and
transferred to 100 mL of an appropriate infusion
solution.

Dosage in Patients with Renal Insufficiency

A suggested procedure is to transfer approximately
10 mL from the 100 mL of the appropriate infusion
solution to the vial (see list of diluents under
COMPATIBILITY AND STABILITY). Shake well.
Return the resulting 10 mL of suspension to the
remaining 90 mL of the infusion solution.

P a tie n ts w ith c r e a tin in e c le a r a n c e s o f
< 5 mL/min/1.73 m* (<0.08 mL/s/1.73 m*) should
not receive PRIMAXIN* unless hemodialysis is
instituted w ithin 48 hours. Both imipenem and
cilastatin are cleared from the circulation during
h e m o d ia ly s is . The p a tie n t sh o u ld re ce ive
PRIMAXIN* after hemodialysis and at 12 hour
intervals timed from the end of that hemodialysis
session. Dialysis patients, especially those with
background CNS disease, should be carefully
m o n ito re d ; fo r p a tie n ts on h e m o d ia ly s is ,
PRIMAXIN* is recommended only when the benefit
outw eighs the potential risk of seizures (see
PRECAUTIONS). Currently, there are inadequate
data to recommend the use of PRIMAXIN* in
patients undergoing peritoneal dialysis.
TABLE 2
MAXIMUM DOSAGE OF PRIMAXIN*
IN RELATION TO RENAL FUNCTION

RENAL
FU NC TIO N

M ild
im p airm e nt

M oderate
im p airm e nt

Severe*
im p airm e nt

PRIMAXiN' (imipenem and cilastatin sodium for
injection) is cleared by hemodialysis.

DOSAGE AND ADMINISTRATION

D osage
Interval

The recommended total daily dosage of PRIMAXIN*
in children and infants 3 months of age and older is
60 to 100 mg/kg of body weight divided into 4 equal
doses given at six hour intervals. The higher
dosages should be used for infants and young
children. The total daily dosage should not exceed
2 gram s. C lin ic a l data are in s u ffic ie n t to
recommend an optimum dose for infants and
children with impaired renal function.

Severe (fully
susceptible)

Electrolytes: Decreased serum sodium, increased
potassium, increased chloride.
Renal: Increased BUN, creatinine.

Dose
(m g o f im ip en em )

sz c.

Skin

ADULT DOSAGE OF PRIMAXIN*

COCO

Renal
oliguria/anuria
polyuria

Dosage in Infants and Children

TABLE 1
0.1
<0.1
<0.1

DOSE
(9)

DOSAGE
INTERVAL
(h)

M AX IM UM
TO T A L
DAILY
DOSAGE
(9)

3 1 -7 0
(0 .5 2 -1 .1 7 )

0.5

6 -8

1 .5 -2

2 1 -3 0
(0.35 - 0.50)

0.5

8 -1 2

1 - 1 .5

0 .2 5 -0 .5

12

0 .5 -1 .0 **

C R EA TIN IN E
CLEARANCE
m L /m in/1.73 m*
(m L /s/1.73 m^)

0 -2 0
(0 - 0.33)

P a tie n ts w ith c re a tin in e clearance o f 6 to
20 mL/min/1.73 m2 (0.1 - 0.3 mL/s/1.73 m2) should
be treated with 250 mg (or 3.5 mg/kg whichever is
lower) every 12 hours for most pathogens. When
the 500 mg aose is used in these patients, there may
be an increased risk of seizures.
xx The h ighest dose is only recommended fo r
infectio n s due to less susceptible organism s
primarily some strains of Ps. aeruginosa.

When only the serum creatinine level is available,
the following formula (based on sex, weight, and
age of the patient) may be used to convert this value
into creatinine clearance (mL/min). The serum
creatinine should represent a steady state of renal
function.
Males:

Weight (kg) x (140 - age)
72 x serum creatinine (mg/100 mL)

Females:

0.85 x above value.

Dosage in Adults

When using the International System of units (SI),
the estimated creatinine clearance (mL/s) in males
can be calculated as follows:

The recommended daily dose is 1 to 2 g adminis
tered in equally divided doses every 6 to 8 hours
(see Table 1).

(lean body weight, kg) x (140 - age, years) x 1.4736

Dosage in Elderly Patients

and in females the estimated creatinine clearance
(mL/s) is:

(72) x (serum creatinine concentration, pmol/L)

Repeat, using 10 mL of the diluted suspension, to
ensure complete transfer of the contents of the vial
to the infusion solution.
CAUTION: CONTENTS OF VIALS NOT FOR
DIRECT INFUSION.

COMPATIBILITY AND STABILITY
List of diluents
0.9% Sodium Chloride Injection
5% or 10% Dextrose Injection
5% Dextrose Injection with 0.02% sodium
bicarbonate solution
5% D extrose and 0.9% Sodium C hloride
Injection
5% Dextrose Injection with 0.225% or 0.45%
saline solution
NORMOSOL-M in D5-W
5% Dextrose Injection with 0.15% potassium
chloride solution
Mannitol 2.5%, 5% and 10%
Reconstituted solutions
Solutions of PRIMAXIN* range from colourless to
yellow. Variations of colour within this range do not
affect the potency of the product.
PRIMAXIN*, as supplied in vials and reconstituted
as above maintains satisfactory potency for four
hours at room temperature and for 24 hours under
refrigeration (4°C). PRIMAXIN* has been found to
be stable in 0.9% Sodium Chloride Injection for
10 hours at room temperature and 48 hours under
refrigeration.

DOSAGE FORMS
AVAILABILITY
PRIMAXIN* is supplied as a sterile powder mixture
in vials containing imipenem anhydrous and
cilastatin sodium as follows:
3514Ca - 250 mg imipenem equivalent and 250 mg
cilastatin equivalent in vials.
3516 Ca - 500 mg imipenem equivalent and 500 mg
cilastatin equivalent in vials.
STORAGE
The dry powder should be stored at a temperature
below 30° C.

FULL PRODUCT MONOGRAPH
AVAILABLE ON REQUEST
(318-a,7,87)
*®Trademark
MEMBEF9

The recommended dosage of PRIMAXIN* in elderly
patients with normal renal function is the same as
given for adults above. Renal status of elderly
pa tie n ts may not be accurately portrayed by
measurement of BUN or creatinine alone. Deter
mination of creatinine clearance is suggested to
provide guidance for dosing in such patients.

(lean body weight, kg) x (140 - age, years) x 1.2526
(72) x (serum creatinine concentration, ,umol/L)
PRIMAXIN* is cleared by hemodialysis. After each
dialysis session the dosage schedule should be
restarted.
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Rectovaginal Fistula: Initial Experience
H. Stern, MD, FRCSC;* Z. Gamliel, MD;* T. Ross, MD, FRCSC;t Z. Dreznik, MD$
Rectovaginal fistulas are not common, but the associated symptoms can be
emotionally and physically disabling. The authors report their experience of 10
patients with a diagnosis of rectovaginal fistula, seen between December 1982 and
July 1986. The women ranged in age from 28 to 74 years. All complained of passing
feces or flatus, or both, through the vagina. In the majority of cases, fistulas were
present for longer than 6 months before surgical repair. The fistulas were due
mainly to trauma. Endorectal advancement flaps were used in seven patients with
excellent results. Small fistulas due to obstetric trauma may heal spontaneously, so
in these cases a 6-month waiting period before operation is recommended. However,
fistulas due to inflammatory bowel disease will not heal spontaneously and should
be repaired as soon as the patients’s condition is optimal.

Les fistules recto-vaginales ne sont pas frequentes, mais les symptomes qui leur
sont associes peuvent toutefois etre emotionellement et physiquement invalidants.
Les auteurs font etat de leur experience aupres de 10 patientes souffrant de fistules
recto-vaginales, qui ont ete vues entres decembre 1982 et juillet 1986. Leur age
variait de 28 a 74 ans. Toutes se plaignaient du passage de matiere fecales ou de
l’expulsion de gaz intestinaux par le vagin. Dans la majorite des cas, les fistules
etaient presentes depuis plus de 6 mois au moment de la reparation chirurgicale.
Les fistules etaient principalement dues a des traumatismes. Des lambeaux
d’avancement endorectaux ont ete utilises chez sept patientes avec d’excellents
resultats. Les petites fistules dues a un traumatisme obstetrical peuvent guerir
spontanement. Dans de tels cas, on recommande une periode d’attente de 6 mois
avant d’operer. Toutefois, les fistules dues a une maladie inflammatoire intestinale
ne guerissent pas spontanement et doivent etre reparees aussitot que l’etat de la
patiente s’y prete.

fistulas constitute
R ectovaginal
less than 5% of anorectal fistu
las.1 They may be congenital or
acquired. Although it is difficult to
determine the precise incidence of
rectovaginal fistulas due to any sin
gle cause, most result from obstetri
cal injuries, inflammatory bowel dis
ease and pelvic irradiation. Al
though these fistulas are not com-

mon, they can be physically and
emotionally disabling.
We present our experience in
managing rectovaginal fistulas.

Patients and Method
We reviewed the charts of 10
women with a diagnosis of rec
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tovaginal fistula, operated upon be
tween December 1982 and July
1986. The mean age at the time of
repair was 39.7 years (ranging from
28 to 74 years). The timing of
repair varied from 1 month to 14
years after the onset of symptoms;
of the 10 fistulas, 8 were present
for more than 6 months and 1 for 5
months before operative repair was
attempted. (One fistula, present for
3 months, healed spontaneously but
sphincteroplasty was required for
persistent anal incontinence.) Fol
low-up after successful repair
ranged from 8 to 46 weeks (mean
20.4 weeks).
The chief presenting complaint
was passage of feces and flatus
through the vagina. Several pa
tients noted that their symptoms
worsened when they had diarrhea.
One woman noted passage of men
strual blood through her rectum. In
all cases, the fistula was demon
strated by proctosigmoidoscopy
and, when the fistula was low, its
course was outlined by passage of a
probe through the vaginal orifice
and by digital palpation (Fig. 1).
The locations and sizes of the fistu
las are listed in Table I.
In 6 of the 10 patients the fistula
developed as a result of obstetrical
trauma. One of them had a medium
sized fistula for 5 years during
which time repair was attempted
four times before referral to our
centre. Barium studies of the large
and small bowel were done to rule
out Crohn’s disease. Another pa
tient had a small fistula for 14 years
with only one previous attempt at
repair.
Pelvic surgery was the cause of
359
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the fistula in two patients. One
fistula developed after posterior colpotomy for tubal ligation, and the
patient had a diverting colostomy
for the next 17 months before
being referred to us. The other
patient had a fistula associated with
strictures for 9 years after surgical
correction of rectal prolapse.
In one woman a fistula developed
just before she underwent subtotal
colectomy for Crohn’s disease. She
had an ileostomy for 7 months
before entering our study. In anoth
er patient a fistula developed after
frequent use of progesterone sup

positories for premenstrual syn
drome; two attempts at repair had
failed. Barium enema examination
demonstrated the fistula but no
other related disease. The cause of
the fistula was presumed to be
traumatic due to repeated insertion
of the suppositories.

inflammatory reaction has subsided
(usually 6 months) and is then
performed only with suitable bowel
preparation, which includes the in
travenous administration of broadspectrum antibiotics. To ensure ad
equate blood supply to the rectal
flap, its base is maintained at least
4.0 cm proximal to the fistula and
approximately twice the width of
the apex. The rectal mucosa and
submucosa are elevated laterally
(Fig. 2) so that the cut edges of the
underlying internal sphincter mus-

Treatment
Our approach to small or medi
um-sized low rectovaginal fistulas is
endorectal advancement of an ano
rectal flap, consisting of mucosa,
submucosa and circular muscle as
described by Goldberg’s group2 (Fig.
1). Repair is deferred until local

FIG. 3 — Reapproximation of internal
sphincter.
Table 1-Patients Treated for Rectovaginal Fistula, December 1982 to July 1986
Patient
no.

Age,
yr

Cause of Fistula
fistula
type

Size,
mm

Duration of
symptoms

Investigations

28 Obstetric
31 Obstetric

Low
Low

10
15

1 mo
5 yr

30 Obstetric
60 Rectal
surgery
36 Posterior
colpotomy
34 Obstetric
32 ? traumatic
(unproven)

Low
High/
complex
High/
complex
Low
Low

3
10

6 mo
9 yr

10

17 mo

4
5

14 yr
18 mo

Low

5

9 mo

“

9

47 Ulcerative
colitis
34 Obstetric

Low

2

13 mo

“

10

31 Obstetric

Low

2

3 mo

1

2
3
4
5
6
7
8

EUA
UGI & FT,
Barium enema

Previous
repairs

-

-

4
-

EUA
Barium enema
-

Barium enema
Small-bowel
enema

~

1
2

Mode of
repair

Outcome

Duration of
follow-up, wk

Transanal flap
Transanal flap

Healed
Healed

15
11

Transanal flap
Transanal suture
(incomplete)
Transabdominal +
colostomy
Transanal flap
Transanal flap +
colostomy

Healed
Unsatisfactory

46
14

Healed

16

Failed
Healed

20
32

Transanal flap +
ileostomy*
Transanal flap +
sphincteroplasty
None. Sphincteroplasty
for persistent anal
incontinence

Healed

24

Healed

8

Healed
spontaneously

13

*ln site before repair. EUA = examination under anesthesia, UGI = upper gastrointestinal, FT = follow though.
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cle may be mobilized and approxi
mated in the midline without ten
sion (Fig. 3). In patients with anal
incontinence, a concomitant plica
tion external sphincteroplasty is
performed (Fig. 4). The rectal flap
is advanced over the repaired area,
the excess trimmed and the flap
sutured in place with 2-0 or 3-0
Dexon (Fig. 5). The vaginal mucosa
is left open for drainage. Postoperatively, the patient is given analge
sics and warm sitz baths as needed,
as well as bulk laxatives to avoid
constipation.

A

Results
There were no operative deaths
or serious complications. Seven pa
tients had their fistula repaired by
endorectal flap advancement; one of
them also required a colostomy and
one already had an ileostomy in
place following subtotal colectomy
(Table I). One patient had a con
comitant sphincteroplasty. Six of
the seven flap advancements were
successful; in the other the fistula
recurred 20 weeks postoperatively
but a second repair 4 weeks later,

FIG. 4 — Advancement of flap of mucosa and internal sphincter.

which included a colostomy and
sphincteroplasty, was successful.
One high, complex fistula, which
lay between two rectal strictures,
could not be adequately repaired by
the transanal route. Only the distal
portion of the fistula was closed
using interrupted sutures, since in
struments could not be passed
proximal to the stricture. One very
small, low fistula caused by obstet
rical trauma closed spontaneously 3
months post partum. In this case,
persistent anal incontinence was
corrected by anterior sphinctero
plasty.
One medium-sized high fistula
was managed by the transabdominal
route. The fistula was repaired with
a colostomy by mobilizing the rec
tovaginal septum, dividing the fistu
la, closing the rectal defect and
interposing a pedicle of omentum
between the rectum and vagina. A
Penrose drain was passed through
the open vaginal defect.
Most patients reported resolution
of their symptoms, although one
(patient no. 2, Table I) complained
of a sensation of gas in the vagina,
which persisted for several weeks.

-*

Discussion
The symptoms of rectovaginal
fistulas depend on their size, loca
tion and cause. While small ones
may be asymptomatic, larger ones
are associated with passage of fla
tus or stool through the vagina.3
These distressing symptoms cause
varying degrees of social and sexual
problems.
Most fistulas are palpable and
easily visualized by rectovaginal ex
amination or proctoscopy. Occa
sionally, more involved techniques
such as methylene blue4 or barium
studies are necessary for diagnosis.
Rectovaginal fistulas may be classi
fied anatomically by location and
size. Rosenshein and colleagues5
VOL. 31, NO. 5 SEPTEMBER 1988/CiS
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described four types occurring in
three zones. Daniels6 classified
them as small, medium or large.
Although a number of classifica
tions have been proposed, we be
lieve these fistulas can most practi
cally be considered as low (anal) or
high (complex or rectal).
Many approaches have been de
scribed for the correction of rec
tovaginal fistulas. The high type
can usually be approached transabdominally, and low fistulas by rec
tal, vaginal, perineal, trans-sphincteric and trans-sacral routes. Re
gardless of the approach used, the
main principle of repair is to create
maximal strength without tension
at the site.7 Complete removal of
the fistula is not necessary, as long
as the tract is adequately drained
and the rectal defect covered by a
flap of healthy rectal mucosa and
muscle. Excellent drainage is
achieved by leaving the vaginal de
fect open. The vaginal mucosa
heals readily once drainage has
ceased.
Timing of the repair is important.
In small fistulas due to obstetrical
trauma, Mattingly8 recommended
waiting at least 6 months before
operative intervention because half
will heal spontaneously; there may
be residual anal incontinence that
requires sphincteroplasty. Con
versely, fistulas due to inflammato
ry bowel disease seldom heal spon
taneously9-10 and the underlying dis
ease should be treated aggressively
so that the patient’s condition is
optimal when operative repair is
attempted. Patients with fistulas
due to pelvic irradiation may require
a defunctioning colostomy for over
1 year before local tissue pliability
allows surgical repair.11
Opinions differ widely about the

362

need for a temporary colostomy
with surgical repair of rectovaginal
fistulas.11-13 We believe that a colos
tomy is not needed for the majority
of uncomplicated rectovaginal fistu
las. However, for more complex
fistulas due to inflammatory bowel
disease, irradiation or cancer, colos
tomy may be useful either as part of
a staged procedure or at the time of
definitive repair. In this series, four
fistulas were successfully repaired
transanally and one transabdominally without a colostomy.
After successful repair, patients
generally report complete resolution
of their symptoms. However, at
least one of our patients reported a
feeling of gas in the vagina, a
feeling that persisted for several
weeks postoperatively, even though
there was no evidence of fistula
recurrence. This phenomenon "has
been reported by Hoexter and asso
ciates14 but lacks a clear explana
tion. We recommend that these
women abstain from sexual inter
course for 3 months after fistula
repair. If sphincteroplasty has been
performed, consideration should be
given to cesarean section for subse
quent deliveries, although no con
clusive data are available on this
issue.
The illustrations have been adapted and
are reproduced by permission from
Goldberg SM, Gordon PH, Nivatvongs
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Liver Blood Flow After Major Hepatic
Resection
Sherif S. Hanna, MB, BCh, FRCSC, FACS; Giuseppe Pagliarello, MD, FRCSC; Alan Ing, MD, FRCSC
The factors involved in liver regeneration are poorly understood, but it has been
suggested that blood flow plays a role. This paper documents the changes in liver
blood flow (LBF) that occur after major hepatic resection. Eight patients, ranging in
age from 37 to 76 years, underwent liver resection. Liver blood flow was measured
preoperatively and on days 1, 4 and 7 postoperatively by low-dose galactose
clearance.
There was a significant (p < 0.01) fall in LBF on day 1 compared with the
baseline value, followed by a significant (p < 0.01) rise from the baseline value by
day 4. By day 7, LBF had returned to baseline levels and was significantly (p < 0.01)
lower than on day 4. These changes in LBF may be related to the stimulus for liver
regeneration and increased functional demands during the early regenerative phase.

The changes in flow have not been
studied clinically in humans.
Using low-dose galactose clear
ance (LDGC) we measured LBF
postoperatively in patients who un
derwent major liver resection. As a
noninvasive technique we hoped
that it would be useful in monitor
ing regeneration after hepatic fail
ure or resection.

Les facteurs participant a la regeneration hepatique sont mal connus. II a toutefois
ete suggere que le debit sanguin y jouait un role. Cet article montre les
changements du debit sanguin hepatique (DSH) qui surviennent apres une resection
hepatique importante. Huit patients ages de 37 a 76 ans ont subi une resection
hepatique. Des determinations du DSH ont ete pratiquees par mesure de la clairance
du galactose a faible dose, avant l’operation, et 1, 4 et 7 jours apres l’intervention.
On a constate une baisse significative (p < 0.01) du DSH au jour 1 par rapport a
la valeur de depart, suivie d’une augmentation significative (p < 0.01) au jour 4. Au
jour 7, le DSH etait retourne a son point de depart et il etait significativement plus
faible (p < 0.01) qu’au jour 4. Ces changements de DSH peuvent etre relies a la
stimulation du processus de regeneration hepatique et a l’augmentation de la
demande fonctionnelle durant la phase precoce de regeneration.

Methods
Eight patients, ranging in age
from 37 to 76 years, underwent
major liver resection. Indications
for resection are listed in Table I
and operations performed in Table
II. Anatomical resections were per
formed, first controlling hilar vesT a b l e 1—Indications fo r Liver R esection
N o . of
In d ic a t i o n

he ability of the liver to regen
erate after major resection has
been studied extensively, but the
factors responsible for regeneration
are not well understood.
The role of hepatic blood flow in
liver regeneration is also poorly

T

understood, but an association be
tween flow and regenerative re
sponse has been suggested. Liver
blood flow (LBF) after hepatic re
section has been studied in small
and large animal models using sev
eral methods of flow measurement.
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sels then dividing liver tissue by
finger fracture and ligation of ves
sels or bile ducts as they were
encountered. Thorough drainage of
the right upper quadrant was pro
vided. Resected specimens were ex
amined for adequacy of resection
and weighed. Early postoperative

FIG. 1 — Mean liver blood flow (LBF)
after partial hepatectomy in eight pa
tients. Note significant decrease (*) in
LBF from baseline to postoperative
day 1 and significant return of LBF to
baseline levels by postoperative day 4.

T a b le

Ill-Operative Data (Mean ± SEM)

Operative time,
min
h
Anesthesia time,
min
h
Blood loss, ml
Packed red cells given,
units
Platelets given, units
Fresh frozen plasma
given, units
Crystalloids given, ml

459.0 ± 24.7
7.65 ± 0.41
564.0 ± 26.4
9.40 ± 0.44
14 750 ±3180
23.4 ± 4.90
7.0 ± 2.00
8.75 ± 1.96
21 090 ± 3780

T im e

Preop
Day of operation
Postop day 1
Postop day 4
Postop day 7
3 wk postop

8.6
63.0
113.8
64.9
46.2
14.8

± 1.5
± 12.9
±34.0
± 13.7
± 10.4
± 2.7

150.4
46.8
42.0
63.7
100.7
163.5

±54.1
± 13.3
±11.0
±11.0
± 19.0
±34.6

A sp artate
a m in o tra n s fe ra s e
(0 - 3 0 U /L)

21.9
131.4
182.8
35.6
35.0
26.8

± 1.8
±28.5
±52.9
± 6.4
± 2.9
± 0.9

A la n in e
a m in o tra n s fe ra s e
(0 - 3 0 U /L )

15.0
120.0
125.5
29.0
29.6
22.6

± 2.3
± 40.8
± 46.1
±12.4
± 5.4
± 3.3

X.

Operative data are shown in
Table III. All patients were hemodynamically stable when studied post
operatively, but one later died of
complications. The mean weight of
resected specimens was 904 ± 227
gCardiac output measurements
were only available for day 1, when
the mean value was 6.29 ± 0.49
L/min. Liver function (Table IV)
was monitored at intervals corre
sponding to the time of the LBF
measurements and also on the day
of operation and 3 weeks later
when the surviving patients were
ambulatory and were discharged.
The patterns of change are illustrat
ed in Figs. 2 and 3 and correlated
with the changes in measured LBF.
Gross abnormalities were recorded
for postoperative day 1 but a rapid
return toward normal values was
noted by day 4, a trend that contin
ued toward full normalization by
the third postoperative week. An
interesting exception to these pat
terns was the serum alkaline phos
phatase. Markedly elevated preoper
atively, it started to fall on the day
of operation toward normal values

P artia l
A lbum in
P rotein
P ro th ro m b in th ro m b o p las tin
(3 5 - 5 0 g /L ) (6 0 - 8 0 g /L )
tim e , s
tim e , s

34.8
26.2
28.3
25.0
23.0
27.8

± 3.9
± 3.1
± 2.1
±1.1
± 1.6
± 4.4

70.7
44.6
47.5
46.9
47.8
64.0

±
±
±
±
±
±

2.3
5.5
2.8
2.2
0.8
6.7

11.5
12.8
13.7
13.1
12.3

± 0.3
± 0.4
± 0.6
± 0.4
± 1.0

30.8
34.9
31.8
32.6
30.6

±
±
±
±
±

0.9
1.9
1.5
2.0
0.8

'Normal ranges.
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Results (Fig. 1)

IV-Liver Function Test Values After Hepatic Resection (Mean

A lk a lin e
B iliru b in
p h o s p h atas e
(2 - 2 0 Mm o l/L * ) (3 0 - 9 0 U /L )

*- V

LU
CO
-H

T a b le

pressed as millilitres per minute.
Results are expressed as the
mean ± standard error for the eight
patients on each day studied. Statis
tical analysis was by the paired
(-test for the mean differences be
tween blood flows on different days.

care was carried out in the surgical
intensive care unit. The LBF was
measured preoperatively for a base
line value and again on days 1, 4
and 7 postoperatively using Hender
son’s method1 of LDGC. When
blood samples were drawn for base
line measurements a 10-ml bolus of
5% galactose (500 mg) was injected
intravenously, followed by a contin
uous infusion at 50 m l/h (42
mg/min). Samples were withdrawn
from a peripheral vein at 60, 70,
80, 90 and 100 minutes. The blood
was centrifuged at 1000 rpm for 10
minutes. The plasma was separated
and frozen and then assayed for
galactose by continuous-flow fluorometry.
Liver blood flow was calculated
from the blood clearance of galac
tose, a simple sugar, 96% of which
is metabolized in the liver. When
infused continuously at a very low
dose, its elimination from the liver
is dependent only on blood flow;2
thus, the LDGC closely approxi
mates LBF. Plasma concentration
of galactose is converted to blood
concentration by multiplying by
1 —(0.5 X hematocrit). Blood clear
ance can then be calculated as the
rate of elimination divided by blood
galactose concentration. A steady
state is reached when the rate of
elimination equals the rate of infu
sion; galactose clearance then
equals the infusion rate divided by
the blood concentration.3
Calculation of galactose clear
ance is based on the steady state
concentration of galactose and ex
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on day 1, then rose steadily thereaf
ter toward preoperative levels.
The baseline LBF was 1978 ±
141 ml/min. On postoperative day

-V

■ s.

a

1 it was 1025 ± 94 ml/min (52%
of baseline). The mean difference in
blood flow from baseline to day 1,
—930 ± 134 ml/min, was statisti
cally significant (p = 0.0004). On
postoperative day 4, the LBF had
rebounded to 2157 ± 288 ml/min,
an increase from day 1 of 1323 ±
174 ml/min (p = 0.0047). The
mean difference from baseline to
day 4 was not significant.
On day 7 the mean LBF was
1899 ± 314 ml/min, which is
similar to baseline levels and the
LBF on day 4, indicating a return
to baseline levels.

Discussion

v

FIG. 2 — Liver function tests after
major hepatic resection. Note that
serum bilirubin (dotted line), alanine
aminotransferase (dashes) and aspar
tate aminotransferase (dots and dash
es) rise after liver resection but alka
line phosphatase (solid line) falls. Al
kaline phosphatase begins to return to
normal at about same time as LBF
returns to normal on postoperative day
4.

These studies are a first attempt
at quantifying changes in LBF after
liver resection in humans. Blood
flow can be estimated noninvasively
by clearance of indocyanine green
or galactose.3-5 Reliable measure
ment requires almost complete
clearance of the indicator in one
pass through the liver. When this
criterion is fulfilled and the indica

■i *

*
~ r -i<

-A

FIG. 3 — Liver function tests after major hepatic resection. Note initial fall in
protein and albumin with gradual return toward normal.

VOL. 31, NO. 5 SEPTEMBER 1988/CJS

tor is administered at sufficiently
low dose, the rate of elimination is
dependent only on blood flow per
fusing the organ.6 The extraction of
galactose by the liver is approxi
mately 96% complete in one pass,
making it an ideal indicator,7 and is
higher than indocyanine green.8
Low-dose galactose clearance has
been used to estimate hepatic blood
flow in both experimental and clini
cal settings, mainly in the study of
portal hypertension.9' 12 In healthy
dogs, galactose extraction is 84%
and in cirrhotic dogs it is still
relatively high at 75%.12
Because galactose is metabolized
almost exclusively by the liver, its
elimination depends on effective
flow perfusing functional hepatocytes. This flow differs from ana
tomic LBF in that a portion of the
latter is shunted away from hepatocytes and appears unchanged in the
hepatic veins (intrahepatic shunt
ing). This functional or effective
flow, perfusing hepatocytes, is what
we wished to measure in studying
the response to subtotal hepatectomy. Because LDGC is a noninvasive
technique and is based on an indica
tor that is highly extracted and
metabolized completely, it closely
approximates effective LBF. This
makes it an ideal test for repeated
measurements of LBF in the clinical
setting.
Hemodynamic changes in the
liver have been studied in the set
ting of hepatic resection and regen
eration in experimental models.13' 16
Rabinovici and Wiener13 studied
partial hepatectomy in rats by clear
ance of albumin labelled with io
dine-131. Almost immediately postoperatively the LBF rose, then de
creased by day 2, returning to base
line levels in 1 week. Restrepo and
Warren14 studied a canine model of
70% hepatectomy. The LBF, as
measured by colloid clearance postoperatively, was 62% of baseline
flow but quickly returned to base365
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line levels. Kahn and associates15
studied a porcine model of 70%
hepatectomy using flow probes.
These have the drawbacks, particu
larly in humans, of requiring repeat
ed laparotomy and measuring com
plete anatomic blood flow rather
than effective hepatocyte perfusion.
Blood flow was elevated postoperatively, rising to maximum (300% of
baseline) on day 1, then returning
to baseline levels on day 6. The
LBF was reported at intervals after
hepatectomy in millilitres per min
ute per gram of liver, calculated
from the weight of remaining liver.
In our study, LBF dropped to 52%
of the baseline level on postopera
tive day 1, returning to the baseline
level by day 4 and remaining at that
level on day 7. The decrease in LBF
on day 1 was not likely the result of
a decrease in cardiac output. Unfor
tunately, cardiac output measure
ments were only available on day 1,
but at that time the mean level was
elevated to 6.29 ± 0.49 L/min.
Thus, the decrease in LBF repre
sents a true decrease in absolute
and relative blood flow to the liver.
Does the rising serum alkaline
phosphatase noted after hepatecto
my (Figs. 2 and 3) parallel increas
ing regeneration and improving he
patic function? Biochemical and his
tologic events in liver regeneration
have been studied extensively by
experimental models of liver resec
tion. In addition to hemodynamic
studies, Rabinovici and Wiener13 re
ported on regeneration as measured
by the proportion of liver weight to
percentage body weight. Preoperatively the rate was 3.47 g liver per
100 g body weight; it declined to
1.31 g /1 0 0 g postoperatively, ris
ing gradually to 3 g /1 0 0 g over the
next 6 weeks. Better indices of
regeneration are provided by mea
surements of DNA synthesis, either
directly17 or indirectly by enzyme
assays.18 In both 44% and 72%
hepatectomy models, DNA synthe
366

sis began rising at 24 hours, peaked
at 3 days, then remained elevated
over baseline levels.
Using thymidine kinase, the peak
in regenerative activity in a pig
model occurred on postoperative
day 3.18 On the basis of these
observations of animal models, it
can be assumed that enhanced syn
thetic activity paralleling liver re
generation occurs after approxi
mately 3 days. The timing of
changes in blood flow after partial
hepatectomy is not as consistent.
The measurements were made in
different models, using different
techniques to measure LBF. Liver
blood flow was reported to increase
progressively in one model;1519 in
another model it decreased early
postoperatively but returned to
baseline levels within a week.13'14
Our findings are consistent with the
latter results. The relation between
changes in LBF and regeneration
can be viewed in two ways. The
increases in LBF postoperatively
may simply reflect perfusion de
mands due to increased synthetic
activity during regeneration; sus
tained increases have been docu
mented by some investigators.15 Al
ternatively, the abrupt decreases in
postoperative LBF observed during
this study and documented by oth
ers13'14 using animal models may be
interpreted as a stimulus to regen
eration in itself or may be seen as
an indicator of another humoral
factor which stimulates regenera
tion. The peak in regenerative activ
ity occurs approximately 3 days
after resection, the most notable
changes in LBF precede the onset
of this peak. One may hypothesize
that the decrease in LBF stimulates
or signals the onset of stimulation
in regenerative activity.
Our study does not purport to
explain mechanisms and interrela
tionships of the hemodynamic and
regenerative responses to partial he
patectomy. It does demonstrate that

changes in blood flow can be mea
sured noninvasively in the human
after hepatic resection. We mea
sured galactose clearance and, by
inference, liver blood flow. The par
allel changes in regenerative activi
ty cannot be followed clinically.
Noninvasive, clinically applicable
methods of following the biochemi
cal, histologic and anatomic
changes with regeneration are not
readily available. The demonstration
that changes in blood flow, as mea
sured noninvasively using LDGC,
parallel the regenerative activity
would allow for noninvasive moni
toring of liver regeneration. Thus,
LDGC may be useful in assessing
various therapies in cases of liver
failure, after hepatic resection and
possibly after hepatic transplanta
tion.
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BOOK REVIEWS
continued from page 340

represents the culmination of two dec
ades of continuing interest and acquired
expertise in this field within the Depart
ment of Anesthesia at the Vancouver
General Hospital. This hard-cover text
is divided into nine chapters and forms
a comprehensive review of the multidis
ciplinary approach to the perioperative
assessment and management of patients
who undergo carotid artery surgery.
Topics discussed include the patient
profile, diagnostic procedures and con
troversies in patient selection, anesthet
ic management, surgical techniques and
optimum monitoring of cerebral perfu
sion and intervention modalities for
brain protection. A review of the Van
couver General Hospital experience
from 1974 to 1984 provides a reference
point for comparison with other cen
tres. Each chapter includes an extensive
bibliography covering all relevant publi
cations up to 1984.
The best chapters are those on moni
toring during carotid endarterectomy
and postoperative complications. Both
are comprehensive and unlikely to be
discussed in more detail elsewhere. The
most disappointing feature is the brevi
ty with which introperative manage
ment is discussed. Despite a clear de
scription of potential perioperative

VOL. 31, NO. 5 SEPTEMBER 1988/O S

problems, few practical suggestions are
made, and the reader is left with a
disjointed and incomplete account of
“how to do it”. Examples of omissions
include: the use of intermittent systemic
heparinization, pharmacologic pressure
manipulation, biochemical monitoring
and an updated management guide for
the treatment of postoperative hyper
tension. For the academic, a discussion
of the use of isoflurane and critical
cerebral blood flow, new pharmacologic
agents offering potential cerebral pro
tective effects, and the effects of anes
thetic agents on cerebrovascular he
modynamics could have been included.
Anesthetic considerations for neuroradiologic investigations or extracranialintracranial arterial anastomosis are not
discussed.
For the most part the book is well
written and easily read in an evening.
Unfortunately there is some repetition
and numerous spelling and typographic
errors.
This publication represents an ambi
tious achievement by two authors who
have successfully compiled a state-ofthe-art review of perioperative medical,
surgical and anesthetic considerations
in patients who undergo carotid endar
terectomy. I would recommend this

book as a valuable reference acquisition
for a departmental library.
K.M. Robertson, MD, FRCPC
Department o f Anesthesia,
University Hospital,
University o f Western Ontario,
PO Box 5339, Station A,
London, Ont.
N6A 5A5

DIAGNOSTIC IMAGING: AN AL
GORITHMIC APPROACH. 2nd ed. Ed
ited by Ronald L. Eisenberg, with 76
contributors. 713 pp. Illust. J.B. Lippincott Company, Philadelphia, 1987.
$79.50 (US). ISBN 0-397-58300-1.

An algorithm is a “step-by-step problem
solving procedure”. In medicine, algo
rithms or critical diagnostic pathways
hold the promise of helping clinicians to
deal with the explosive growth of diag
nostic imaging by depicting the optimal
sequence of investigative procedures for
the patient’s clinical problem. In this
textbook, Dr. Eisenberg has enlisted 76
radiologists and internists, many of incontinued on page 371
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Management of Acute Postoperative
Occlusion of an Internal Carotid Artery
Thomas M. Egan, MD, MSc, FRCSC; Paul M. Walker, MD, PhD, FRCSC
Complete occlusion of an endarterectomized internal carotid artery in the early
postoperative period is uncommon. In a series of 325 consecutive carotid
endarterectomies, the authors recognized this complication on five occasions. In
each instance, early reoperation resulted in neurologic improvement of the patient.
Awareness of the condition is important in making the diagnosis; in two patients the
deficit was mild, despite complete occlusion of the endarterectomized artery.
Therefore, the authors believe that any neurologic deficit early after endarterectomy
of an internal carotid artery should be aggressively investigated and patency of the
affected segment re-established.

II est peu frequent d’observer l’occlusion complete d’une carotide interne endarterectomisee durant la periode post-operatoire immediate. Sur une serie de 325
endarterectomies carotidiennes consecutives, les auteurs ont reconnu cette complica
tion en cinq occasions. Dans chaque cas, une reintervention precoce a amene une
amelioration neurologique. Le diagnostic exige de toujours avoir cette complication
a l’esprit, puisque, chez deux patients, le deficit etait leger en depit d’une
obliteration complete de Tartere endarterectomisee. Les auteurs croient qu’il y a lieu
d’etudier a fond tout deficit neurologique survenant tot apres l’endarterectomie
d’une carotide interne, afin de retablir la permeabilite du segment affecte.

ver the last three decades the
role of surgery in the treat
ment of extracranial atherosclerotic
disease has been controversial. Sur
gery is now generally accepted as
being contraindicated in patients
with a massive completed stroke
because it is associated with a high
incidence of operative complications
and bestows little benefit.12 Some
surgeons have advocated carotid
endarterectomy for selected asymp
tomatic bruits3 or acute occlusion.4
The occurrence of transient isch

O

emic attacks (TIAs) is considered an
indication for surgery when there is
an extracranial lesion in the appro
priate internal carotid artery.3-5
Even in this setting, there is a wide
range of morbidity and mortality.6
With the advent of newer antiplate
let agents7 the role of surgery has
been further challenged.
The most serious complication of
carotid endarterectomy is stroke,
which may be due to acute occlu
sion of the internal carotid arte
ry.8-10 The hazards of primary sur

From the Division o f Vascular Surgery, Toronto General Hospital, University o f Toronto,
Toronto, Ont.
Accepted fo r publication Mar. 21, 1988
Reprint requests to: Dr. P.M. Walker, EN 9-215, Toronto General Hospital, 200 Elizabeth St.,
Toronto, Ont. M5G 2C4
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gery after such occlusion have been
elucidated.3-5 The role of reopera
tion for acute occlusion after endar
terectomy is unclear. In this paper
we describe our experience with
occlusion of endarterectomized in
ternal carotid arteries. On the basis
of this experience, we have adopted
an aggressive approach to the diag
nosis and management of any neu
rologic deficit in the period immedi
ately after endarterectomy.

Patients and Findings
The data on 325 consecutive pa
tients who underwent carotid endar
terectomy between July 1980 and
June 1987 on the vascular service
at the Toronto General Hospital
were analysed. The indications for
surgery were: TIAs (214 patients),
reversible ischemic neurologic de
fects (RINDs) (26), small completed
strokes (36), asymptomatic severe
stenosis in the artery opposite a
surgically corrected lesion (21) and
opposite an occlusion (5) and for
vertebral basilar insufficiency (23).
When general anesthesia was used
a temporary indwelling shunt was
placed to provide cerebral protec
tion. Two patients had temporary
global dysfunction which resolved
in less than 24 hours. Acute focal
neurologic deficit developed in five
patients all of whom were investi
gated and managed promptly. Preoperatively, each had severe inter
nal carotid artery stenosis ipsilateral
to the symptomatic hemisphere.
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One had an occluded contralateral
internal carotid artery, two had
moderate contralateral stenosis and
two had no contralateral stenosis.
Notable contralateral disease was
present in 46% (146 patients) of the
whole group. Each of the five pa
tients with acute postoperative oc
clusion of an endarterectomized in
ternal carotid artery are briefly re
viewed.

Case Reports
Case 1
A 53-year-old, non-insulindependent, diabetic man suffered a
right-sided stroke and had mild re
sidual impairment. Cerebral angiog
raphy demonstrated a 95% steno
sis, 1 cm long, of the left internal
carotid artery and a 70% stenosis of
the right carotid siphon.
Left internal carotid endarterecto
my was performed. Approximately 9
hours later, the patient had a dimin
ished level of consciousness, was
unable to speak or move his right
arm and was incontinent. At reoper
ation the left internal carotid artery
was found to be blocked with plate
let aggregates. Thrombectomy was
performed and the artery closed
using a saphenous vein patch. Postoperatively, he had mild residual
weakness in the right hand, un
changed from his initial preopera
tive status. Three years later, his
condition remains stable.
Case 2
For 2 years this 66-year-old man
had episodic weakness of the right
arm and increasingly frequent brief
episodes (2 to 3 minutes) of disori
entation. Digital intravenous angi
ography demonstrated a 99% steno
sis in the left internal carotid artery
and a moderate stenosis of the right
internal carotid artery. The left ver
VOL. 31, NO. 5 SEPTEMBER 1988A2JS

tebral artery was occluded and the
right vertebral artery had a severe
stenosis at its origin.
A left internal carotid endarterec
tomy was performed. Two hours
postoperatively, the patient had a
dense right hemiplegia with facial
droop; he became disoriented and
difficult to rouse. At reoperation,
the lumen of the internal carotid
artery was found to be completely
occluded with white thrombus; this
was removed and the arteriotomy
closed using a saphenous vein
patch. His neurologic function im
proved over the next 24 hours, and
only minimal weakness in the grip
of his right hand remained. At
discharge he had no notable neuro
logic deficit. Follow-up 4 years later
demonstrated no neurologic deficit.
Case 3
A 58-year-old insulin-dependent
woman had a 2-year history of
episodic weakness of right arm and
right lower limb lasting up to 1
hour. A digital subtraction angio
gram demonstrated a completely oc
cluded right internal carotid artery
with a severe stenosis of the left
internal carotid artery and stenosis
at the origin of the left subclavian
artery.
A left internal carotid endarterec
tomy was performed, and saphe
nous vein patch was used to close
the vessel. Ninety minutes postop
eratively she was found to have a
paralysed right hand and weakness
of flexion and extension at the wrist
and elbow. At reoperation an area
of thrombus formation was identi
fied on the intimal surface of the
patch. A second saphenous vein
patch was fashioned for carotid ar
tery closure. Postoperatively she re
gained function in her right elbow
and wrist, but at discharge had little
function in the fingers of the right
hand and no sensation in the sec
ond and fourth digits. Residual defi

cit 4.5 years later consisted of re
duced fine motor function and de
creased sensation in the fingers.
Case 4
This 70-year-old man experienced
episodes of weakness of the right
leg, clumsiness of the right arm and
numbness of the right side of his
face. His symptoms occurred two to
three times weekly and lasted 15 to
20 minutes. He had had a complet
ed stroke in the identical distribu
tion 3 years before, but the symp
toms had resolved. A digital sub
traction angiogram showed a 90%
stenosis of his left internal carotid
artery.
Endarterectomy of the stenotic
artery was performed. One hour
postoperatively he was found to
have loss of extension at the right
wrist, decreased flexion of the right
digits and severely decreased exten
sion of the digits; there was no
sensory loss. In addition his blood
pressure was labile, ranging from
140/60 mm to 9 0 /5 0 mm Hg.
Cerebral angiography demonstrated
a complete occlusion of his left
internal carotid artery.
At reoperation his internal carot
id artery contained fresh red throm
bus. A no. 3 Fogarty catheter,
passed cephalad, retrieved a large
amount of red clot from the vessel.
Good back bleeding was established
and the artery was closed using a
saphenous vein patch. After this
procedure, his right hand grip was
improved. Four years later his fine
motor function was intact.
Case 5
A 67-year-old man suffered a
TIA, noted clinically as tingling in
the right hand. An intravenous digi
tal subtraction angiogram revealed
a severe stenosis in the left internal
carotid artery and an absent left
vertebral artery.
369

EGAN & WALKER

He underwent a left internal ca
rotid endarterectomy with primary
closure of the artery. In the recov
ery room, no neurologic deficit was
noted initially, but 90 minutes postoperatively weakness in the right
hand was noted, progressing over
15 minutes to paralysis. He also
became aphasic. At reoperation, the
internal carotid artery was found to
be kinked at the distal junction of
the endarterectomy and the normal
internal carotid artery. A saphenous
vein patch angioplasty was per
formed. Postoperatively he had
slight lack of coordination of his
right hand, which resolved com
pletely over the next 2 weeks. Two
and a half years later he had no
neurologic deficit.

Discussion
The true incidence of occlusion
early after endarterectomy is diffi
cult to establish. Obviously, the
condition will be recognized only in
patients with symptoms. Asymp
tomatic postoperative thrombosis of
an internal carotid artery has been
documented by digital subtraction
angiography in 1.2% of patients
after endarterectomy.11 Six patients
had strokes postoperatively but the
angiogram was normal in four.11 In
another series,12 postoperative oc
clusion was documented by angiog
raphy in 2 of 48 patients.
The presence of only a mild neu
rologic deficit in two of our patients
(cases 3 and 4) underlines the im
portance of acute awareness of the
possibility of carotid occlusion after
endarterectomy of that vessel. Al
though the published experience
with this complication is scanty, it
appears that if surgeons elect to
reoperate they should do so without
delay.1314 Angiography may be of
value when the diagnosis is not
clearly established, but we believe it
is not required in the presence of an
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extensive, new, appropriately dis
tributed, neurologic deficit.
The cause of early occlusion of
the endarterectomized carotid ar
tery is unclear. Spasm of the distal
extracranial vasculature has been
documented angiographically and
associated with occlusion.15 Embol
ic events have also been document
ed16 in the early postoperative peri
od and could predispose to throm
bosis. Also, technical problems and
perioperative hypotension have
been implicated.17
Our experience supports the poli
cy of monitoring patients in a surgi
cal intensive care unit after endar
terectomy; there, neurologic status
and blood pressure can be closely
monitored. In one instance (case 4),
untreated hypotension may have
contributed to subsequent occlusion
at the endarterectomy site.
When surgery was performed
under general anesthesia a tempo
rary indwelling shunt was routinely
employed to provide cerebral pro
tection and minimize ischemia;918 if
regional anesthesia was used a
shunt was placed only when neces
sary. No patient suffered a focal
neurologic deficit related solely to
the operative period.
Since each of our patients im
proved following re-exploration, it
is our opinion that an aggressive
surgical approach is warranted. A
recent report19 of improved neuro
logic function in four or five pa
tients re-explored for occlusion
after endarterectomy supports our
position. We did not subject our
patients to follow-up arteriography
as a study of long-term patency, so
our assumption that re-establishing
internal carotid flow was beneficial
is open to challenge. Nevertheless,
the prompt reversal of profound
ischemic neurologic symptoms in
three of our patients after throm
bectomy supports our contention
that patients who experience neuro
logic symptoms in the first 12

hours after endarterectomy should
be re-explored or investigated by
carotid angiography.
The beneficial effects of carotid
endarterectomy in reducing subse
quent strokes depend on low peri
operative morbidity and mortality.
Although original operative compli
cation rates reached 18%, more re
cent reports20 indicate that they
may be reduced to the 2% level.
Despite attempts to reduce this rate
even further, there is an inevitable
occurrence of sudden internal caro
tid artery occlusion after endarte
rectomy of that vessel. Since the
incidence of this potentially devasta
ting problem is low, the individual
surgeon’s experience in its man
agement is limited. We suggest
that careful postoperative moni
toring and early reoperation for
any new neurologic deficit may fur
ther reduce operation-related
complications.
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ternational stature, to discuss 47 clini
cal problems ranging from abdominal
abscess to pulmonary embolism to loss
of vision. One chapter is devoted to
each problem, and the chapters are
organized into seven sections — chest,
gastrointestinal tract, genitourinary
tract, musculoskeletal system, head and
neck, cancer staging and miscellaneous.
For each problem a differential diagno
sis is presented, followed by a discus
sion of the available diagnostic modali
ties, including their sensitivities and
specificities, advantages and disadvan
tages, complications and relative cost.
Each chapter ends with a graphic depic
tion of the algorithm or decision tree
recommended to deal with the problem.
The authors stress the need for radi
ologists and clinicians to work together
to develop algorithms that are flexible
and relate to local expertise and equip
ment. Such cooperative effort provides
our best hope of keeping abreast of
technical advances and containing cost
without sacrificing the quality of medi
cal care.
This book should be in the library of
every hospital that trains clinical or
radiology residents. Most of its 47
chapters are directly relevant to the
surgical resident since almost all of the
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algorithms have surgery as an end
point. Established surgeons (and radiol
ogists) who are bewildered or intimidat
ed by the rapid pace of technical ad
vance will also benefit from the wealth
of information that Dr. Eisenberg has
assembled in this timely and compre
hensive text.
D. Ian Hammond, MD, FRCPC
Associate Professor,
University o f Ottawa.
Department o f Radiology.
Ottawa General Hospital,
Ottawa, Ont.

TRAUMA. Edited by Kenneth L. Mat
tox, Ernest Eugene Moore and David
V. Feliciano. 944 pp. Illust. Appleton
& Lange, East Norwalk, Conn., 1987.
$125.00 (US). ISBN 0-8385-9004-7.

In my opinion this is the most compre
hensive, best organized and written text
on the subject. It is current and has
been written by numerous authorities
each representing their field of special
ty. Every aspect from field triage, resus
citation, surgery, intensive care and
rehabilitation is included. Current scor

ing systems, crash models, missile bal
listics and military surgery are dis
cussed. Anyone called upon to deal with
injured patients — the trauma surgeon,
the rural physician or the medical stu
dent — will find the text an invaluable
reference.
The contributors discuss controver
sial treatment, giving divergent opin
ions and expressing their preference in
conclusion. For readers wishing even
greater detail, the references with each
chapter contain the significant contribu
tions to the literature.
Dr. Walt's foreword highlights the
major trauma statistics, which unfortuately place trauma as the major killer of
young adults and the cause of untold
economic loss from morbidity. The
chapters on injury statistics and history
are interesting. The frustrations associ
ated with attempts to develop injury
countermeasures are well supported.
The value of seat-belt and helmet legis
lation is clearly documented. The dis
cussion of the importance of the trauma
centre registries emphasizes that with
out such data it is impossible to develop
treatment protocols and planning effi-

continued on page 372
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ciently and appropriately for a large
region. Fortunately, the large Canadian
health care data banks give us the
opportunity to be leaders in this field.
The authors of the Advanced Trauma
Life Support Course are the contribu
tors to the chapters on “golden hour”
patient management, which provide an
excellent overview of the subject. Trau
ma, radiologic and anesthetic manage
ment are presented in a fashion that
emphasizes the need for a team ap
proach. These chapters are particularly
well illustrated.
The management of head injuries is a
major concern to non-neurosurgeons.
Intracranial, facial, spinal and neck in
juries are described in sufficient detail
to provide satisfying isight.
The several hundred pages devoted
to injuries of the chest and abdomen
are invaluable references to specific
management protocols and are support
ed by detailed reviews and excellent
illustrations and diagrams.
The trauma team, intensive care, des
ignated “captain” approach to decision
making and organization are outlined in
the chapters dealing with critical care
management. The life-threatening com
plications resulting from trauma, inten
sive resuscitation, sepsis and multior
gan failure — their monitoring and
management — are described nicely in
the final chapters.
Trauma is a major contribution to
the literature. It is a library in itself. It
should be required reading for all sur
geons and intensivists, and is a superb
reference for those likely to be called
upon to treat an injured patient. At a
cost of $125.00, it replaces the need to
attend many expensive meetings and
symposia.
Charles M. Burns, MD, FRCSC
Director,
Trauma Services,
Department o f Surgery,
Health Sciences Centre,
University o f Manitoba,
Winnipeg, Man.
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TUMORS OF THE KIDNEY. Interna
tional Perspectives in Urology, Vol
ume 13. Edited by Jean B. deKernion
and M. Pavone-Macaluso. 339 pp. IIlust. Williams & Wilkins, Baltimore,
1986. Price not stated. ISBN
0-683-02426-4.

In this volume, international experts
review recent advances in the manage
ment of renal tumours. They describe
and evaluate the available methods for
early diagnosis and staging, and they
present techniques that have been de
veloped to deal with difficult surgical
urologic problems. In addition, the
book focuses on research into the treat
ment of metastatic disease which re
mains a challenge.
The early chapters deal with current
issues in the diagnosis of renal tu
mours. One conclusion is that comput
ed tomography compares favourably
with other techniques, although it has
limited application to nodal disease or
localized spread. At a practical level, a
cost-effective work-up is presented for a
patient with an asymptomatic renal
mass. This provides a particularly use
ful diagnostic guideline to the practis
ing urologist. One of the more informa
tive chapters deals with paraneoplastic
syndromes, providing insight on how
they may affect diagnosis.
The surgical treatment of complex
lesions is the subject of several chap
ters, and extensive justification is given
for the use of modified lymph-node
dissection, a practice that is not univer
sally accepted. The technical problems
of bilateral renal tumours and tumours
in solitary kidneys are dealt with sepa
rately and thoroughly. This section is
augmented by data on tumours that
extend into the vena cava. Such tu
mours can evidently be treated success
fully unless there is actual infiltration
into the caval wall or distinct metastatic
disease.
Much attention is paid to metastatic
renal cell carcinoma. The authors of
this section discuss their indications for

angioinfarction before nephrectomy. Al
though this technique is not widely
accepted, the authors state their case
for its use, at the same time acknowl
edging that the results of their studies
are inconclusive.
The clinical findings on the efficacy
of chemotherapy are consistent with
past experience, namely, that the re
sults are disappointing. Vinblastine,
chloroethyl-cyclohexy-nitrosourea and
methyl-glyoxal bisgnanylhydrazone ap
pear to give the best palliative results in
terminal cases. Researchers in this field
will be interested in the comprehensive
technical review of experimental chemo
therapy and in-vitro chemotherapy test
ing that is provided. In-vitro testing
with soft agar colonies has given some
useful information on chemotherapy
sensitivity, but practical application of
this method is limited.
New experimental and clinical infor
mation on hormonal therapy is present
ed. There are indications that research
into hormone receptors, analogous to
research relating to breast cancer, may
produce good results. The principal
shortcoming of this volume is the ab
sence of current data relating to immu
notherapy; it includes only a brief his
torical review of the subject.
Although this book is a collection of
articles written by authors with differ
ent perspectives and styles, the editing
has made it into a coherent entity. The
information is presented with scientific
detachment so that the reader is given a
balanced view of the management of
patients with renal cancer. Particularly
helpful are the numerous illustrations
of the technical aspects of surgery that
most residents, and even experienced
surgeons, rarely see. Consequently, this
book can serve as an invaluable refer
ence in hospital and university libraries.
Colin Dinney, MD
Said Awad. MD, FRCSC
Department o f Urology,
Dalhousie University,
Halifax, NS
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Acute Pancreatitis. Experimental and
Clinical Aspects of Pathogenesis and
Management. Edited by G. Glazer and
John H.C. Ranson. 456 pp. Illust. Balliere Tindall, London; W.B. Saunders
Company Canada Limited, Toronto,
Ont., 1988. $95.00. ISBN 0-70201248-3.
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Clinical Imperatives in Surgery and
Orthopaedics. Edited by G.F. Dommisse
and B.G.P. Lindeque. 450 pp. Illust.
Haum Educational Publishers, Pretoria,
1988. Price not stated. ISBN
0-7986-1876-0.

t

Controversies in Breast Disease. Diag
nosis and Management. Edited by Shar
on Grundfest-Broniatowski and Cald
well B. Esselstyn, Jr. 514 pp. Illust.
Marcel Dekker, Inc., New York, 1988.
$150.00 (US). ISBN 0-8247-7880-4.
I Don’t Know What To Say. How to
Help and Support Someone Who Is
Dying. Robert Buckman. 195 pp. Key
Porter Books Limited, Toronto, Ont.,
1988. $19.95. ISBN 1-55013-070-6
(hardcover), ISBN 1-55013-092-7 (pa
perback).
Perspectives in Colon and Rectal Sur
gery. Edited by Theodore R. Schrock.
152 pp. Illust. Quality Medical Publish
ing, Inc., St. Louis, Missouri, 1988.
Price not stated. ISSN 0894-8054.
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Rush University Review of Surgery.
Steven G. Economou, Steven D. Bines,
Daniel J. Deziel and Thomas R. Witt.
426 pp. Illust. W.B. Saunders Compa
ny, Philadelphia, 1988. $35.75. ISBN
0-7216-2070-1.

Canadians all over are
waiting for the gift of a
life-saving transplant.
The Kidney
Foundation of Canada
urges you to sign an
organ donor card.
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ORTHOPAEDIC
SURGEON
The Manpower Committee and the four Or
thopaedic Surgeons of Burnaby Hospital invite
applications for an additional Orthopaedic
Surgeon to join the Medical Staff as a consul
tant.
The new individual would be expected to share
general trauma on-call and be ATLS certified.
An area of sub-specialization would be an
asset.
Fellowship candidates as well as those with a
Canadian Fellowship are encouraged to apply.
Burnaby Hospital is a 386 acute bed community
hospital situated in Greater Vancouver with a
catchment area of approximately 200,000 peo
ple.
Direct written inquiries by October 1,1988 to:
Chapin Key, M.D., M.H.A.
Vice President - Medicine
Burnaby Hospital
3935 Kincaid Street
Burnaby, B.C. V5G 2X6
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NOTICES
British Columbia Surgical
Society Meeting
Vancouver’s Four Seasons Hotel will be
the setting for the British Columbia
Surgical Society’s fall dinner meeting
on Nov. 25, 1988. Dr. Michael Walker,
founder and director of the Fraser Insti
tute, will be the guest speaker. In
conjunction with the dinner, “Trauma
Update 88’’ will be held on Nov. 24 and
25 at the hotel. Further information
can be obtained by calling Ms Tanyss
Noftle (604)736-5551.
Percutaneous Gallbladder
Surgery
A 1-day course concerning a new onestage technique to remove gallstones
percutaneously will be held in London,
England, Oct. 17, 1988. Recent radi
ologic developments will be summarized
and the new technique demonstrated
using live closed-circuit television ses
sions. Please contact: BDI Conferences
Ltd, 9-11 Kensington High St., London
W8 5NP, England.
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CLASSIFIED ADVERTISING
As a further service to its readers the Canadian Journal o f Surgery is pleased to accept suitable
classified advertisements. The deadline is 1 month before issue date. Regular classified rates
(for each insertion): $42.00 for the first 40 words or less, additional words 55<f each
(additional $16.00 for frame). Special Display under 75 words, 2V4 in. X 2 in., $105.00. $6.00
charge (first insertion only) for CJS box numbers. Display rates available on request.
Copy should be mailed to the Canadian Journal o f Surgery, PO Box 8650, Ottawa, Ontario
K1G0G8.
RESEARCH ASSOCIATE: AB - The joint
unjury and diseases research group at the
university of Calgary is seeking a biomechanics
research associate with expertise in biome
chanical testing of ligaments. This individual
must have a PHD or equivalent in biomechanical
engineering and must have experience with
multidisciplinary bench research in the field of
mechanical testing of connective tissues. This
term position is funded from external sources
and is not a university support staff position. In
accordance with Canadian immigration require
ments, priority will be given to Canadian citi
zens and permanent residents of Canada. The
closing date for applications is September 30,
1988. Address all correspondence to: Dr. C.
Frank, Dept, of Surgery, University of Calga
ry, 13 Heritage Medical Research Building,
3 3 3 0 Hospital Drive NW , Calgary, AB T2N
4M 1.
-S88-30
GENERAL SURGEON: ON - An opportunity
exists for a general surgeon to join the staff of
the Oakville-Trafalgar Memorial Hospital. At
present there are 4 general surgeons in this fully
accredited 330-bed hospital. Applications to:
Dr. G. Lloyd, Dept, of Surgery, Oakville-Tra
falgar Memorial Hospital, 327 Reynolds
Street, Oakville, ON L6J 3L7.
-S88-36

CHIEF, DIVISION OF GENERAL SURGERY:
ON - The Children's Hospital of Eastern Ontar
io, a bilingual and progressive tertiary care
facility affiliated with the University of Ottawa,
invites applications for this position which be
comes available following the retirement of the
present incumbent on June 30, 1989. This
should be of particular interest to specialists in
pediatric surgery. In accordance with Canadian
immigration requirement, this advertisement is
directed to Canadian citizens and permanent
residents of Canada. Other candidates will be
considered if no suitable Canadian is found.
Send application with curriculum vitae to: Dr.
Hans Heick, Chairman of the Medical Advi
sory Committee, Children's Hospital of East
ern Ontario, 401 Smyth Road, Ottawa, ON
K1 H 8L1.
-S88-34
CHEF DE LA SECTION DE CHIRURGIE
GENERALE: ON — Ce poste, qui devient disponsible a la retraite du chef actuel le 30 juin,
1989, sera d'interet aux specialistes en chirurgie pediatrique a I'hopital pour enfants de Test
de I'Ontario un hdpital bilingue de soins tertiaires affilie a I'universite d'Ottawa. Aux termes
de reglements canadiens sur I'immigration,
cette annonce s'adresse aux personnes de
nationalite canadienne et aux residents perma
nents. D'autres candidatures pourraient etre
considerees si on ne peut trouver de candidat
canadien repondant aux exigences. Veuillez envoyer votre curriculum vitae au: Dr Hans
Heick, president du Comite consultatif
Medical, Hdpital pour enfants de Test de
I'Ontario, 401, chemin Smyth, Ottawa, ON
K1H8L1.
-S88-35

BIOGRAPHY: — Material for biography of the
late Professor J. C. B. Grant required. Personal
memoirs, anecdotes, photographs, welcome.
Information treated with discretion and material
returned promptly. Reply to: Dr. Clayton Rob
inson, 8 08 - 750 West Broadway, Vancou
ver, BC V5Z 1 H7.
-S88-31
GENERAL SURGEON: NWT - The board is
seeking a general surgeon to join a medical staff
of 7 physicians, to function as a team member
in an isolated location. The Baffin Regional
Hospital is located in Iqaluit (Frobisher Bay) on
Baffin Island. The hospital acts as a referral
centre for 12 outlying health centres in the
eastern arctic and serves a total population of
10 000. The candidate is required to undertake
cesarian sections, general surgery, emergency
trauma and some general practitioner clinical
sessions. Surgical specialists ENT; GYNE;
ORTHO visit on a regular basis from McGill
University affiliated hospitals. Candidates for
this position will preferably be FRCSC and be
eligible for licensing in the Northwest Territo
ries. Competitive salary, generous incentive bo
nus. Benefits: housing allowance; vacation trav
el assistance, paid educational leave, relocation
expenses, dental, pension and insurance plan.
Furnished accommodation. Closing date: to re
main until suitable candidate is recruited. Please
send resume to: Chief executive officer. Head
Office, Baffin Regional Health, Board, Bag
20 0 , Iqaluit, NW T, XOA OHO.
-S88-37
CHIEF, DEPT. OF SURGERY: ON - The
Children's hospital of Eastern Ontario, a bilin
gual and progressive tertiary care facility affiliat
ed with the University of Ottawa, invites appli
cations for the position of Chief, Department of
Surgery. This position which becomes available
following the retirement of the present incum
bent on June 30, 1989, will be of interest to
specialists in pediatric surgery. In accordance
with Canadian immigration requirements, this
advertisement is directed to Canadian citizens
and permanent residents of Canada. Other can
didates will be considered if no suitable Canadi
an is found. Send application with curriculum
vitae to: Dr. Hans Heick, Chairman of the
Medical Advisory Committee, Children's
Hospital of Eastern Ontario, 401 Smyth
Road, Ottawa, ON K1 H 8L1.
-S88-32
CHEF, SERVICE DE CHIRURGIE: ON - Ce
poste, qui devient disponsible a la retraite du
chef actuel le 30 juin, 1989, sera d'interet aux
specialistes en chirurgie pediatrique a I'hopital
pour enfants de Test de I'Ontario un hopital
bilingue de soins tertiaires affilie d I'universite
d'Ottawa. Aux termes des reglements canadi
ens sur I'immigration, cette annonce s'adresse
aux personnes de nationalite canadienne et aux
residents permanents. D'autres candidatures
pourraient etre considerees si on ne peut trouv
er de candidat canadien repondant aux exi
gences. Veuillez envoyer votre curriculum vitae
au: Dr Hans Heick, president du Comite
consultatif Medical, Hdpital pour enfants de
Test de I’Ontario, 4 0 1 , chemin Smyth, Otta
-S88-33
wa, ON K1 H 8L1.
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ThisPTFE gra ft w ill be stabbed,
poked, pierced, pricked,
pinched and contorted
6 times a week.

Under the harsh conditions o f
blood access,
studies show only I
can m aintain high patency rates beyond 5 years.
Hemodialysis is punishing for a
vascular graft. Yet the documented
5-year patency rate of IMPRA®
grafts in blood access applications
exceeds 57%.
To put this into perspective,
IMPRA’s 5 year patency rate is
superior to what any other graft
reports at just 3 years.
Furthermore, published studies
report less infection and 35% fewer
complications with IMPRA, com
pared to other PTFE grafts.
How is this high long-term patency
possible? The reason lies in IMPRA’s
one-piece wall design. An IMPRA
graft has no stiff outer wrap to retard
tissue ingrowth. Healing is faster
and thrombosis is reduced.
For the surgeon, suture retention
is greater than natural vein and the
pliant one-piece graft better con
forms to host vessels.
For the dialysis technician, the
IMPRA graft is easy to palpate.
Needle holes heal fast and of
course, there is no outer wrap
to nick or separate.

IMPRA grafts are available in
11 styles, including Stepped and
Tapered to help manage Steal
Syndrome and Center Flex to avoid
kinking of loop fistulas. For more
product information, fill out the
coupon below. For faster response,
call toll free.

IMPRA’s one-piece design gives higher
long-term patency than wrapped grafts.

The Fine Line of Excellence

Please send more
information on:
□ IMPRA grafts
□ Kelly Wick Tunneler

For faster service call 1 (800) 321-4254.

□ NEW! Dialysis Patient
Handbook

T itle .

N a m e.

Hospital A ffilia tio n .
A d d re s s _________

In Canada:
IMPRA International, Inc.
43 Old Maple Lane
Kitchener. Ontario
Canada N2N 2L2
(519) 742-8472
1-800-321-4254

IMPRA International, Inc.
1625 West 3rd Street
P.O. Box 1740
Tempe. Arizona 85281 USA
(602) 894-9515
Telex No. 910-950-0122
Cable: IMPRAINC

City _
©Copyright 1988
®IMPRA is a registered
trademark of IMPRA, Inc.

Phone.
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Meet some members
of our family
Now a monofilam ent suture
that is easy to handle and tie:

Soft, supple, flexible
• Resists kinking
• Yields secure knots
•Strong

the manageable monofilam ent.

...n o w comes the
Even Greater Stapler

Ultra Light Compact
disposable skin stapler

Automatically released staples
Improved staple visibility
Proven reliability
Allows for excellent accuracy
Quality stapler supplied inexpensively

FO RAD IFFt:r e n c e
YOUCAN1 FEEL.
N E W P R E f CYDE*
(ChkxheaSnc Qua male)

TV Tew Pre-Cyde is the only
germicidal antiseptic hand
wash that combines all the
effectiveness of chlorhexidine
with a gentle emollient to
sooth the skin

IN

1I
;

Pre-Cyde's broad antibacterial
spectrum makes it an excellent
bactericidal and fungicidal

DEXON* PLUS
Excellent knot security plus superior handling
and smoother tissue passage.

Pre-Cyde is safe, virtually
non-irritating,1and has a
pleasant emollient... for a
difference you can feel

quality professional products from
DAVIS+GECK
Cyanamid Canada Inc.
‘ Registered Trademark of Cyanamid Canada Inc.
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